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Abstract
Technological advancements of particle therapy for high-precision cancer treatment
require in situ and in vivo beam range and dose verifications to ensure safe and accurate targeted
dose delivery while sparing healthy tissue and critical organs-at-risk. The use of prompt gamma
(PG) rays, which are emitted as secondary by-products during beam irradiation, have been
proposed as a promising means for in vivo Bragg peak (BP) tracking. Although significant
research efforts have been made worldwide in the past two decades, the technological
challenges for clinically applicable PG detection device development and associated system
integration with the particle therapy treatment still remain to be tackled.
The research effort of this thesis was targeted at those challenges in PG detection
methodology and technology. This work thus spans three major aspects: (i) Systematic Geant4
simulation studies of PG emission and detection characteristics from multi-dimensions of
energy, space and time. This study aimed to determine optimal PG detection methodologies and
technologies. (ii) Characterisation of commercially available advanced scintillation crystals to
explore suitable high-performance detectors for energy- and time-resolved PG measurements
toward a potential hybrid PG detection system. The measurements were performed at the
Australian Nuclear Science and Technology Organisation (ANSTO). (iii) Performance
evaluation of Monte Carlo simulation predictions of PG rays with a dedicated PG spectroscopy
(PGS) prototype system at the Massachusetts General Hospital (MGH) (Boston, USA).
The PG emission characteristics were investigated for the most commonly used particle
therapy ions of proton, 12C and 4He ion beam irradiations of both homogeneous (water, PMMA,
adipose tissue) and heterogeneous (DICOM-formulated head phantom) targets, while the
detectable PG characteristics were investigated by virtue of an air-filled idealised detecting
sphere encompassing the phantoms. Several important results were obtained: the PG signal is a
reliable means for in vivo BP tracking in particle therapy, particularly the primary PG rays;
quantitative data showed that the PG-BP correlation holds for heterogeneous targets as well as
homogeneous ones; a movable detector coordinated with respect to the beam range could
optimise the PG detection efficiency; and the time-of-flight (TOF) information was seen to
correlate with the particle beam range, and so can be utilised not only for interference
background rejection but also for beam range extraction. Hence, a hybrid PG detection system
that utilises the energy, spatial as well as TOF information could offer superior in vivo range
and dose monitoring.
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The energy- and time-resolved spectroscopy capabilities of several scintillation
detectors were characterised, and showed that LaBr3(Ce) offered superior time (34 ns rise time,
790 ns decay time) and energy resolution (3.5% at 662 keV). Elpasolite crystals, such as CLYC
and CLLBC, have not yet been studied for the purpose of particle range monitoring using PG
rays, but have the added ability of gamma-neutron discrimination, and thus have the potential
for hybrid PG systems. In this work, CLYC was seen to offer a good energy resolution of 3.4%
at 662 keV.
The performance comparison between Monte Carlo simuations and experimental data
from the MGH PGS system was the first comprehensive evaluation study of both PG signal
intensity and the interference background in a realistic clinical condition. Several important
results were obtained: the Geant4 QGSP_BIC_HP physics list showed a suitable prediction of
the overall proton-induced PG emission lines, yet it slightly overestimated the PG lines in the
lower energy region (1-3.5 MeV) and underestimated the PG lines in the higher energy region
(5-7 MeV), whereas QGSP_BIC_AllHP provides a better overall spectrum base shape,
compared with the measured gamma spectrum; future PG simulations may benefit from taking
into account potential neutron sources in close proximity to the measuring device, to more
accurately predict the PG signal; and simulation results can greatly depend on the Geant4
version utilised, so it is recommended to perform regression testing on some physical
observables among different versions of Geant4, including the latest one.
In conclusion, hybrid PG detection that utilises multi-features of PG rays in energy,
space and time dimensions is highly recommended. High-throughput and highly efficient
detector systems are needed for simultaneous energy- and time-resolved PG measurements. The
current physics lists in the Geant4 simulation package need further improvement for its
prediction accuracy of PG emissions and interference backgrounds. The studies in this thesis
pave an effective pathway in the development of clinically applicable and reliable PG
procedures and detectors, which can further improve cancer treatment precision and release the
full clinical efficacy of particle therapy.
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1 Introduction
1.1 General Aspects of Particle Therapy
Particle therapy uses beams of charged particles, such as protons or the heavier helium
and carbon ions, to deliver radiation dose to patients for the treatment of cancers. Robert R.
Wilson first proposed the use of protons as a method of radiation therapy in 1946 [1]. The first
patient treatment was performed in 1954 at Lawrence Berkeley Laboratory (LBL), Berkeley
USA [2], and then heavier ions followed at the Bevalac facility at LBL in1975 [3]. Then in 1990,
the first hospital-based proton therapy facility opened at the Loma Linda University Medical
Center (LLUMC) in California [4]. Since then, research and developments have paved the way
for improvements in radiation therapy dose delivery accuracy and techniques. Currently, there
are 98 proton therapy facilities and 12 carbon ion facilities in clinical operation worldwide [5].
The goal of radiation therapy is to deliver a highly localised and uniform dose to the
target volume to kill cancer cells while sparing normal healthy tissue. Unlike conventional
photon beams which have a high entrance dose as well as exit dose, beams of charged particles
deposit most of the energy at the end-of-range with little entrance dose and lateral scattering,
where the particles stop inside the patient at the distal edge of the target volume. The maximum
energy deposition at the particle beam end-of-range is called the Bragg peak (BP), where a
mono-energetic particle beam produces a Bragg curve with a single pristine BP. By summing
several pristine BPs of varied energies, a so-called spread-out-Bragg-peak (SOBP) can be
achieved, where the dose is uniform and maximum across the entire target volume. Hence, dose
can be conformed closely to the target volume. Figure 1 shows the depth dose comparison of
photon and proton (pristine BP and SOBP) beams. Particle therapy therefore has the potential
for higher probability of local control and disease-free survival, and lower probability of normal
tissue damage [6], reducing the risk of side effects and further complications. Additionally, the
enhanced relative biological effectiveness (RBE) of heavy ions is beneficial for the treatment of
radio-resistant or paediatric tumours [7]. However, the ability to fully exploit the advantages of
particle therapy and to release its full clinical efficacy is still limited by various uncertainties in
predicting and determining the beam range within the patient [8]. These uncertainties, which are
discussed in the next section, affect the achievable treatment precision and lead to the
employment of clinical safety margins [9]. Therefore, in vivo range verification and dose
monitoring in real-time are desired so to ensure high quality particle therapy treatment,
eventually limiting collateral effects to organs-at-risk (OAR) close to the treatment target.
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Although much progress has been made, these methods are still unavailable in clinical routine
and this project contributes to fill the knowledge gap, towards a clinical implementation of PG
detection for particle therapy Quality Assurance (QA).

Figure 1: Depth dose curves for photon and proton (pristine BP and SOBP) beams. From Ref. [10].

1.2 Requirements and Challenges of in vivo Range Verification and
Dosimetry in Particle Therapy
In charged particle therapy, there exists an unavoidable technical issue, referred to as
beam range uncertainty [8,9]. Due to the electromagnetic interaction characteristics between
charged particles and human tissues, the beam range is very sensitive to the tissue composition
and density, and further complicated by multiple Coulomb scattering (MCS) and nuclear
reactions. The ion beam BP position and beam range can therefore be difficult to estimate and
determine.
The main causes of beam range uncertainty arise from both treatment planning and
treatment delivery [11]. There exists some degree of errors in converting Hounsfield units (HUs)
of CT images into particle stopping power maps, which can result in an uncertainty in
predicting the beam range in tissues during the treatment planning [9]. To address this problem,
proton CT (pCT) is a technique under development that directly measures relative proton
stopping power with respect to water; uncertainties in proton therapy can be reduced, such that
the uncertainty in converting x-ray CT HU to relative stopping power (RSP) and x-ray CT
artifacts can be eliminated [12-15]. Additional uncertainties arise from patient position set-up
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errors, intra-fractional organ motion and anatomical changes during the course of the treatment
delivery.
These uncertainties can largely affect the treatment accuracy and precision of charged
particle therapy, and the delivered dose may be different to the prescribed dose distribution,
which can result in under-dosing the targeted tumour volume or over-dosing the adjacent critical
structures and healthy tissues. Therefore, conservative safety margins have been generally
adopted in current clinical practices. For example, MGH employs a proton beam range margin
of 3.5% plus an additional 1 mm, which result in about 8 mm of tissue added to the treated
target volume [9]. Yet, with range verification techniques, the margins could be reduced.
Worldwide research efforts have been made to develop clinically applicable detector systems
and procedures for reducing range uncertainties and the safety margins over the past two
decades.
As the technology advances to intensity modulated pencil beam scanning (PBS) with
sharpening beam spots to give the precision of a scalpel [16], the influence of these uncertainties
become more significant, which deeply affect the accuracy of the delivered dose to the tumour
target and limit the advantage of the PBS conformity. Significant challenges of clinical
dosimetry for PBS charged particle therapy have been comprehensively discussed in a recent
review paper, Giordanengo et al. (2017) [17]. In this context, the method of safety margin
would inevitably lose its effectiveness. Spot-by-spot based beam range verification in situ and
in vivo dosimetry for 3D treatment verification is required. The combination of prompt gamma
(PG) ray measurements with 4D CT and motion monitoring has been proposed to control the
range and dose distribution [18].
Moreover, other factors to consider in the clinical implementation of an in vivo
dosimetry system include: the system itself should not physically interfere with the delivery of
treatment; the monitoring process should not lengthen the time in which the patient is in the
treatment room, considering the high throughput of patient treatments and operational costs; and
the system should be able to handle the delivery characteristics of short irradiation times and
high treatment beam intensities [19].

1.3 Overview of in vivo Range Verification and Dosimetry Methods
Several approaches for in vivo range verification and dosimetry have been and are
currently being developed for particle therapy QA. The method can be classified as direct, such
that the beam range is obtained directly from dose or fluence measurements, or indirect, such
that the beam range is determined from other signals. In vivo range verification methods, both
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direct and indirect, have been reviewed in Knopf and Lomax (2013) [20]. Here, indirect
methods will mainly be discussed as they are more relevant to this thesis.
Indirect range verification methods use the by-products of secondary radiations that
occur during irradiation and escape the patient, since the primary beam stops within the patient.
Secondary radiation may include gamma rays, such as PG rays used in the PG imaging (PGI)
method, or photons coming from positron-electron annihilation which are used in the positron
emission tomography (PET) imaging method. Neutrons, along with photons, can also be used to
identify a correlation between secondary radiation and dosimetric parameters [21], but the
associated detection challenges are greater than those of photons. Other methods include
magnetic resonance imaging (MRI), interaction vertex imaging (IVI), secondary electron
bremsstrahlung (SEB), and ionoacoustic tomography.
Prompt gamma for beam range verification in particle therapy is becoming increasingly
popular. While traversing tissue, the incident ions undergo nuclear reactions whereby the
nucleus is excited to a higher energy state, and decays by emitting gamma rays. If the gamma
ray is emitted promptly, i.e. within a few nanoseconds, it is referred to as a prompt gamma (PG).
As the energy of the incident ion decreases in the medium, the total non-elastic nuclear
interaction cross section increases up to a few millimetres before the BP. Then, the inelastic
reaction cross section begins to drop, such that the incident kinetic energy falls below the
Coulomb barrier threshold [22]. Hence, the position of production of PG rays is well-correlated
with the beam range, but it is not exact, as the PG emission and dose deposition result from
different physical processes. Thus, a consistent PG-dose distal fall-off difference is required for
beam range verification [23]. Further details on the physics of PG emission via nuclear
interactions are given in Section 2.1. Since PG rays are emitted within a few nanoseconds
following the nuclear interaction generating an excited nucleus in the medium, they offer the
ability to perform real-time monitoring of the dose delivery. This is a major advantage
compared to PET, for example, which gives a delayed signal and also suffers biological
washout effects. Figure 2 shows a time scale of PG emission compared to PET gamma emission.
Furthermore, PG rays have a wide energy spectrum, up to around 15 MeV [24], which are
unique and characteristic to the element since the excited nuclear states are quantised. The
discrete spectral lines therefore contain valuable information of tissue composition and
elemental concentration for spectral analysis [25]. Other advantages of utilising PG rays are the
absence of washout effects, on-line treatment monitoring without additional dose, and high
count rates [20,23,26-28]. However, the use of PG rays for beam range verification is still
unavailable in clinical routine as challenges remain in detection methodology and technology
(further discussed in the next section), yet significant efforts continue to be pursued and are
discussed in the next chapter of this thesis.
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Figure 2: Schematic showing the time scale in emission of a PG ray and PET gamma rays.

Positron emission tomography (PET) uses coincident 511 keV gamma rays resulting
from electron-positron annihilation. Inelastic interactions of protons with atomic nuclei can
create positron-emitting isotopes (e.g.

11

C,

13

N and

15

O [29]) via β+-decay. Positrons then

annihilate with electrons of the target, resulting in the emission of two coincident annihilation
photons of 511 keV, emitted in opposite directions [30]. For proton beams, β+-activation only
results from induced target fragmentation, whereas for heavier ions the activation may arise
from projectile as well as target fragmentation [31]. Hence the activation is dependent on the
tissue composition, making the relationship between induced activity and dose distributions
complicated, such that the same dose distribution delivered to different geometries/tissue
composition results in different activity distributions [20,32]. Also, the PET signal is generated
from various radionuclides of different half-lives, which translates to a change of the activity
distribution with time, so PET imaging for range verification is sensitive to the time of data
acquisition [31]. Similarly to PG emission, the threshold energies for β + radioisotope production
causes the activity distribution to fall before the incident particle dose distribution fall-off [29].
Hence, PET measurements must be compared with predicted activity distributions [31], such as
from Monte Carlo calculations or a convolution of the dose distribution with a filter function
[20,33]. PET imaging can be performed on-line (during irradiation) or off-line (a certain time
after the treatment is completed) [29]. On-line allows shorter imaging times (however gaining
sufficient statistics is important) and it minimises the effect of biological washout, patient
repositioning errors and anatomical morphological changes since PET data are acquired with the
patient at the treatment position, whereas off-line does not require capital investment for the
installation of a scanner in the treatment room and has no impact on the patient treatment
throughput [20,29,31].
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Magnetic resonance imaging (MRI) reveals changes in the formation of human tissue
caused by radiation. It involves imaging the nucleus of the hydrogen atom (i.e. the proton)
which is abundant in the human body. The angular momentum of a positively charged proton
produces a nuclear magnetic moment. In the absence of an external magnetic field, a collection
of these moments (or spins) will have random orientations which results in zero net
magnetisation, while in an external magnetic field each spin will align either parallel or antiparallel to the direction of the applied field. A radiofrequency (RF) coil is used for signal
reception, to detect the rotating magnetisation, such that the changing magnetic flux through the
coil induces voltage changes that are subsequently detected by a receiver [34]. For beam range
verification, visual inspection of MRI images alone is not sufficient since the location of
greatest signal intensity (SI) gradient does not exactly correspond to the greatest dose gradient,
instead a relationship between dose and SI must be established. A dose-SI curve for fatty
marrow conversion has been established for a data set of 10 spine patients, and used to estimate
range errors in the lumbar spine distal dose fall-off region [35]. Similarly, a conversion has been
established with a data set of 5 liver patients [36]. MRI scanners are widely available, the
imaging offers superior soft tissue contrast and high spatial resolution, with no additional
ionising radiation exposure. However, temporal evolution i.e. side-effects of irradiation (hours
to days later) such as cellular depletion, haemorrhage etc, may interfere with the MRI signal as a
result of fatty replacement. As well, a ground truth dose-SI relationship is essential. In summary,
despite the advantages of MRI, the availability of such scanners, and previous studies showing
promising outcomes, further work is necessary for the use of MRI for in vivo range verification
[20].
Interaction vertex imaging (IVI) is based on the detection of secondary particles (such
as protons that escape the patient) to reconstruct nuclear emission vertices. First proposed by
Amaldi et al. (2010) [37], the technique has been studied in simulations [38-40] and
experiments [39,41,42]. Popular for carbon ion therapy, IVI offers the ability for real-time
monitoring since the secondary particles are emitted and detected promptly during irradiation.
Yet, since the energy of incident carbon ions decreases significantly at the end-of-range, the
corresponding secondary particles produced in this region will also be of low energy and so may
not escape the patient for detection. Hence, IVI may not offer a method to directly measure the
BP position, but using information from the distribution of reaction sites superficial to the BP
can allow indirect localisation [40]. Two methods of IVI for real-time BP localisation have been
described in an early study [38]: single-proton IVI (SP-IVI) where the vertex is reconstructed
using the incident carbon ion trajectory that is determined by a beam hodoscope; and doubleproton IVI (DP-IVI) which detects coincidence between two protons emitted from the same
vertex. This study found SP-IVI to be the more promising technique, with target thickness and
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ion energy having a major influence on reconstructed vertex profiles. In a recent study [40], the
group combined SP-IVI and DP-IVI, using a novel Triangulation IVI technique for reliable submillimetre BP localisation, and developed a software filter used to classify secondary particles
as appropriate candidates for reconstruction. The study also identified the relationship between
the distal edge of the filtered vertex distribution and the BP position using a sigmoid fit of the
entire distal edge, rather than using an inflection point as in previous studies [38,39,41]. With
improved detector technologies, such as a larger area for reasonable statistics to produce useful
images and accurate reference distributions for verification, IVI has the potential to be clinically
implemented for carbon ion therapy range monitoring [40].
Secondary electron bremsstrahlung (SEB) involves the detection of bremsstrahlung
along the beam path to monitor proton [43,44] and carbon ion [45,46] therapeutic beams.
Bremsstrahlung radiation is produced through the acceleration or deceleration of a charged
particle (such as the electron) passing through the electric field of a nucleus. An early
experiment showed that the SEB process provides the dominant bremsstrahlung contribution
[45], and in agreement with simulation results for the characteristic shape of the bremsstrahlung
spectrum, the group demonstrated the feasibility of the method to estimate the ion beam range.
Similar to PGI, a gamma camera is placed perpendicular to the ion path to acquire a distribution
of the SEB production positions along the beam axis, with pinhole cameras [43,44,46] and slit
collimators [43] being used in studies. Since SEB is emitted promptly, the method does not
suffer from washout effects. As well, the sensitivity can be improved since the emission
intensity is relatively large (compared to PG and PET gamma rays) and high-sensitivity imaging
devices (collimators and detectors) can be easily fabricated for low-energy photons such as SEB
[46]. Yet, the SEB method is limited by the background of PG rays, annihilation photons,
scattered beam particles and secondary particles produced by the beam. The distribution of SEB
from carbon beams extends beyond the BP position due to fragment components that penetrate
beyond the BP and generate SEB, whereas this affect is not an issue for proton beams. Further
work is being conducted for SEB therapeutic beam range estimation, where reducing the
interference background and improving detection efficiency and sensitivity are required for
clinical applicability [44,46].
Ionoacoustic tomography employs the thermoacoustic waves generated by the ions as
they traverse tissue, whereby localised heating of the medium and a corresponding pressure
pulse result from the ions’ energy deposition [47]. The ultrasonic pressure waves are detected
by an ultrasound transducer, where the arrival time of the detected pulses relative to the beam
pulse time is directly proportional to the distance from the BP to the detector. This provides the
basis of the BP localisation within the patient [48]. The ionoacoustic signal depends on
parameters such as the beam pulse width, energy, spot size, transducer position and sensitivity,
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and measurement noise, where the signal amplitude corresponds to the dose deposition [47-49].
Multiple transducer detectors may be used to reconstruct a tomographic image of the dose
distribution [49]. Ionoacoustic range monitoring has the potential to be simpler and more
accurate for BP localisation than nuclear-based techniques [47] such as PG, PET and SEB.
Studies indicate the possibility of BP localisation with about 1 mm accuracy [49] and the
potential for sub-millimetre precision with new or next generation ion accelerators [47]. This
method has the advantage of real-time feedback, the spatial resolution is relatively better and
ultrasonic instrumentation is generally less expensive than nuclear-based methods [48].
However, in clinical conditions where the ion energies are high, challenges include an increased
noise, lower signal amplitude (due to the greater spread in dose deposition), density differences
in heterogeneous tissue, and generally higher signal attenuation [47,49]. Since this method relies
on beam pulses, localising the SOBP can also be achieved by monitoring all pulses that make up
the SOBP. Improved resolution, reduced noise and increasing the sensitivity of detection are
necessary for the clinical application of ionoacoustic tomography for in vivo dosimetry in
particle therapy [48,49].
On the other hand, direct methods of in vivo dosimetry utilise detectors positioned on or
in the patient for dose or fluence measurements. Such detectors include diodes [50], metal oxide
semiconductor field effect transistor (MOSFET) detectors [51,52], plastic scintillation detectors
(PSDs) [53,54], thermo-luminescence dosimeters (TLDs) [55], among others. However, direct
methods are invasive, such that detectors may need to be positioned on the patient skin surface
or within body cavities. As well, dosimeters require calibration to obtain dose, they may suffer
from an energy, angular, temperature or LET dependence, sensitivity changes with accumulated
dose, and corrections [56]. These direct dose measurements are generally limited to specific
locations and provide limited information of point doses only. Challenges are not only on the
dosimetry itself, but also on the placement at suitable locations to extract meaningful
information. Hence, indirect methods such as the PG method may be more favourable in
specific cases, particularly because they eliminate the need for invasive procedures.
The PG signal not only offers information on the BP position and range but also
provides tissue composition and density information, which could offer a desirable means for in
vivo dosimetry in particle therapy. That is, range verification is the determination of the BP
position whereas dosimetry requires accurate tissue composition and density information to
convert CT numbers into RSP. The PG signal can provide both information and thus lead to in
vivo dosimetry.
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1.4 Challenges of in vivo Range Verification and Dosimetry Using
Prompt Gamma
This project was aimed at the characterisation and development of PG techniques for in
vivo beam range verification during charged particle therapy treatment and further advancing
toward in vivo delivered dose verification. The PG-based method has been considered as the
most promising since it can provide in vivo, in situ and real-time range assessment during
treatment delivery [57]. Using the PG method, information of range shifts or deviations of the
range from the prescribed treatment plan can be obtained, and the delivered dose distribution in
the patient could be reconstructed with Monte Carlo simulation calculations. Thus, the delivered
dose distribution could be verified in vivo as well.
Several major challenges are currently present in the development of clinically
applicable and reliable devices and procedures regarding the PG method [19,57]. These include:
(i)

PG detection challenges: PG rays are generated from different nuclear reactions and have
a broad and relatively high-energy range (between 2 and 15 MeV) [24], compared to PET,
with strong interference background from neutrons and other stray radiations. PG
detection systems must face a complex compromise or trade-off between the PG signal
and the background. Innovative detection methods, by utilising either or complementary
features of PG ray characteristics in spatial, energy and timing dimensions, are pursued to
extract the PG signal from the background. Several types of detection methods and
techniques, utilising either imaging or non-imaging capabilities, have been proposed and
extensively explored worldwide over the past decade. Such detection methods and
techniques are further discussed in the next chapter of this thesis.

(ii)

PG-based indirect in vivo dosimetry challenges: The correlation between PG emission
and dose is complicated since the two result from different physical processes. Factors
include the knowledge of tissue composition, attenuation of gamma rays within the target,
the yield of PG rays emitted from various tissues and the intensity of the characteristic
emission lines [58]. For accurate dose calculation, not only does the CT number to RSP
conversion need to be accurate, but the detector energy resolution must also be superior to
produce sufficient PG emission spectra. Studies on the correlation between PG
measurements and relevant dosimetric parameters are still mostly lacking.

(iii)

Clinical environment and workflow constraints: These include the limitation of
acceptable device size and weight incorporation into the treatment gantry. A compact and
light weight PG system with low footprint set-up would be more favourable in clinical
practice.
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Beam delivery time structure and intensity constraints: In a PBS treatment, spatiallyresolved range verification requires spot-by-spot assessment. The macro time structure of
the treatment beam imposes extreme load tolerance, electronic throughput capability and
stability of the PG detection system against load leaps. The millisecond-level
measurement time for individual beam spots may have statistical issues for both
mechanical and electronic collimation based PGI systems to obtain adequate statistics for
in vivo range verification.
To overcome these challenges, the PG detectors play a crucial role. Hybrid PG

detection methods with energy- and time-resolved detectors may be necessary to overcome the
challenges of a broad- and high-energy PG distribution with dominating background
interferences. High-resolution and high-performance novel detector systems with fast
electronics for high-throughput processing are required. As reviewed in Pausch et al. (2020)
[19], the key detector parameters required for a hybrid PG system have already been achieved
[59-64], such as an energy resolution of 1.2-1.3% at 6.1 MeV, a time resolution (CRT) of 250
ps at 4.5 MeV, 1 Mcps tolerable detector load, 500 kcps electronic throughput at tolerable
detector load, 0.1% gain stability, and for detector/array sizes of 1 cm2 with 3-5 cm thickness
for sufficient gamma ray absorption. However, achieving these requirements simultaneously for
hybrid PG systems is the challenge.
Furthermore, in vivo range verification and dose monitoring based on a PG method
(developed methods and those under development are described in Chapter 2) would, in general,
rely on comparing the reconstructed PG signal or dose in the patient with expected outcomes
from theoretical calculations, to determine deviations from the prescribed treatment plan. Monte
Carlo simulations, modelling particle transport and interactions in a medium, play a crucial role
in obtaining such expected outcomes, calculating important physical quantities such as spatial
distribution (1D, 2D, 3D), energy spectra or timing profiles [65]. Monte Carlo simulations are
also important in PG system design and feasibility studies, supporting the development of a
detector system for PG range monitoring in particle therapy. Yet, there are challenges with the
Monte Carlo modelling that should be improved to advance the reliability and accuracy of the
predictions for clinical implementation of PG rays for range/dose verification. Important aspects
to consider include improving the accuracy of physics models in Monte Carlo simulations,
increasing the speed of calculations, validation of the applied Monte Carlo codes, comparing
measurements and expected results for heterogeneous targets, and analysing uncertainties
(quantifying the influence of CT calibrations, etc) [65]. These will be discussed further in
Section 2.4.
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1.5 Research Scope and Motivation of this Thesis
Although significant research efforts have been made and prototype detection systems
developed, PG range verification remains absent in clinical routine. Dose monitoring using PG
rays requires further research efforts, particularly on the methodology and technology. The
technique requires real-time BP tracking as well as on-line quantitative element analysis of
tissue in the BP region. The latter can be achieved via PG spectral measurement and analysis,
such that the obtained tissue composition information along with the CT numbers from the
treatment planning system (TPS) may be used to accurately determine the tissue dose. This
thesis therefore spans three major areas of work:
(i) Geant4 Monte Carlo simulations investigating the emission and detection (for an ideal
case) characteristics of PG rays from particle beam irradiations for potential hybrid
systems. Hybrid PG detection systems, utilising multiple features of PG rays
simultaneously, such as energy and TOF information, may significantly improve PG
range monitoring and toward in vivo dosimetry. Recommendations on optimal PG
detection methodologies and technologies resulted from this work.
(ii) Exploring suitable detector technology for energy- and time-resolved PG measurements.
The wide energy range of PG emissions and instantaneous count rates calls for high
resolution, fast and efficient gamma ray detector technology. Thus, experimental studies
were performed to investigate a suitable choice for fast PG measurements from a range
of commercially available scintillation detectors.
(iii) Studying the performance of simulations used for PG range verification and dose
monitoring in a more realistic, clinical scenario. Clinical PG measurements have been
compared to expected outcomes obtained from Monte Carlo simulations to quantify the
accuracy of the results deriving from the in-silico calculations. This study is important
because of the extensive use of Monte Carlo simulations to develop PG detection
systems, and in practice, whereby the PG range/dose monitoring method may rely on
comparing measured data with expected outcomes to determine deviations from the
prescribed treatment plan.
The novelty of this project is such that it combines several areas of research to improve
the techniques (detection methodology and technology) and resources (simulation codes which
play a major role in both research and clinical practice) of using PG rays for BP tracking and
toward in vivo dosimetry in particle therapy. Furthermore, the characteristic properties of PG
emission and detection have been investigated for proton and carbon ion beam irradiation, as
well as helium ions for which the PG distributions have not yet been widely studied. The work
of this thesis will aid in developing optimal strategies of PG detection for real-time dose
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monitoring in particle therapy and support the implementation of clinically feasible PG systems
for improving cancer treatment QA.
The work involved in this project was conducted at three major sites: the Centre for
Medical Radiation Physics (CMRP) at the University of Wollongong, Australia, the Australian
Nuclear Science and Technology Organisation (ANSTO) in Lucas Heights, Australia, and the
Massachusetts General Hospital (MGH) in Boston, USA. Geant4 simulations to characterise PG
emission were performed at CMRP, thanks to the UOW IMTS High Performance Computing
(HPC) Cluster and access to Australia’s National Computing Infrastructure (NCI) Raijin and
Gadi. Detector characterisations to determine a suitable scintillation detector for fast and
efficient PG ray measurements were performed at the Nuclear Stewardship facility at ANSTO.
TOPAS modelling and clinical PG ray measurements were performed in the Radiation
Oncology Research Department and Francis H. Burr Proton Therapy Center at MGH.
Since this project spans across three different areas of work, Chapters 3-5 of this thesis
each present a research topic, while Chapter 2 presents a literature review of particle therapy
and the role of PG rays for in vivo beam range verification and dosimetry. Chapter 3 contains
the simulation work performed at the CMRP to characterise the emission and detection
properties of PG rays. Chapter 4 presents the experimental measurements performed at ANSTO
to characterise several scintillation detectors and determine a suitable choice for PG ray
measurements. Chapter 5 shows simulation and experimental work performed at MGH in
relation to the MGH PG detection system prototype. Finally, Chapter 6 presents a summary of
the research performed and a conclusion based on the findings of this work, as well as future
perspectives.

31

2 Literature Review
2.1 The Physics of Particle Therapy
Charged particles, such as protons, alpha particles and heavier nuclei, undergo two
fundamental interactions with the atoms of the tissue they traverse, electromagnetic and nuclear
interactions. Electromagnetic interactions are Coulomb interactions with atomic electrons –
which results in energy loss via ionisation of target atoms and determines the range of the
particles – or with the atomic nucleus – which results in lateral scattering and determines the
lateral beam spread. Nuclear interactions are particle-nucleus interactions that contribute
significantly less to energy loss but results in the loss of beam fluence and the generation of
various secondary particles such as protons, neutrons, gamma rays and light fragments [22].
Figure 3 shows illustrations of the particle interaction mechanisms.

Figure 3: Illustration of particle interaction mechanisms: electromagnetic interactions (a) inelastic
Coulomb interaction of the particle with atomic electrons (energy loss) and (b) elastic Coulomb scattering
of the particle with atomic nucleus (lateral scattering/beam spread), and nuclear interactions (c) nonelastic interaction of the particle with the atomic nucleus (loss of beam fluence and fragmentation). (p:
proton, e: electron, n: neutron, γ: gamma ray). From Ref. [22].
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2.1.1 Electromagnetic Interactions
2.1.1.1 Energy Loss
For moderately relativistic charged particles (the general case in particle therapy) the
predominant energy loss of the particles is via inelastic Coulomb interactions with atomic
electrons i.e. ionisation and excitation of the atomic shell electrons. An electron ejected from the
atom, called a delta (𝛿) ray, may have enough energy to cause ionisation itself along a separate
track from the primary particle. The energy loss via Coulomb interactions with the atomic
nucleus is minor [65].
The energy loss can be quantified by the stopping power 𝑆 (or LET, described later in
Section 2.1.3) with units of energy/distance given by the differential energy loss for the particle
within the material divided by the corresponding differential path length [66]:
𝑆=−

𝑑𝐸
𝑑𝑥

(1)

The stopping power describes the mean energy loss as it is defined for a beam, not an
individual particle [22]. For a large energy range in terms of mean energy loss and shell
corrections in the Bethe-Bloch formula [67,68], including Barkas–Anderson–Bloch corrections
[69-72]:
𝑆=

4𝜋 𝑁 𝑒 𝑍 𝑍
𝜌
𝑚𝑐
𝛽 𝐴

ln

2𝑚𝑐 𝛽 𝛾
𝐼

−𝛽 −

𝐶(𝛽)
+ 𝑍 𝐿 (𝛽) + 𝑍 𝐿 (𝛽) + 𝐿 (𝛽)
𝑍

(2)

where 𝑒 is the electronic charge, 𝑁 is Avogadro’s number, 𝑚 is electron mass, 𝑍 is the charge
number of the projectile, 𝛽 is the relative velocity of the projectile, 𝑍 is the atomic number of
the material, 𝐴 is the molar mass of the material, 𝜌 is density of the material, and 𝐼 is the mean
ionisation potential/excitation energy of the material. 𝛽 = 𝑣/𝑐, where 𝑣 is the velocity of the
projectile and 𝑐 is the speed of light, and 𝛾 = (1 − 𝛽 )

/

. 𝐶 is the shell correction term, 𝐿 is

Barkas correction, 𝐿 is the Bloch term and 𝐿 is Mott and density corrections. Due to the 1/𝛽
dependence, the energy loss increases as the particle energy decreases. The Bethe-Bloch
formula is generally considered accurate at high energies, while other models are used to
describe energy loss at lower particle energies such as the Lindhard theory [73] (where 𝛽
becomes less than the orbital electron velocity) and the Anderson-Ziegler model [74] (where the
Bethe-Bloch and Lindhard models can be joined by a polynomial). Detailed discussion of the
Bethe-Bloch formula can be found elsewhere [7,69-72].
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As the particles continue to lose kinetic energy, they eventually come to a stop, and so
the range is often referred to as the continuous-slowing-down-approximation (CSDA). The
CSDA range as evaluated from the stopping power is:
𝑅

=

𝑑𝑥 =

𝑑𝐸
𝑑𝐸/𝑑𝑥

(3)

where 𝐸 is the initial energy and 𝐿 is the maximum range. The continuous ionisation energy
losses of charged particles are normally modelled in Monte Carlo codes analytically (down to
~2 MeV), based on a continuous-slow-down-approach that builds on the Bethe-Bloch equation,
including relevant correction factors for 𝑍 [65]. Thus the range (like the stopping power) is
essentially an average quantity defined for a beam, not for individual particles [22]. Figure 4
shows the mass stopping power and corresponding range as a function of proton energy in water.
The Bethe-Bloch formula shows that the energy loss is proportional to the inverse square of the
particle velocity (1/𝑣 classically and 1/𝛽 relativistically) and the square of the ion charge,
with no dependence on the projectile mass. Since the energy loss is predominantly due to
Coulomb interactions between projectile and atomic electrons, the linear stopping power is also
proportional to the material mass density (𝑁 𝜌𝑍 /𝐴 ) [22]. For the same energy per nucleon
the proton range is about three times the range of 12C, while protons and 4He ions have the same
range at the same velocity [69].

Figure 4: Plots showing the mass stopping power 𝑆 as a function of proton energy 𝐸 in liquid water, and
the corresponding range 𝑅 calculated using the 𝑆 values with the CSDA. From Ref. [22].

The shape of the Bragg curve (position and height of the BP) is governed by several
factors such as energy loss and stopping power, the removal of primary particles and the
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emission of secondary particles from nuclear reactions, and the accumulation of lateral
deflections from MCS (see Figure 5). As the particle velocity decreases with penetration depth,
the interaction cross section increases and the energy loss increases, thereby causing the
characteristic BP [22]. Additionally, as the particles slow down they get partly neutralised by
the material through electron pickup, which reduces the particles’ effective charge (𝑍 )
𝑍

or

(which must replace 𝑍 in equation 2) and therefore the Bragg curve exhibits the sharp fall-

off as the particles lose energy and stop [65,66]. The statistical fluctuation in energy loss of the
particles cause the broadening in the BP, generally referred to as energy straggling or
longitudinal straggling. The energy loss straggling is described by the asymmetric Vavilov
distribution [75] that is approximated by a Gaussian function in the limit of many collisions
[76,77]:
𝑓(∆𝐸) =

where 𝜎 = 4𝜋𝑍 𝑍 𝑒 𝑁∆𝑥(1 −

1
√2𝜋𝜎

𝑒 (∆

∆ ) ⁄

(4)

/1 − 𝛽 ) . The energy loss variance 𝜎 can be used to

determine the range straggling variance:

𝜎 =

𝑑𝜎 𝑑𝐸
𝑑𝑥 𝑑𝑥

𝑑𝐸

(5)

From this equation, the range straggling variance as a function of depth 𝑥 in the
material can be written as [78]:
𝑑𝜎
𝑧 ∗ (𝑥)
= 4𝜋𝑁𝑒
𝑑𝑥
(𝑥)

(6)

where 𝑁 is the material electron density and 𝑧 ∗ is the effective charge of the projectile.
The relative range straggling of a particle with energy 𝐸 and mass 𝑀 is almost constant:
𝜎
1
𝐸
=
𝑓
𝑅
√𝑀 𝑀𝑐

(7)

where 𝑓 is a slowly varying function that depends on the material [79]. Due to the 1/√𝑀
dependence, the relative straggling is smaller for heavier ions than for protons e.g. a factor of
3.5 for 12C ions [7,69].
Energy loss straggling varies with distance along the particle track; initially the
distribution is narrow but becomes wider and more skewed with depth, and before the particle
range the distribution narrows again due to the significant decrease in mean particle energy (see
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Figure 5) [66]. Although the energy loss from MCS is negligible, it also contributes to lateral
broadening of the pencil beam and a reduction of beam fluence [22,65].

Figure 5: Left: Shape of a mono-energetic pristine BP (absorbed dose 𝐷 vs depth 𝑧) for an initial 154
MeV broad proton beam. The protonic buildup region (buildup of secondary protons) is mainly attributed
to proton-induced non-elastic nuclear interactions. The sub-peak region is where the stopping power’s
dependence on the inverse-square of the proton velocity is most significant, nuclear reactions cause
removal of protons and liberation of secondary particles, and accumulation of lateral deflections (very
small fields) from MCS. (𝑧 BP, 𝑧 d80, 𝑧 d20: depth of maximum dose at the BP, distal-80% and distal-20%
depths, respectively. 𝑙 80-80, 𝑙 d80-20: 80%-to-80% pristine peak width, distance between distal-80% and
distal-20% depths, respectively). From Ref. [22]. Right: Energy E distributions of an initially monoenergetic beam of charged particles along penetration depth X. From Ref. [66].

2.1.1.2 Lateral Beam Spread
The beam spread is predominantly caused by elastic Coulomb interactions with atomic
nuclei, but secondary particles produced by nuclear fragmentation reactions also contribute to
the spread. Single scattering gives a small deviation angle on average, while plural scattering
refers to a greater number of Coulomb scattering events but less than a few tens of interactions
which occurs in thin targets [69]. In thicker targets, MCS dominates the lateral scattering and
hence the beam spread. A theoretical calculation of the scattering angle was performed by
Molière (1948) [80], and other more practical derivations have been performed [81-84]. For
small angles, the angular spread can be approximated by a Gaussian distribution with a standard
deviation given by [82,83]:

𝜎 [rad] =

where 𝑑 is the thickness and 𝐿

14.1 MeV
𝑍
𝛽𝑝𝑐

𝑑
𝐿

1
1 + 𝑙𝑜𝑔
9

𝑑
𝐿

(8)

is the radiation length of the absorber material. This equation

shows that the angular spread increases for thicker targets and materials of higher atomic
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number. The scattering for a particular particle decreases at higher energy due to the 1/𝛽𝑝𝑐
term [69]. For particles with the same range, the heavier ions undergo smaller scattering e.g. the
angular spread for 12C ions is three times less than that for protons for a 15.6 cm range in water
(150 MeV protons and 285 MeV/u 12C ions) [7].
The angular beam spread in practice arises mainly from two sources: scattering caused
by materials in front of the patient, and scattering within the patient. At low energies, the former
represents the dominant contribution due to the distance (0.5-1.0 m) the beam travels before
entering the patient, while the latter is the dominant contribution at higher energies due to the
larger penetration depths [7]. Although MCS in the scattering foils in the treatment head allows
the beam to spread laterally to useful dimensions in proton therapy, MCS in the treatment head
and patient blurs lateral penumbral sharpness. These factors, as well as implanted metal objects
such as fiducial markers, need to be considered in clinical practice regarding the effects of MCS
[22].

2.1.2 Nuclear Interactions
Charged particles may interact elastically or non-elastically with the atomic nucleus. In
elastic collisions, the kinetic energy is conserved and the nucleus remains intact; they are due to
strong rather than electromagnetic interactions, and although do not occur frequently they still
cause broadening of the beam. On the other hand, in non-elastic collisions the total kinetic
energy is not conserved, whereby the nucleus is transformed and secondary particles may be
knocked out by the projectile [22,65]. As discussed in Section 1.3, it is these secondary particles
that may be used for beam range verification/dosimetry in particle therapy treatment delivery.
To enter the nucleus, particles need to have sufficient energy to overcome the Coulomb
barrier of the nucleus, which depends on its atomic number. The Coulomb barrier can be
described by 𝐵 = 𝑍𝑧𝑒 /𝑅, where 𝑍 and 𝑧 are the atomic numbers of the projectile and target, 𝑒
is the electric charge, and 𝑅 is the distance (cm) at which the Coulomb repulsion can be
overcome [85]. In the atomic nuclei of biologically relevant elements, such as oxygen and
carbon, the total inelastic cross section for proton-induced nuclear reactions has a threshold of
the order of 8 MeV [22].
Gamma rays emitted via de-excitation of the nucleus have energies that are essentially
equal to the difference in energy between the initial and final nuclear states. PG emission
usually occurs without beta decay, depending on the reaction channel, but if so then the gamma
rays will appear with a half-life characteristic of the parent beta decay but with energy reflecting
the energy level structure of the daughter nucleus [66]. Prominant PG ray emissions include:
2.23 and 2.74 MeV (single escape peaks), 5.11 MeV (double escape peak), and 5.62 and 6.13
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MeV (single escape peaks) from 16O; 4.19 MeV (double escape peak), and 4.70 and 5.21 MeV
(single escape peaks) from 15O; and 3.42 MeV (double escape peak), and 3.93 and 4.44 MeV
(single escape peaks) from 12C [86].
The spatial distribution of the absorbed dose is therefore altered by the presence of
nuclear interactions, since some of the kinetic energy that would be deposited as local ionisation
and excitation is instead carried away by neutrons and gamma rays [86]. The correlation
between incident particle dose deposition and PG ray emission is therefore not one-to-one, since
(at typical particle therapy energies) charged particles deposit dose primarly by imparting
energy to atomic electrons through electromagnetic interactions whereas PG rays (and positron
emitter production in the PET method) arise from nuclear reactions.
Nuclear interactions cause a significant loss of beam fluence and a build-up of lower-Z
fragments. This becomes more pronounced with increasing penetration depth, for which the
exponentially diminishing flux of primary particles causes the peak-to-entrance dose ratio to
gradually decrease [7]. Nuclear fragmentation is an important aspect in particle therapy,
particularly heavy ion therapy. In a typical carbon therapy treatment, only 50% of the primary
ions reach the BP while the remaining undergo fragmentation [69]. The fragments contribute to
the broadening of the BP due to straggling, and move (typically forward directed) with
approximately the same velocity as the incident particles, which generally have longer ranges
and thus cause the dose tail beyond the BP (also more pronounced at larger depths) [7]. Figure 6
shows an example of the depth dose profiles of primary 330 MeV/u 12C ions and the associated
secondary fragments (left), and build-up curves of secondary fragments produced by 400
MeV/u

12

C ions (right), in water. In practice, where opposite beams are used, the dose tail is

within the high dose region in the patient, but in single beam angles projectile fragmentation
becomes non-negligible to the normal tissue dose. This is a concern for normal tissue effects in
heavy ion therapy, whereas in proton therapy the concern is target fragmentation [69].
In most Monte Carlo codes, the probability of the incident particles not having
undergone a nuclear interaction after travelling a distance 𝑥, or in other words the number of
particles remaining at depth 𝑥 (which depends on the inelastic nuclear cross section), in a
material is given by:
𝑃(𝑥) =

𝑁(𝑥)
=𝑒
𝑁(0)

(9)

where 𝑁(0) is the number of incident particles, 𝑁(𝑥) is the number of incident particles after a
distance 𝑥, and the mean free path or interaction length is given by 𝜆
the total cross section [65].

= 𝐴 /𝑁 𝜎𝜌, where 𝜎 is
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Figure 6: Left: Depth dose profiles of primary 330 MeV/u 12C ions and the associated secondary/tertiary
fragments in water. Right: Build-up curves of secondary fragments produced by 400 MeV/u 12C ions in
water. From Ref. [87].

The modelling of nuclear reaction processes involving protons and heavier ions are
slightly different; Figure 7 illustrates the reaction process of protons and that of heavier ions
with target nuclei. Proton-nucleus interactions initiate a series of nucleon-nucleus collisions
which leads to the emission of secondary particles and to equilibration of the remnant nucleus.
This process can be described in three stages: intra-nuclear cascade (INC), pre-equilibrium and
de-excitation. The (generalised) INC describes the incident particle interacting with quasi-free
nucleons in the target nucleus through a series of two-body interactions. In pre-equilibrium, the
energy of the particles has reached a lower limit (few tens of MeV) but the nucleus is not yet in
thermal equilibrium. Finally, de-excitation depends on the mass of the target nucleus and the
remaining energy, for which the remaining energy can be dissipated via nuclear evaporation,
fission, Fermi-breakup or gamma emission [65].
For heavier ions, nucleus-nucleus interactions are variants of the abrasion-ablation
model [88]. During abrasion, the projectile and target nuclei overlap and an excited quasiprojectile (with most of the initial velocity) and a quasi-target fragment (at rest) are formed, as
well as several excited light fragments. During ablation, the projectile, target and fragments that
remain de-excite by evaporating light nuclei or fragments. Here, both projectile and target
nuclei can fragment, in comparison to protons where only the target nuclei can fragment [65].
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Figure 7: Top: Illustration showing a nucleon-nucleus reaction for protons, whereby a neutron is created
and a gamma emitted from the residual target nucleus. Bottom: Illustration showing a nucleus-nucleus
reaction for heavy ions, whereby light fragments are created and gamma rays can be emitted from both
residual projectile and target nuclei. From Ref. [65].

2.1.3 Comparison of Different Ion Species
Aside from protons and carbon ions which are used clinically in particle therapy today,
other ions are gaining interest such as helium, lithium, oxygen and neon [89-93]. In this thesis,
proton, helium and carbon ions are studied, so the discussion in this section will focus on these
three particle species. The main differences between protons and heavier ions, such as helium
and carbon, are that heavier ions exhibit reduced multiple scattering inside the patient, result in
a dose tail beyond the BP due to secondary fragments that are produced from nuclear reactions
along the beam path, and have an increased LET, RBE and OER [7,94]. The RBE for heavier
ions is low in the plateau region and increases to a significant enhancement in the BP. The
average RBE for protons is around 1.1 [95], while for carbon ions the RBE distribution in the
target volume varies between 2 and 5 [96,97] and for helium ions between around 1.2 and 2.9
[98,99]. The RBE is largely a reflection of LET, which is related to DNA damage; the greater
the RBE the higher the LET, and in turn, more cellular damage that is less likely to repair, in
addition to improved effectiveness in killing hypoxic cells that are normally radioresistant
[89,100]. Hence, this is related to the OER which, as stated in Tommasino et al. (2015) [89], is
“defined as the ratio of doses under hypoxia to normoxic conditions needed to obtain the same
biological effect”. Lighter ions, such as protons and helium, produce high LET at the distal edge
of the BP only, whereas carbon ions produce high LET in the entire BP resulting in high LET to
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healthy tissue proximal to the BP [89]. Furthermore, the projectile particles caused by nuclear
fragmentation reactions have the same velocity as the primary particles but with reduced mass
and charge. This results in a complex radiation field which contribute a low LET dose to the
tumour, and since low LET particles travel further in tissue they may also contribute to a dose to
normal tissue beyond the BP [7,100]. Due to the 𝑍 dependence of LET, fewer carbon ions are
necessary to deposit the same amount of physical dose as protons. Considering the higher RBE
in the SOBP region, typically 102 times more protons than carbon ions are required to irradiate a
given tumour volume at the same therapeutic dose [57].
Studies have explored and compared the physical and biological properties of various
ions [101-105]. It has been found that the charge collection efficiency for heavier ions is lower
due to less lateral and longitudinal straggling and superior ionisation density. The beam width of
secondary particles was found to be larger for helium ions than for carbon ions, which
corresponds to the lighter fragments originating from the fragmentation of helium ions and since
fragments from heavier ions are more forward directed [104]. Yet, the lateral straggling of
helium ions due to MCS was shown to be about half that of protons [106]. From depth and
lateral dose distributions, the SOBP characteristics for the different ions seem to be consistent.
Helium ions offer a lower fragmentation tail and an advantageous entrance dose compared to
heavier ions, with similar lateral and distal fall-off properties [104]. A recent study [91]
presented a simulation model for therapeutic 4He beams, experimentally validated by means of
physical and biological dosimetries, and showed that detailed treatment planning studies with
such beams is possible. Yet heavier ions remain of clinical interest for certain types of tumours,
such as hypoxic tumours, due to the difference in achievable LET [104].
As with dosimetric comparisons between the ion species, the secondary radiation field
also differs, and hence in the PG emission. Due to the greater number of fragmentations, heavier
ions produce more PG rays than protons per projectile. The PG yields for carbon ions are higher
than those for protons, generally by a factor of 5-6 [57]. The secondary particles are also a
source of PG ray production, both in the build-up region and beyond the BP, justifying the need
for discrimination techniques (e.g. TOF) for carbon ions. The PG fall-off is therefore more welldefined for protons compared to carbon ions, with less background. Hence, it is unlikely that
millimetric precision can be achieved for on-line carbon ion verification with the gamma
cameras currently under development; efficiencies of the order of 10-2 would be required [57].
The prompt photons produced by various ions in a PMMA target were recently studied [94],
where measurements confirmed that 4He beams of therapeutic energy produce non-negligible
prompt photon yields, with resolutions below 2-3 mm obtained in different scenarios,
supporting the feasibility of 4He and 12C beams for PG range verification techniques.
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Unlike protons and carbon ions, clinical data available to support simulations for helium
ions is limited. Although experimental studies have been performed [91,94,106-108], further
measurements of dose profiles and fragmentation cross sections would help to benchmark and
improve the beam models adopted in Monte Carlo codes. Further experimental efforts would
also be beneficial to implement helium (and other) ions in treatment planning software, such as
obtaining RBE data over a wide range of energies and cell lines. This would be important in the
future, where radiation-quality optimised treatments based on particle species selection may be
personalised to the patient and the specific disease [89].

2.2 Gamma Ray Detection and Measurement
2.2.1 General Properties of Radiation Detectors
This section presents general properties of radiation detectors that are relevant to
Chapter 4 of this thesis, where the study on the characterisation of scintillation detectors for
potential hybrid PG detection systems for fast and efficiency beam range monitoring is given.
2.2.1.1 Energy Resolution and Detection Efficiency
The energy resolution of a detector describes its ability to resolve fine detail in the
incident radiation energy, or to distinguish between two energies close together. It is commonly
written as:
𝑅=

𝐹𝑊𝐻𝑀
𝐻

(10)

where 𝐹𝑊𝐻𝑀 is the full-width-at-half-maximum of the detector response function (peak in the
differential pulse height spectrum) and 𝐻 is the centroid of that peak. 𝑅 is therefore a
dimensionless fraction that is commonly expressed as a percentage; the smaller this value, the
better the energy resolution of a detector. That is, the peak width reflects the amount of
fluctuations recorded from pulse to pulse regardless that each event deposited the same energy
in the detector. Semiconductor detectors used for alpha spectroscopy can have an energy
resolution <1%, while scintillation detectors used for gamma ray spectroscopy range from 3%
to 10% [66].
The detection efficiency describes the ability of a detector to record events considering
the number of radiation quanta (particles or photons) incident on the detector. The detection
efficiency is divided into two classes: absolute and intrinsic. Absolute detection efficiency is
dependent on both the detector itself and geometric properties, such as distance from the
radiation source to the detector, and is defined as:
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=

𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑢𝑙𝑠𝑒𝑠 𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑞𝑢𝑎𝑛𝑡𝑎 𝑒𝑚𝑖𝑡𝑡𝑒𝑑 𝑏𝑦 𝑠𝑜𝑢𝑟𝑐𝑒

(11)

Intrinsic detection efficiency mostly depends on the detector material, radiation energy, and the
detector thickness in the direction of radiation incidence, and is defined as:
𝜀

=

𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑢𝑙𝑠𝑒𝑠 𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑞𝑢𝑎𝑛𝑡𝑎 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑡 𝑜𝑛 𝑑𝑒𝑡𝑒𝑐𝑡𝑜𝑟

For isotropic sources, the absolute and intrinsic efficiencies are related by 𝜀

(12)
=𝜀

∙

(4𝜋/Ω), where Ω is the solid angle of the detector subtended from the source position [66].
Further discussion on detection efficiency will be discussed in Chapter 4.
2.2.1.2 Dead Time
The term dead time (or resolving time) refers to the minimum time separation between
two events such that they can be recorded as two individual pulses. The time limitation may
arise from the detector processes or associated electronics. For example, for scintillation
detectors, the dead time is the combination of three time intervals: time taken to produce the
scintillation (i.e. the decay time of the scintillator), time taken for electron multiplication in the
photocathode (order of 20-40 ns), and time taken to amplify and record the signal. The resulting
dead time of a scintillatior is of the order to 1-5 μs, in comparison to gas-filled detectors which
is much larger, in the order of tens to hundreds of microseconds [109].

2.2.2 Conventional Gamma Detector Technology
Here, the focus is on scintillation detectors, outlining the physics of their operation and
performance in terms of timing, since they are investigated as potential PG measurement
devices in Chapter 4 of this thesis. Associated photo-detectors for scintillation light readout are
also discussed, specifically photomultiplier tubes (PMTs) and silicon photomultipliers (SiPMs).
An overview of pulse processing, shaping and timing is also given, which are also relevant for
the study presented in Chapter 4.
2.2.2.1 Scintillation Detectors
Scintillation detectors are used for a wide range of applications, for the detection and
spectroscopy of ionising radiation. The choice of scintillation material is subject to the specific
application, such that there is a compromise between the properties of the particular scintillator.
Ideally, a scintillator should be of high efficiency, the light yield should be proportional to the
deposited energy over a wide range, the decay time of induced luminescence should be short to
generate fast signal pulses, the index of refraction should be near that of glass (~1.5) to allow
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efficient coupling to a PMT (discussed further in the next section) or other light sensor, among
other factors [66].
Scintillation in inorganic materials depends on the energy states which are governed by
the crystal lattice of the material. With energy absorption, electrons can rise from the valence
band (where electrons are essentially bound at lattice sites) to the conduction band (where
electrons move freely through the crystal) leaving a hole in the valence band (electron-hole pair),
and when the electron returns to the valence band the de-excitation results in the emission of a
visible photon. To increase the probability of visible photon emission, small amounts of
impurities (activators) are added to the scintillator which creates energy states within the
forbidden band (between the lower and upper bands where electrons cannot exist in pure
crystals). The energy structure of the de-excitation sites (luminescence centres or recombination
centres) in the crystal lattice governs the emission spectrum of the scintillator [66,109].
From the creation of electron-hole pairs, the positive hole quickly drifts to an activator
site and ionises it while the electron moves freely through the crystal until it encounters such an
ionised activator. The electron can arrive at the activator site and create its own set of excited
energy states. If transition to the ground state is possible in an excited configuration activator
site, the de-excitation will occur rapidly and with high chance of a photon emission. Such
excited states commonly have lifetimes of the order of 30-500 ns [66]. The decay time of the
excited states therefore determines the emitted scintillation light timing characteristics. A
possible scenario that can occur is electron capture at the activator site, termed quenching,
whereby no photon is produced. Moreover, electron-hole pairs can alternatively move together
in a loose configuration referred to as an exciton. They move freely through the crystal until
they reach an activator atom site, where excited activator configurations can again be formed
and scintillation light produced from the de-excitation to the ground state [66,109].
For the detection of photons, scintillators have superior timing resolution and good
energy resolution, whereas for charged particles, they have good timing resolution but
semiconductor detectors have better energy resolution. Gas-filled detectors have very low
efficiency of gamma rays and x-rays compared with scintillation detectors, since the incident
radiation travels through the low-density gas with few interactions. Also, for scintillators, alphaand beta-gamma radiation measurement (simultaneous and separate) can be achieved by pulse
analysis, the size and weight can be much lower, the temperature range is not limited by
condensation, they do not require gas supply or gas refilling, and the uniformity of the response
across the sensitive area is comparable to gas-filled counters. Scintillators are an excellent
choice for particular applications with the advantage of excellent efficiency, high precision, high
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counting rates achievable, relatively simple experimental set-up and accurate energy/intensity
measurement i.e. spectroscopy (particularly for gamma rays) [110,111].
2.2.2.2 Photo-detectors for Scintillation Light Readout
A PMT is an instrument that converts the weak light output of a scintillator into a
usable electrical signal. The main components of a PMT include: a photocathode, focusing
electrodes, dynodes and anode. These components are enclosed within a vacuum tube in order
for low-energy electrons to be accelerated efficiently by internal electric fields, such that the
photocathode is at negative potential and the anode at positive potential. Figure 8 shows the
elements and basic principles of a PMT. The photocathode is a photosensitive layer that
converts the incident scintillation light to a few hundred low-energy electrons (photoelectrons).
Dynodes are electrodes that re-emit electrons once energy is deposited in its surface by incident
electrons. Amplification results in 107-1010 electrons from a typical scintillation pulse and are
then sufficient to serve as the electrical signal for the original scintillation event; this charge is
collected at the photosensitive anode for the output signal. PMTs generally perform
amplification linearly, such that the output pulse at the anode remains proportional to the
number of initial photoelectrons across a wide range of amplitudes [30,66,109].

Figure 8: The components and basic principles of a PMT. From Ref. [30].

A SiPM is a semiconductor device that consists of an array of small avalanche
photodiode (APD) cells (tens of microns) produced using complementary metal-oxide
semiconductor (CMOS) processes on a silicon chip and operated in Geiger mode. Avalanche
photodiodes feature an internal gain through which high electric fields increase the number of
collected charge carriers. Geiger mode refers to the principle that charges produced in the initial
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interaction are multiplied without limit, but quenching by an active or passive external circuit
ceases the self-sustaining avalanche. The avalanche photodiode cells are so small that the
probability for a scintillation photon to hit a cell during a scintillation pulse is low. The number
of cells producing an avalanche is thus proportional to the number of incident scintillation
photons. When operated in Geiger mode, the output of each cell are close in amplitude, and
adding these in parallel generates an analogue pulse where the amplitude is proportional to the
number of photons detected [66].
The time characteristics of a PMT is determined solely by the electron trajectories, since
the time for electron emission in the photocathode and dynodes is very short (0.1 ns or less).
The average time taken for an electron burst to occur at the anode from the corresponding
photon arrival at the photocathode is termed the electron transit time; ranging from 20-80 ns for
various designs of PMTs [66]. However, in most timing applications the transit time is not of
great importance since it generally introduces only a fixed delay in the derived signal. The time
width of the pulse of electrons arriving at the anode is more important. This transit time spread
is primarily due to the distance between the photocathode and first dynode; photocathodes are
therefore usually curved to minimise the affect across its diameter. The variation in emitted
photoelectron velocities is another source of spread in the transit time, but can be minimised by
employing a large voltage difference between the photocathode and first dynode. Operating the
PMT at maximum voltage permissible is generally done for superior timing performance, as a
high inter-dynode voltage can also decrease the effect of time spread in the electron multiplier
region. However, improving the time response of the PMT can be a compromise to the
photoelectron collection efficiency and therefore the electron gain; the time resolution is
basically inversely proportional to the square root of the number of photoelectrons per pulse
[66,112,113].
Photodiodes (or SiPMs) are also effective devices for coincidence and other timing
applications, such that the time response is comparable to that of PMTs since the distances in
which the charges move are relatively small. The rise time of SiPMs is determined by the
avalanche formation rise time and the variation in the transit times of signals arriving from
different points on the sensor’s active area; careful design of the tracking to minimise the transit
time spread can improve the rise time. On the other hand, the decay time of a pulse (or recovery
time of the sensor) is determined by the microcell (operating unit of a single photon avalanche
diode and quench resistor) recharge time constant, given by 𝜏

= 𝐶 (𝑅 + 𝑅 ∙ 𝑁), where 𝐶

is the microcell effective capacitance, 𝑅 is the microcell quench resistor, 𝑅 is any resistance in
series with the sensor, and 𝑁 is the total number of microcells in the sensor. Although the
microcell can respond during the recovery time, the gain will be reduced proportional to the
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reduced overvoltage. The percentage of sensor surface area that is sensitive to light is termed the
fill factor. For a lower fill factor (smaller microcells) the recovery times are shorter and the
dynamic range is larger, but compromises to a lower photon detection efficiency and gain, and
results in lower capacitances [114]. For single-celled avalanche photodiode SiPMs, timing
resolutions on the order of tens of picoseconds are achievable, while for array cells are on the
order of hundreds of picoseconds [66].
Advances in semiconductor photodiodes have led to them potentially replacing PMTs
for particular applications. Photodiodes generally offer higher quantum efficiency and so
potentially superior energy resolution, lower power consumption, compact size, improved
ruggedness and insusceptibility to magnetic fields. However, SiPMs have a nonlinear response
to intense light pulses such that the probability of hitting a cell is no longer low, but a correction
based on an initial calibration can restore linearity. Thermal noise and dark noise are additional
challenges, as is the dependence of SiPM gain, noise and photon detection efficiency on
temperature and voltage [66].
2.2.2.3 Pulse Processing, Shaping and Timing
The output signal from a PMT or SiPM becomes the input to the pulse processing
system, where the series of current pulses occur randomly and typically vary in amplitude and
duration. The system output is generally a count rate (rate of pulses that meet specific criteria)
or an energy spectrum (pulse energy depositions in the detector). The main components of a
typical pulse processing chain include: a preamplifier, shaping amplifier, discriminator or
trigger, and counter or multichannel analyser (MCA). The preamplifier integrates the current
pulse to generate a voltage step that is proportional to the corresponding charge in the detector.
The shaping amplifier then converts this signal into a suitable form, where the output voltage
pulse height is proportional to the deposited charge. The output should return to baseline as
quickly as possible to prevent pulses from overlapping, or pulse pile-up, which in turn distorts
the measurement. High- and low-frequency noise filtering is also performed by the shaping
amplifier to improve the signal-to-noise ratio. The shaping amplifier is therefore characterised
by a shaping time constant that relates to its output pulse duration; a short shaping time
minimises pulse pile-up but is a trade-off to greater noise. Shaped pulses then go through a
selection process; an integral discriminator selects all pulses with height above a particular
threshold, whereas a differential discriminator (or single channel analyser) selects those with
height between upper and lower thresholds. The output result is an accumulation of the selected
events over a certain period of time, which can be presented with a counter or MCA. A counter
simply counts the number of selected events over the certain time period, whereas an MCA
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measures and assigns the pulse height of selected events to a particular range or channel to
produce a pulse height spectrum [66,109].
Signal pulses can either be linear, whereby the pulse amplitude and at times the shape
holds information, or logic, whereby the pulse only carries information through its presence or
particular arrival time. A linear tail pulse has its leading edge time determined by the detector
charge collection time, while its decay (return to zero) is determined by the time constant of the
collection circuit; the latter must be larger than the former to ensure complete charge collection.
The rise time of the leading edge of linear tail pulses is an important property in particular
applications, which is commonly defined as the time interval between 10% and 90% of the
pulse’s final amplitude. On the other hand, the decay time is commonly used to refer to the time
interval between 90% and 10% along the pulse tail. With regards to scintillators, the decay time
characterises the prompt scintillation yield from a material [66,113].
Since the amplitude of pulses correlates to the charge 𝑄 deposited in the detector, pulse
pile-up can be a major issue. Shaping the pulses in such a way that significantly reduces the
pulse tail, but maintaining the proportionality of its amplitude to 𝑄, is an ideal solution. Shaping
may be in the form of a CR (capacitor-resistor) differentiator/high-pass filter, RC (resistorcapacitor) integrator/low-pass filter, CR-RC shaping, Gaussian shaping, active filter shaping,
triangular or trapezoidal shaping. Shaped linear pulses commonly have a time width of several
microseconds only, compared to 50 or 100 μs decay times of tail pulses [66]. Pulses can pile-up
on the tails of preceding pulses which have not completely decayed to zero, such that a
superposition of pulses arises, or there may be an undershoot of the preceding pulse, either of
which result in the amplitude no longer being an adequate measure of 𝑄; referred to as tail pileup. The use of pole-zero cancellation or active baseline restoration techniques can solve these
issues [66]. Another form of pulse pile-up is where two pulses occur so close in time that they
are treated as one pulse; referred to as peak pile-up. This has a major effect on the amplitude of
the recorded pulse, for which the combined pulse will have amplitude equal to the sum of the
two individual pulses. Commercial linear amplifiers are generally capable of discarding pulses
that are expected to be affected by pile-up. Pulse shape discrimination can also be employed,
since piled-up pulses have a different shape to those not affected by pile-up. Digital pulse
processing is a technique which allows rejection of pile-up as well as the possibility to recover
information lost by pile-up [66].
As with pulse height measurement, obtaining timing information is another common
goal in many applications, the accuracy of which depends on the properties of the detector being
employed as well as the type of electronics used for signal processing. The characteristics of
timing heavily depend on the dynamic range (amplitude) of the signal pulses; better timing
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performance is achieved for systems that have signal pulses confined to a narrow range of
amplitudes [66]. Time pick-off units, or triggers, are essential in timing measurements; they are
devices that generate a logic pulse whose leading edge signifies the time at which an input linear
pulse occurs. Sources of uncertainty may be due to time jitter, when the input pulse amplitude is
constant (e.g. electronic noise, statistical fluctuations), or amplitude walk, when the input pulse
amplitude varies. Leading edge triggering is the easiest, most direct and common method,
whereby the pulse is triggered when it crosses a fixed discrimination level. Setting the
discrimination level very low minimises the effects of amplitude walk, but setting the level in a
steep slope region on the pulse leading edge minimises time jitter; optimal time resolution is
achieved for levels set at around 10-20% of the average pulse amplitude [66]. Figure 9 shows
time jitter and amplitude walk in the leading edge triggering method.

Figure 9: Top: Time jitter in leading edge triggering resulting from random noise. Signal pulses with the
same amplitude and shape, but with random noise, are enclosed in an envelope. Bottom: Amplitude walk
in leading edge triggering. Two pulses that have the same time of occurrence and shape, but different
amplitude, cross the trigger level at different times. From Ref. [66].

2.2.3 Challenges of Detector Technology for Prompt Gamma Measurement
As mentioned in the previous chapter, PG emissions from charged particle therapy
present complicated spectral distributions of high-energy, broad range of discrete energy lines
with strong interference background from neutrons and other stray radiation induced continua.
These impose significant challenges on detector technology for PG measurements. Hybrid PG
detection methods are desired to combine the spectral and temporal information of PG rays.
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This requires advanced detector technology with high stopping power, high energy and timing
resolutions for both energy- and time-resolved spectral measurements.
Another challenge is on the detector system load capability for high instantaneous count
rates (~107 events per second) from pencil beam spot scanning. This requires fast detector
response with ultra-fast electronics and data acquisition systems, as well as innovative data
processing techniques such as pile-up rejection, scatter rejection, spectral line extraction, etc.
A recent breakthrough of clinical prototype for proton range verification has been
demonstrated from the Massachusetts General Hospital (MGH) group [59]. This prototype
utilised a high-performance detector array based on LaBr3(Ce) for energy- and time-resolved
spectral measurements of PG rays. The gamma ray backgrounds from neutron-induced and
proton-induced continua can be well resolved and rejected. Then, the discrete PG lines can be
well resolved and obtained in both energy and time dimensions.

2.2.4 Overview of Advanced Detectors for Prompt Gamma Detection
To overcome the challenges stated in the previous section, advanced detectors based on
fast, dense and high light yield scintillators are desirable to provide high-throughput
measurements with high energy and timing resolutions. For a typical PBS treatment, estimating
108 incident protons per second at a beam current of 2 nA, PG timing detection systems should
have a time resolution equal or better than ~200 ps FWHM (i.e. not exceed the minimum bunch
spread of 200 ps FWHM at 230 MeV), energy resolution <5% FWHM at 662 keV (to support
sharp energy cuts and clearly identify PG emission lines), detector and data acquisition counting
rates >106 counts per second to achieve statistics of 104 for the PG rays of interest (to determine
range variations of 5 mm with >80% probability) [60].
Cerium-activated lanthanide halide and cerium bromide scintillators have very
promising properties to meet the requirements for PG detection. Energy resolutions of <3% at
662 keV and timing properties down to 100 ps can be achieved with LaBr 3(Ce) detectors in
optimal conditions, with crystal size being one variable studied and various PMTs [115-119].
CeBr3 has very short rise (<1 ns) and decay (17-24 ns) times, good energy resolution <4% at
662 keV, excellent time resolution of 120-150 ps FWHM for 60Co energies, high count rates and
reasonable photo-absorption probability [60,120-122] (see Table 1). CeBr3 was also found to
have an energy resolution of 2.2% at the higher PG energy of 4.4 MeV, with a time resolution
of 190 ps FWHM [123]. However, CeBr3 is limited by its characteristic scintillation selfabsorption and re-emission processes which cause a lower light yield compared to LaBr 3(Ce).
Yet due to the reduced intrinsic activity of CeBr3, its detection sensitivity is, on average, around
5 times greater than that of LaBr3(Ce) [124].
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Other scintillators are also commercially available, such as SrI2(Eu), GYGAG(Ce),
CLYC, CLLB, CLLC and CLLBC. A study characterising SrI2(Eu), CeBr3 and GYGAG(Ce)
found energy resolutions at 662 keV of 4.0% for SrI2(Eu), 4.4% for CeBr3 and 5.2% for
GYGAG(Ce) [125] (see Table 1). The study showed SrI2(Eu) having an excellent energy
resolution but a very long decay time, whereas CeBr3 had the fastest response with a good
energy resolution, and GYGAG(Ce) had high efficiency with good energy resolution and the
possibility to be produced in all shapes/dimensions.
The

elpasolite

crystal

family,

including

CLYC

(Cs2LiYCl6(Ce)),

CLLC

(Cs2LiLaCl6(Ce)), CLLB (Cs2LiLaBr6(Ce)), CLYB (Cs2LiYBr6(Ce)) and CLLBC (Cs2LiLaBr6x Clx(Ce)),

are very promising scintillation detectors for identifying and discriminating gamma

and neutron radiations. They have been widely studied by several groups [126-131]. CLYC has
an energy resolution better than NaI(Tl) but worse than LaBr3(Ce), yet features at least 100
times less internal radiation than LaBr3(Ce). CLYC also has very high efficiency in identifying
thermal neutrons, particularly if enriched with 6Li as it uses the reaction 6Li + n = 3H + α which
has a cross section of 940 barns for thermal neutrons [132]. The pulse shape produced by
gamma rays is characterised by a quicker rise and decay time compared to the neutron pulse,
while also containing the core-to-valence luminescence (CVL) component of the scintillation
light which is not present in the pulse produced by thermal neutrons. Pulse shape discrimination
techniques can therefore be used to distinguish gamma rays and neutrons. In a recent study, two
CLYC scintillators were characterised, one enriched at 95% of 6Li and another at 99% of 7Li
[125]. Energy resolutions at 662 keV were found to be 4.8% for the crystal enriched with 6Li
and 4.5% for that with 7Li. The decay time for the fast component of the gamma ray signal for
CLYC was found to be 72 ns, while for CLLBC was 89 ns and CLYB was 53 ns [127]. The
gamma-neutron discrimination can be utilised for further improvement of PG measurements;
such study has not yet been reported and is worth for further exploration.
And so, the requirements for a good PG range monitoring system can be achieved with
available detector systems, but achieving the requirements simultaneously for potential hybrid
systems is a challenge. Table 1 presents a summary of scintillation detector performance
achieved in various studies.
When choosing a scintillator for a particular detection system, the applicability should
be explicitly verified and optimal conditions can be achieved depending on the crystal volume,
doping percentage, the PMT used and associated electronics [124,132,133]. A technique known
as co-doping has the potential to increase the scintillation crystal proportionality and detector
mechanical properties, whereby the reliability and energy resolution of the detector are
significantly improved. The non-linearity between low-energy electrons and scintillator photons

2 Literature Review

51

is predominantly induced by non-radiative electron recombination, which is related to hole
mobility in inorganic crystals. Better linearity is achieved with larger hole mobility, and
therefore better energy resolution. Inserting a secondary dopant, such as Sr++ in LaBr 3(Ce) or
Ca++ in CeBr3 can improve detector performance, for example, achieving an energy resolution
of 2% for LaBr3(Ce) and 3% for CeBr3, at 661 keV [133]. Commercial PMTs are generally
matched for a particular scintillator size and coupling mechanism/material. To reach superior
time resolutions, PMTs should be specifically designed and trigger set-ups improved, such that
the time resolution has a dependence on the scintillation decay time and the number of
photoelectrons [123]. Operating the PMT at higher bias voltage and optimising the constant
fraction discriminator (CFD) settings (external delay and walk adjustment) with respect to the
timing resolution have also been explored for improving timing properties [122].
Table 1: Summary of energy resolutions and timing properties of several scintillators published in the
literature, with reference given.
Scintillation
detector

Energy resolution at
662 keV (%)

Rise time (ns)

Decay time (ns)

Timing resolution
FWHM (ps)

LaBr3(Ce)

2.4 [117]

0.7 [134]

15 [134]

107 [116]

3.1 [124]

10 [118]

16 [124]

LaCl3(Ce)

3.2 [134]

~20 [116]

<4 [118]

25 [118]

3.2 [135]

20 [135]

3.5 [117]

~25 [116]

181 [135]

3.8 [136]
CeBr3

SrI2(Eu)

~3.6 [121]

0.1 [121]

17 [121]

4.3 [124]

<1 [120]

17 [124]

4.4 [125]

~18 [125]

17-24 [120]

4.6 [123]

~70 [125]

3.0 [137]

1200 [137]

3.3 [123]

~7000 [125]

189 (at 4.4 MeV) [123]

824 (at 4.4 MeV) [123]

4.0 [125]
NaI(Tl)

6.1 [117]

~210 [116]

9.0 [123]
CLYC

CLLBC

4.8 (95% 6Li) [125]

5 [129]

65 [129]

4.5 (99% 7Li) [125]

72 [127]

4.1 [138]

~55 [138]
89 [127]

856 (at 4.4 MeV) [123]
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2.3 Current Research Status of Prompt Gamma for in vivo Beam
Range Verification and Dosimetry
The use of PG rays for monitoring the beam range in particle therapy was first proposed
by Stichelbaut and Jongen in 2003 [139], and a proof of principle was performed by Min et al.
(2006) [27] with a collimated detector for proton beam irradiation of a water phantom. The
close correlation between the PG emission and the BP position was reported within 1-2 mm
accuracy. Since then, many authors have reiterated the feasibility of utilising PG emission for
range verification, with simulations and experimental work being performed to understand PG
emission during particle beam irradiations and its use for monitoring the BP during treatment, as
well as to optimise PG detection methodology and overcome the challenges of PG detection
technology.
The viability of employing PG rays for in vivo BP tracking for mono-energetic particle
beams of therapeutic energies has been demonstrated [26,91,140-142], particularly for proton
beams with heavier ions, such as helium and carbon, becoming of greater interest. The notion
has also been demonstrated for passively scattered SOBP fields. The good correlation between
the production position and intensity of PG rays with the dose delivered has been shown in
homogeneous and heterogeneous media. However, as the PG production fall-off position does
not exactly equal the dose profile fall-off, since they result from different physical mechanisms,
a consistent PG-BP fall-off difference may be a key factor to enable direct correlation of the
distributions [23,140].
The characteristics of PG emission during particle irradiations have been studied for a
range of target compositions. The gamma energy spectrum has been shown to be characteristic
to the elemental composition of the irradiated material, with emission lines from specific
nuclear de-excitations determined: 16O, single escape peaks 6.13 and 5.62 MeV, double escape
peak 5.11 MeV, and single escape peaks 2.74 and 2.23 MeV; 15O, single escape peaks 5.21 and
4.70 MeV, and double escape peak 4.19 MeV; and 12C, single escape peaks 4.44 and 3.93 MeV,
and double escape peak 3.42 MeV [26]. The PG emission line of 6.13 MeV was found to be
directly proportional to the oxygen concentration in a volume of irradiated tissues, whereas the
4.44 MeV PG peak is dependent on both carbon and oxygen concentration [26]. The relative
intensity of gamma emission peaks was found to be a function of both the elemental
concentration and the physical density of the tissue [143]. Due to the characteristic spectra of
PG rays, which depends on the medium composition, the PG signal can potentially be used to
determine the elemental composition of the irradiated tissue [26,28,140]. A greater yield of lowenergy gamma rays are produced during irradiation, though it is the higher energy gamma rays
that have been found to better discriminate the distal dose fall-off, since these high-energy
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gamma rays experience less scattering when traversing and leaving the target and so their
production has improved localisation with respect to the dose fall-off [27,141].
The capability of verifying the beam range in vivo using PG rays depends greatly on the
design optimisation of not only intrinsically efficient detectors, but also detector position
relative to the target to maximise detection efficiency. The angular dependence of PG detection
has therefore also been investigated [144]. It was found that regardless of proton beam energy,
the total PG and

16

O gamma detection rates were higher at locations proximal to the proton

treatment nozzle, with no significant dependence on the azimuthal angular rotation of the
detector around the beam axis. Another study found that for a narrow angular collimation
window, the PG profile displays a steep fall-off that is well-correlated with the BP, whereas a
wider window allows for gamma spatial profiles to be detected while still exhibiting a good falloff correlation with the BP position [145].
The interference background induced by neutrons presents one main challenge for
accurate BP tracking using PG detection, particularly for heavier ions, such as carbon, due to
nuclear fragmentation reactions. Exploiting the timing properties of PG rays has been shown to
be a promising method for overcoming this challenge. A TOF technique to reject the neutron
background of PGI by means of a shifting 1 ns TOF acceptance window, which accounts for
proton propagation through the patient, has been studied [145] (see Figure 10). The Monte
Carlo codes predicted than at a proton energy of 200 MeV, more than 99.6% of neutrons are
rejected between initial entrance and the proton range. Testa et al. (2010) [142] implemented
this TOF technique experimentally for 95 and 305 MeV/u

12

C beams irradiating PMMA and

water phantoms. A clear correlation was obtained between the carbon ion range and the PG
profile. The study demonstrated that a collimated set-up can be used to detect single photons by
means of TOF measurements at therapeutic ion energies. As well, the detected photon count
rates provide sufficient statistics to allow real-time control of the longitudinal BP position under
clinical conditions [142]. The TOF technique, which differentiates the PG signal from the
interference background, does not only improve the PG signal-to-noise ratio, but could also
eliminate the need for heavy shielding around the detectors in the clinic.
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Figure 10: Yield of PG rays (blue and red) and neutrons (black) registered in the detector, and depth dose
profile for a mono-energetic 100 MeV proton pencil beam, as a function of the longitudinal distance 𝑧 in
a PMMA phantom (purple), without (left) and with (right) a 1 ns shifting TOF acceptance window. PG
profiles are shown for a narrow angular collimation window ∆θ2 (red) and a wide window ∆θ1 (blue).
Simulated data with Geant4 is presented as (1) and MCNPX as (2). Bin width along 𝑧 is 1 mm. Depth
dose was calculated with Geant4 and is given in arbitrary units (a.u.). From Ref. [145].

The behaviour of PG rays during proton beam irradiation is quite well-understood.
Several studies for carbon ions have been performed mainly with TOF techniques [146-148].
However, further research is still required to fully understand the use of PG rays for in vivo
range and dose verification, mainly for other heavy ions which are becoming of greater interest.
Recent dosimetry characteristics studies of helium ions have shown their potential to offer a
more conformal treatment in clinical applications, which would result in increased tumour
control [89,91,104], but the PG emission characteristics from helium ion irradiation have not yet
been widely studied [94]. This knowledge is also required for the development of clinically
suitable and reliable PG detection systems. For accurate and efficient range/dose verification
using PG emission, the detection system is required to measure the high-energy PG rays and
determine with millimetre precision their production position, in addition to excellent timing
resolution (particularly if the temporal characteristics of PG rays are to be employed also).
Detector designs and developments have advanced through the years, but the challenges
of PG detection technology are still present, which inhibit this technique from becoming a
clinically wide-spread application for particle therapy QA. Several avenues of employing PG
rays for range verification have been explored, including imaging and non-imaging modalities.
Techniques to overcome some of the PG detection challenges have also been studied, with a
particular interest in utilising the timing properties of PG rays for discriminating the PG signal
from the interference background induced by neutrons, as well as for BP tracking itself.
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2.3.1 Prompt Gamma Imaging (PGI)
Various imaging detector designs have been explored for locating the position of PG
origination, including passive (mechanical) collimation systems [27,149-152] such as slit
cameras placed perpendicular to the beam direction which offer a 1D projection of the ion track,
and active (electronic) collimation systems [153-156] which rely on Compton kinematics to
trace the gamma source and offer 2D or 3D images.
2.3.1.1 Passive Collimation Imaging System
In the proof of principle study, Min et al. (2006) [27] constructed a multi-layered
collimator system to measure PG rays while moderating and capturing fast neutrons, and
preventing interference gamma rays from reaching the scintillation detector. The correlation
between the PG production distribution and the BP was found to be within 1-2 mm difference in
position at 100 MeV proton beam energy.
In another study, a pinhole camera was designed to image PG rays while shielding
neutrons and stray gamma rays, with the aperture shape and position selected in order to view
the endpoint of the proton range [149]. A 0.2 mm shift in the peak of the total gamma
distribution was observed for an energy variation of 1 MeV. This study showed that pinhole
cameras may be a simple and viable tool for dose deposition verification in a patient, when the
therapeutic beam range is less than a few centimetres.
Slit cameras have also been developed and tested for real-time beam range monitoring
[150] (see Figure 11). The 1D projection of the beam path shows the gamma profile sharply
decrease at the BP, such that gamma rays predominantly produced by primary protons along the
beam path are emitted isotropically and not heavily influenced by scattering before exiting the
target, and so the fluence of these gamma rays indicate the beam range. Gamma rays between 4
and 5 MeV were found to offer the most useful information for identifying the beam range. The
prototype slit camera with knife-edge aperture using the HiCam system in Ref. [150] achieved a
1-2 mm standard deviation on estimating the beam range. A recent Geant4 study by Kim et al.
(2019) [157] for a multi-slit PG camera showed that merging the PG distributions of several
individual spots improved the statistical precision of the measurement. Beam range verification
accuracy within ~1.4 mm error was achieved, demonstrating the viability of the technique to
improve PG statistics. Knife-edge shaped slits provide a larger field-of-view than parallel-edge
slits, and a higher photon collection efficiency can be obtained compared with a pinhole camera.
A knife-edge slit in combination with a position-sensitive gamma camera placed perpendicular
to the beam direction has been studied [151], and results showed that under common therapy
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conditions for proton spot scanning, sufficient data may be collected during one spot-step (~10
ms) to locate the distal dose edge with a 1σ accuracy of better than 1 mm.

Figure 11: Left: Concept of the PGI method with a slit camera, whereby the slit collimation gives a 1D
projection of PG emissions along the beam path on a scintillation detector. From Ref. [158]. Right:
Simulated incident 160 MeV protons (blue) and secondary photons (green) which are emitted and reach
the detector after passing through the collimator. From Ref. [150].

Recently, Richter et al. (2016) [152] performed clinical proton therapy measurements
with a prototype knife-edge shaped slit camera developed by IBA. The prototype consisted of
an array of 40 individual scintillation detectors arranged in two rows and optimised for
detecting gamma rays of 3-6 MeV. The PG depth distribution was measured during passive
scattered proton therapy (PSPT) treatment of a head and neck tumour for seven consecutive
fractions. Inter-fractional global range variations in the range of ±2 mm were obtained for all
evaluated fractions. Xie et al. (2017) [159] also employed a knife-edge slit camera, performing
clinical range verification for a brain cancer patient where the measured profiles of individual
pencil beam spots were compared to predicted profiles from the treatment plan. With a spot
aggregation kernel of 7 mm sigma, 52 spots could be retrieved with accuracy better than 1 mm.
The group demonstrated the feasibility of PGI for in vivo proton beam range verification in
actively delivered PBS on spot-by-spot tracking. However, the count statistics is still one of the
main issues in such systems to achieve higher statistical precision. Petzoldt et al. (2018) [160]
derived a geometrical correction model for a knife-edge slit camera from Monte Carlo
simulations in water. The correction considered four parameters: the beam range, the distance
between collimator and beam axis, the distance between camera and collimator, and the offset in
the beam direction between the BP position and the camera field-of-view centre. The geometric
correction was shown to improve the agreement between simulated and measured PG profiles
which improved range retrieval and the accuracy for absolute range verification.
Mechanically collimated PG cameras may be a more straightforward approach, and the
slit width can be adjusted to optimise system efficiency and resolution, but the neutron
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background and stray gamma rays have presented a challenge in early configurations, requiring
thick layers of collimation. Electronically collimated systems, on the other hand, measure the
position and energy of scattered photons and electrons to reconstruct the location and direction
of incident gamma rays by means of Compton kinematics.
2.3.1.2 Active Collimation Imaging System
Compton cameras use multi-stage detectors in which the energy deposited and position
of each gamma ray interaction is measured while scattering in the various stages of the camera,
and the gamma ray is traced back to its position of origin. That is, from the interaction positions
and deposited energies the direction of the incident gamma can be restricted to a cone with
Compton kinematics. The vertex of the gamma origin is then obtained via the superposition of
the multiple cones. Compton cameras offer an increased efficiency of potentially up to two
orders of magnitude compared to collimated gamma cameras, since performance-limiting
absorbing collimators are replaced by an electronically operating collimator [153-156]. Doublescattering Compton cameras enable direct analytical reconstruction and offer an improved
spatial resolution [154]. Richard et al. (2011) [154] performed a Monte Carlo simulation study
on design guidelines for a double-scattering Compton camera for PGI during ion beam therapy.
In order to maximise the camera efficiency and minimise the spatial resolution, the source-tocamera distance should be considerably small, the detectors should be relatively thick, and the
area of the second scatter detector should be larger than the first with the absorber detector
larger than the second scatter detector. Recently, Draeger et al. (2019) [161] demonstrated the
feasibility of a single Compton camera prototype to perform 3D PGI for proton range
verification; detecting beam range shifts as small as 2 mm for a 2 Gy spot. A three-stage
Compton camera has also been studied in terms of design specifications and to determine its
feasibility to measure and image PG rays emitted during proton beam irradiation [155] (see
Figure 12). Geant4 was used to model three high-purity germanium detector stages arranged in
parallel-plane geometry, with an isotropic gamma source (0-15 MeV) used to determine the
lateral width and thickness of the detector stages that yielded the optimal detection efficiency,
and then a proton beam (50-250 MeV) irradiating a tissue phantom used to determine the
overall efficiency of the camera. Overall efficiencies varied from ~10-6 to 10-3 PG rays detected
per incident proton, and the suitability of a three-stage Compton camera for PGI during proton
therapy was demonstrated. In order to minimise the radiation damage resulting from neutrons,
as well as the cost, and the need for cryogenic coolants in the case of high-purity germanium,
room-temperature alternatives such as cadmium zinc telluride (CZT) and cerium bromide
(CeBr3) would be more suitable. CZT is a semiconductor detector which offers good energy
resolution for high-energy gamma rays, yet it lacks in sensitivity for high-energy gamma and is
poor for timing measurements. Alternatively, CeBr3 is a scintillator which offers good energy
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resolution, excellent sensitivity and timing for high-energy gamma measurements. The
feasibility and effectiveness of using the stochastic origin ensemble (SOE) algorithm for
reconstructing proton pencil beam images from a three-stage Compton camera and for
modelling the distal fall-off of secondary gamma emission has also been demonstrated [24].
Yao et al. (2019) [162] proposed modifications of origin ensembles with resolution recovery
(OE-RR) algorithm based on Markov chains [163] to accelerate the algorithm and improve
image quality. The modifications were in calculating the acceptance probability to implement
ensemble transitions, using random sampling method in sequence to obtain the initial event
density distribution in the volume of interest based on corrected values, and a correction for the
finite energy resolution. The results demonstrated good resolution recovery and accurate
estimation of the PG emission peak and distal fall-off with significantly faster reconstruction.

Figure 12: Concept of a three-stage Compton camera (two scatter detectors and one absorber detector).
The gamma rays with energies (E0, E1, E2) scatter in the detectors (D1, D2, D3) with Compton scatter
angles ( θ 1, θ 2). The projected cone (into the target/patient) is used to reconstruct the images. The
interaction position and energy deposition in each detector is shown. From Ref. [155].

An alternative method, such as the electron tracking Compton camera (ETCC) has been
developed for reconstructing 3D tracks of scattered electrons in the Compton process for subMeV and MeV gamma rays [164]. The direction of the incident gamma ray is determined for
each individual photon by measuring the direction and energy of the recoil gamma ray as well
as the scattered electron. Background rejection is realised with Compton kinematics of a
residual measured angle between the recoil electron and scattered gamma ray. The ETCC
comprises of a gaseous time projection chamber (TPC) for 3D tracking of the electrons, and
pixel scintillator arrays (PSAs) for detecting recoil gamma rays. Tests have been performed with
140 MeV proton beam irradiation of a water target [165]. The TPC (10 × 10 × 15 cm3) was
filled with Argon and C2H6 (9:1) at 1 atm pressure, based on micro pixel chamber (μ-PIC). The
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PSAs were GSO(Ce) (6 × 6 × 26 mm3) coupled to a multi-anode PMT (H8500). The overall
efficiency of the system was determined to be ~3×10-6. 2D PG images showed correlation to the
BP position, but further study and improvements are required.
Gamma electron vertex imaging (GEVI) was explored in a simulation study by Kim et
al. (2012) [166]. The technique relies on the conversion of high-energy gamma rays, by
Compton scattering, to electrons which are subsequently traced by hodoscopes to determine the
location of the gamma source of vertices of the nuclear interactions. A prototype system was
developed for proton beam range measurements [167]. It comprised a beryllium (Be) plate, two
double-sided silicon strip detectors (DSSDs), a plastic scintillation detector, as well as dedicated
signal processing and DAQ systems. The 1.08 mm thick Be plate (electron converter) was
chosen to ensure a high probability of Compton scattering and limit MCS on the converted
electrons. The DSSDs were used to determine the trajectories of the converted electrons, each
with an active area of 50 × 50 mm2 and 16 strips on each side, with thickness of 150 and 300
μm for the first and second layer, respectively. The plastic scintillator (100 × 100 × 20 mm3)
measured the energy of the converted electrons. Triple coincidence logic and multiple energy
windows were used to select only PG events. The detectors of the GEVI prototype were
evaluated for electronic noise, energy and timing resolution, with the imaging capability tested
with a 90Sr beta source, a 60Co gamma source, and a 45 MeV proton beam incident on a PMMA
phantom. The study showed promising results for imaging PG vertices from proton irradiation.
More recently, Kim et al. (2018) [168] performed experimental measurements of GEVI for
proton therapy and determined a beam range verification accuracy within 2.7 mm. Although the
group demonstrated the feasibility of GEVI for real-time beam range monitoring, further work
for practical clinical applications are necessary, such as experiments for various number of
protons, phantom materials, and beam incidence position and size. Though, the technique is
promising since GEVI requires no mechanical collimation, provides higher imaging sensitivity
than other PGI systems, and offers the potential to obtain images of almost no noise, i.e. using
triple-coincidence logic and triple energy windows, only trajectories of the electrons produced
from the PG rays can be selected, thereby effectively excluding proton and neutron signals from
the detection system [168].
In conclusion, extensive work has been carried out in the area of PGI for BP tracking
during particle therapy treatment delivery. However, the count statistics remains a major issue
in PGI systems to achieve higher statistical precision of in vivo beam range verification. The slit
cameras only offer 1D range information in the longitudinal beam direction, lacking information
in the lateral spread. Compton cameras may offer 2D or 3D imaging but such systems suffer
from challenges in detectors and image reconstruction to achieve clinically acceptable images
[169]. Other monitoring techniques using PG rays are also being explored, which take
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advantage of specific characteristics of PG emission. For example, novel techniques exploiting
the temporal properties of PG rays have the potential to offer a simpler means of beam range
verification, and eliminate the need for expensive, bulky equipment in the clinic. The following
non-imaging approaches for in vivo beam range verification have an advantage of low footprint
detector set-up in clinical practice.

2.3.2 Prompt Gamma Spectroscopy (PGS)
This method of beam range verification directly relates measurements of discrete PG
lines to nuclear reaction cross sections. Verburg et al. (2014) [170] studied this concept with the
aim to develop a method entirely based on quantitative physics models and is robust in the
presence of tissue with an unknown elemental composition. Differential cross sections were
measured for 15 PG lines from proton-nuclear interactions with 12C and 16O at proton energies
up to 150 MeV. Fitting measured cross sections with detector models, an optimisation method
was developed to simultaneously determine the proton range and the composition of the
irradiated tissue. A small-scale prototype detector was also used to test experimentally this
method with various phantoms. Cerium-doped lanthanum (III) bromide (LaBr3(Ce)) crystal was
used as the primary detector, read out by PMTs, with a tungsten collimator (127 mm thickness,
9.5 mm slit opening). The prototype achieved statistical precision of ~1 mm standard deviation
for absolute range verification and 0.4 mm for relative verification, based on 5 pencil beams
delivering 5 × 108 protons. However, improving the detection efficiency by an order of
magnitude was anticipated to be feasible for a full-scale system and can achieve the clinically
required dose for millimetre accuracy [170]. More recently, preliminary experimental
measurements of the full-scale prototype were published in Hueso-González et al. (2018) [59].
The energy- and time-resolved spectral measurements of PG rays were employed with slit
collimation and integrated with a Monte Carlo simulation-based treatment planning system. In
realistic clinical conditions, the clinical prototype can verify the absolute range of the proton
pencil beams with high spatial precision (1.1 mm). In this approach, the temporal information of
PG rays was used to reject the background gamma rays from proton-induced and neutroninduced continua, but the temporal information could further be employed with hybrid PG
detection systems for extracting beam range information.

2.3.3 Prompt Gamma Timing (PGT)
PGT is a novel method of range assessment proposed by Golnik et al. (2014) [171],
which is based on an elementary physical effect whereby ions traversing tissue have a time
interval of transit from entering the patient to stopping in the target volume. It has been
determined that protons with a 5-20 cm range have a 1-2 ns transit time. Since the transit time
increases with the particle range, there are measureable effects in the PGT spectra that can be
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used for beam range tracking. The PGT spectrum was defined in this study as the transit time of
the ion through the material as well as the flight time of the PG ray to the detector. In this study,
kinematical relations were used to describe the relationship between PG emission and resultant
time profiles. The technique was explored for homogeneous and inhomogeneous targets. Proton
irradiation experimental measurements were also performed to verify the concept, at the AGOR
cyclotron KVI-CART University of Groningen. The proton beam energy was fixed at 150 MeV
for all the experiments, with various PMMA and graphite targets irradiated, and PGT spectra
measured with a GAGG(Ce) scintillator coupled to a Photonis PMT. Model calculations
precisely reproduced the experimental results. The analysis was focused to an energy window
ROI set to 4.3-4.5 MeV. The proton transit time was shown to directly correlate to, and be
measurable, with statistical moments such as the mean μ and standard deviation σ of the PGT
spectra, and hence also correlate to the proton range (see Figure 13). A change in the target
position corresponded to a change in the PGT spectrum mean. Increasing the thickness of
protons traversing the target from 5 to 15 cm led to a broadening in the PGT spectra, which was
also observed when increasing the beam energy from 50 to 230 MeV corresponding to a change
in the range from 2 to 17 cm. Range variations of 2 mm were expected to be clearly detectable
with this monitoring approach [171]. More recently, Werner et al. (2017) [172] demonstrated
the feasibility of the PGT method to enable range verification with 2-3 mm accuracy in clinical
conditions. Six PG detection units were employed, each consisting of a 2” × 1” diameter or 2”
× 2” diameter CeBr3 scintillation detectors, with no collimation hardware; the use of multiple
detectors improves the measured statistics. The main limiting factors of this method were
identified as the long-term phase shifts and strongly damped phase oscillations between the RF
and proton bunches after changing the beam energy between PBS layers. Yet, introducing a
bunch phase monitor may improve the accuracy of the method. Further work by the group is
being conducted to construct a ‘PGT snout’ that integrates up to 8 CeBr 3/U100 detection units
in the beam delivery system of the proton therapy facility [172]. Unlike PET and other
collimated PGI systems, PGT is based on straightforward measurements with an uncollimated
detector, and could perhaps be used for active treatment control [171].
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Figure 13: Range-dependent mean 𝜇γ (left) and standard deviation 𝜎 γ (right) values of modelled PGT
spectra. Proton energies are in the range of 50 to 230 MeV, corresponding to proton ranges of 2 to 27 cm
in a PMMA target. The assumed system time resolution is 450 ps. From Ref. [171].

2.3.4 Prompt Gamma Peak Integration (PGPI)
PGPI is a technique that has also been introduced as a simple and cost-effective means
of detecting deviations from the prescribed treatment during particle therapy, using the integrals
of uncollimated PG timing distributions. As with the PGT method, the correlation of the mean
value and width of TOF distributions with the energy and range of incident particles is utilised.
However, this PGPI technique uses, in addition, the integral to verify the beam range and
energy deposited, thus approaching in vivo dosimetry. Krimmer et al. (2017) [173] performed
measurements with 65 MeV protons, where the proton range inside a homogeneous PMMA
target was varied using a modulator wheel. Scintillation detectors LaBr3(Ce) (25.4 × 25.4 ×
72.2 mm3) and BaF2 (hexagonal shaped, with an edge length of 50 mm and length of 140 mm)
were positioned at 90o or 45o, with respect to the beamline, to reduce background events (since
neutrons are predominantly forward emitted). PG rays registered with the LaBr 3(Ce) scintillator
were read out via a dedicated DAQ card. The high frequency signal of the accelerator served as
time reference for determining the TOF. The measured variation of the PG TOF peak integrals
as a function of the modulator position was found to be consistent with simulations. With 108
incident protons and detectors covering a solid angle of 25 msr (corresponding to a diameter of
3-4 inch at a distance of 50 cm from the beam axis), deviations of a few per cent in the PG count
rate can be detected. For the configuration in the study, this change in count rate corresponded
to a 3 mm change in the proton range in a PMMA target. A displacement of the target toward or
away from the detector alters the PG count rate due to the difference in the absorption, whose
effect is of the same order of magnitude as a possible deviation to be detected. Moreover,
simulations showed that the signals from multiple detectors may be combined as ratios to obtain
information about the target placement or as (geometric) mean which is independent on the
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actual target position. This technique may be a simple monitoring device used independently
from other monitoring devices of the beamline [173].
Each approach developed to utilise PG rays for beam range monitoring for particle
therapy treatment delivery has its own advantages and limitations. The techniques however
exploit one specific feature of the PG rays (such as spatial in PGI, energy in PGS and time in
PGT), where complementary features are used for event filtering (such as using timing
information in PGI and PGS for reducing background interference caused by neutrons) rather
than extracting range information [19]. Hybrid detection methods may instead be essential in
overcoming the challenges of a broad- and high-energy PG ray distribution, significant
interference background, high instantaneous count rates, and compatibility constraints with
patient irradiation. This therefore calls for systematic studies of PG ray emission and detection
characteristics in multi-dimensions of space, energy and time.

2.4 The Role of Monte Carlo Simulations in in vivo Dosimetry Using
Prompt Gamma
Monte Carlo simulations play a crucial role in in vivo range and dosimetry verifications
with PG rays because such verifications are based on comparisons between measured data and
predicated ones. The role of simulations and PG has been reviewed by Krimmer et al. (2018)
[57] and that of Monte Carlo simulations in the context of range uncertainties discussed by
Paganetti (2012) [9]. In this section, some of these aspects are mentioned but focus is placed
upon the topics of relevance to this thesis.
Simulation tools are not only employed for the research of PG rays as reviewed in the
previous section, they are also used clinically as a means of comparing the obtained
measurements with expected outcomes. The predicted results are obtained from simulations that
are based on specific DICOM data (patient planning CT volume and treatment plan) and beam
models (radiation quality). Thus, it is important that the physics models and data in the
simulation are accurate and reliable, since the production of PG rays depends on the particle
energy and target nucleus [57].
The predicted outcomes may be obtained via Monte Carlo or analytical methods. Using
Monte Carlo to simulate PG emissions for treatment plans can be very time consuming [174176]. Ways to improve efficiency include, for example, a GPU-oriented implementation of the
Monte Carlo engine, such as goCMC which can accurately calculate dose within a few tens of
seconds (without electron and neutron transport) and CUDA gPMC which can improve the
efficiency by three orders of magnitude [177,178]. Approximate methods, such as condensed
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history transport and basic Variance Reduction Techniques (VRT), can also improve efficiency,
which are already implemented in most Monte Carlo packages [179]. Analytical models using
ray-tracing is more efficient, whereby PG emission profiles are generally precomputed with
Monte Carlo simulations (e.g. PENELOPE [180]) and scored in tables while getting proton
differential cross section data from ICRU report No. 63 [181] [57].
In the work of this thesis, the Monte Carlo simulation tools Geant4 (GEometry ANd
Tracking) [182,183] and TOPAS (TOol for PArticle Simulation) [184] were employed to
investigate PG rays for range verification and toward in vivo dosimetry in particle therapy.
Geant4 is a Monte Carlo code written in C++ and uses the Object-Oriented Technology for
simulating the passage of particles through matter [185]. It is used from High Energy Physics to
medical physics, nuclear and accelerator physics, as well as space science. Geant4 provides a
complete set of tools for radiation physics related problems, including extensive physics
capability coupled with powerful geometry functionality. It also has other components, such as
tracking, detector response modelling, visualisation, event biasing techniques, analysis, etc
[186]. TOPAS is dedicated to proton therapy simulations. It wraps and extends the Geant4
simulation toolkit with a unique parameter control system that allows the user to assemble and
control a rich library of simulations objects, such as geometry components, particle sources,
scorers, etc, with no need to write C++ code. However, simulation objects in C++ code may still
be implemented in TOPAS via an extension mechanism. The full flexibility of Geant4 can be
exploited while user-written objects benefit from underlying functionality of TOPAS base
classes and the parameter system [187].
Geant4 has been extremely popular for the development and clinical implementation of
particle therapy techniques. Validation studies of the Geant4 models for protons [174,188-193],
carbon ions [174,194-199] and helium ions [200] have been performed. TOPAS has also been
used in several studies, particularly for proton therapy applications [201-204]. A validation of
TOPAS was performed for proton therapy treatments with passive scattering at MGH based on
routinely performed QA measurements [205], and the feasibility and accuracy of TOPAS for
carbon ion therapy has been investigated [206].
In terms of calculating the stopping power and particle range in Monte Carlo, the main
uncertainties are from the material density and the ionisation energy 𝐼 in water. As mentioned
in Section 1.2, stopping powers obtained from CT scans have uncertainties, such as calibration
of the CT scanner and conversion from HU. Stopping power models in Monte Carlo are
typically benchmarked with standard QA in-house dosimetry measurements performed with
ionisation chambers, calorimeters, and Faraday cups. The validation of these models at
therapeutic energies is important [65]. In terms of the PG emission and yield, uncertainties in
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modelling nuclear interactions are mainly from cross sections, where total cross sections and
double differential (energy and angle) cross sections are most relevant. Uncertainties also arise
when tissue composition is inferred from CT scans. Dosimetry can assist in the validation of
nuclear models, which can be done in-house with Faraday cup measurements, but it is often
impossible to perform direct experimental validation [57,65].
Several studies have evaluated nuclear models for secondary particle production and
depth-dose profiles, and quantitatively characterised PG emission yields with Monte Carlo
codes [174,207-212]. Differences of the PG emission between Monte Carlo codes and existing
evaluated data exist depending on the target and gamma line under consideration. Le Foulher et
al. (2010) [207] compared simulation with experiments and found that simulations overestimate
PG detection yields by a factor of 12. Verburg et al. (2012) [143] simulated proton-induced
nuclear reactions using Geant4 and MCNP6 with TALYS and EMPIRE, and optimised input
parameters and model selection. The results were compared to evaluated ENDF/B-VII cross
sections, where model estimates of the total gamma production near the end-of-range differed
by a factor of about 2. Recent efforts to assess and improve the accuracy of PG productions in
Geant4 physics for particle therapy have been reported. Dedes et al. (2014) [208] found
improvements of the Geant4 hadronic models when decreasing the width of the Gaussian wave
function in the QMD model. Jeyasugiththan et al. (2015) [209] found that the precompound
model with modified initial exciton state of 2 produced more accurate discrete gamma lines in
comparing with available gamma production cross section data. Vanstelle et al. (2017) [212]
found INCL++ to more accurately reproduce PG emission compared to BIC and QMD, in
comparing with experimental data. Further work is required for the improvement of hadronic
models and differential cross sections as well as PG yield measurements from particles at
clinical energy range [22]. Although experiments have been performed for protons [170,211,213]
and carbon ions [94,148,214] to evaluate PG emission yields, more precise nuclear physics
models and accurate data for predicting the PG distribution are necessary in clinical routine [57].

2.5 Further Research Required in the Prompt Gamma Method
After years of research, the first clinical application of PGI-based range verification was
performed with the knife-edge slit camera design by Richter et al. (2016) [152], with successful
measurements of PG profiles during proton therapy, obtaining inter-fractional global range
variations in the range of ±2 mm for all evaluated fractions. With the same camera design, Xie
et al. (2017) [159] also performed clinical measurements and obtained range shift precision
better than 2 mm. However, despite the developments for using PG rays to promote in vivo

2 Literature Review

66

particle beam range verification and beam dose delivery in real-time, the technology remains
clinically unavailable.
Dedicated detector systems are required to overcome the challenges of the broad PG
energy spectrum, large background, high instantaneous count rates, and compatibility
constraints with patient irradiation [24,28,140]. Hybrid detector systems, which utilise more
than one feature of PG rays for extracting range information or dosimetry have potential, but a
system that meets the requirements of such PG measurement require further research efforts;
excellent energy and time resolution, high-throughput spectroscopy, and comprehensive data
analysis and reconstruction [19]. As well, although studies have shown a good correlation
between the PG production position and dose delivered, there is no exact one-to-one
relationship representing this correlation since they result from different physical processes.
Hence, numerous factors influence the accuracy of beam range and dose verification using PG
rays, including also changes in the primary particle energy and phantom properties [215]. A
recent study from Krimmer et al. (2017) [173] showed that the count variations of the PG TOF
peak integral have a strong correlation with the beam range deviation. Further investigation into
the effect of heterogeneous targets, beam type and energy, as well as the necessary technology
for fast timing detection, may lead to a simple cost-effective technique for particle range
verification during particle therapy treatment. Furthermore, the challenges of Monte Carlo codes
should also be addressed to improve the accuracy and efficiency of the codes for use with the
PG method.
Our project aims to further develop the understanding of PG ray characteristics with
determining optimal methodologies for PG detection, detector technology requirements and
toward potential hybrid systems, and the performance of Monte Carlo codes.
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3 Characterisation of Prompt Gamma Rays for
Beam Range Verification
The detection of PG rays is challenging due to the broad and relatively high-energy
range (compared to PET) with strong interference background from neutrons and other stray
radiations. Innovative detection methods, by utilising either or complementary features of PG
ray characteristics, are pursued to extract the PG signal from the background; this can therefore
lead to hybrid PG detection systems. Hence, the Monte Carlo simulation Toolkit Geant4
[182,183] was adopted in this study for the characterisation of PG rays in terms of energy, space
and time to determine optimal detection methodologies and technologies for particle beam range
monitoring. Initially, a homogeneous spherical-shaped water phantom was used to characterise
the emission and detection with an ideal detecting sphere surface encompassing the phantom. In
this study, three different ion species were investigated: proton, helium (4He) and carbon (12C).
Each particle beam was simulated at four different energies to also observe the influence of
varying beam range on PG emission and detection profiles for range monitoring purposes. To
study the PG characteristics from various target materials and the effect of phantom geometry,
homogeneous cylindrical-shaped water, polymethyl methacrylate (PMMA) and adipose tissue
phantoms were also irradiated with the same three ion species. To then investigate the PG
characteristics from heterogeneous phantoms, a realistic head phantom, the Computerized
Imaging Reference Systems (CIRS) paediatric head phantom, Giacometti et al. (2017) [216],
was modelled in the Geant4 simulation as treatment target and irradiated with 100 MeV protons.
The model was also adapted such that the head phantom was made water-based, with only the
air-pockets remaining. This allows direct comparison between a water-based and realistic head
phantom, to investigate the effect of modelling a realistic target treatment, with different tissues,
on the proton beam range as well as the characteristic properties of PG rays.
Part of the work in this chapter has been published in Characterization of prompt
gamma ray emission for in vivo range verification in particle therapy: A simulation study,
Physica Medica, 62, 2019 (Ref. [217]). Certain figures have been reproduced from the
publication.
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3.1 Monte Carlo Geant4 Simulation Set-up
3.1.1 Homogeneous Spherical and Cylindrical Phantoms
Geant4 (version 10.02.p02) was used to investigate the characteristic emission of PG
rays from particle beam irradiations of a homogeneous spherical-shaped water phantom (density
of 1 g/cm3). The simulation set-up is shown in Figure 14. Mono-energetic pencil beams of
proton, 4He and 12C ions were studied, irradiating the phantoms with the beam axis crossing the
centre of the phantom. The primary particles originate at the phantom surface, such that they do
not interact with air before reaching the target; the beam is therefore not degraded before
irradiating the phantom. The phantom size was chosen as 40 cm diameter to represent the size
of a human abdomen, and for simplicity, a spherical shape was initially used. Depth dose curves
were obtained by calculating the energy deposited in the phantom along the direction of
incidence of the beam (z-axis). The bin size of the depth dose profile was 1 mm. At the position
of the BP the energy deposited along the x-axis was also calculated, for a longitudinal width of
10 mm. Proton and 4He beams of 62, 150, 200 and 250 MeV/u, and 12C beams of 120, 285, 385
and 490 MeV/u were simulated. These energies correspond to ranges (80% distal dose fall-off)
of approximately 30, 160, 260 and 380 mm in water, as determined from the simulation results
of this thesis. These values are consistent with NIST [218] for proton/helium ions and SRIM
[219] for carbon ions taking into consideration that they calculate the ranges with the CSDA and
projected range algorithm (PRAL), respectively. These energies were chosen since they are
typical of therapy treatment for the respective particle types with the exception of the energies
250 MeV/u of 4He and 490 MeV/u of 12C, which were also included for comparison.
To study the characteristic PG emission from different material compositions and the
PG detection from phantom geometric effects, the study was repeated for cylindrical-shaped
water, PMMA and adipose tissue materials of 40 cm diameter and 40 cm height. Adopting the
same set-up, the cylindrical phantoms replace the spherical phantoms in Figure 14. The cylinder
phantom materials were based on the Geant4 NIST materials database [220]: water (H2O,
density of 1.0 g/cm3), plexiglass (C5H8O2, density of 1.19 g/cm3) (also referred to as PMMA)
and adipose tissue (ICRP) (primarily H (11.4%), C (59.8%) and O (27.8%) with 0.7% N,
density of 0.95 g/cm3). The particle beam energies for each phantom were:
Water – proton 61, 149, 197, 248 MeV, 4He 60, 148, 196, 247 MeV/u,

12

C 112, 282,

380, 486 MeV/u;
PMMA – proton 66, 163, 216, 272 MeV, 4He 65, 162, 215, 271 MeV/u, 12C 122, 309,
418, 536 MeV/u; and
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Tissue – proton 60, 147, 195, 245 MeV, 4He 59, 146, 194, 244 MeV/u, 12C 109, 280,
379, 484 MeV/u.
These energies correspond to ranges of approximately 30, 160, 260 and 380 mm, such
that the deviation between the respective beam range in the phantoms were within 3 mm.
In all cases, the number of incident particles was 108 for protons, 107 for 4He ions and
106 for 12C ions to obtain a statistical uncertainty of 5% in the yield of PG rays. The statistical
uncertainty was calculated with 1/√𝑁, where 𝑁 is the number of counts. The uncertainties are
purely statistical; those that affect physics concepts are not taken into account here.
Characterising the photon and neutron radiation fields escaping the phantom provides
beneficial information which assists in choosing potential PG detectors. To score the photons
and neutrons that are emitted from the phantom, an air-filled idealised detecting sphere surface
(referred to as detection sphere) encompassing the phantom was used, with a diameter of 100
cm. When the photon/neutron traverses the surface of the sphere, they are counted.
A fixed point-of-reference, corresponding to the centre of the Geant4 simulation
coordinate system (see Figure 14), was chosen at the surface of the phantom for simplicity. An
alternative option would have been to select the BP position as point-of-reference, however, this
position varies within the phantom depending on the particle beam energy, therefore it was not
identified as a suitable reference point for all the simulation set-ups considered; the chosen
point-of-reference is similar to the clinical practice of having a fixed point-of-reference on the
patient surface.
The angular emission characteristics of PG rays was studied in terms of the polar angle
θ between the incident beam direction and the line connecting the point-of-reference to the point
𝑃 traversed by the photon on the detection sphere (see Figure 14). φ is the azimuthal angle
between the x-axis and the line connecting the point-of-reference to the point 𝑃 traversed by the
photon on the detection sphere. The angular emission study allows identifying eventual
preferential PG emission directions, which would allow identifying preferential locations of the
PG detector/s to maximise the detected PG yield and minimise the neutron yield.
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Figure 14: Left: Geometrical simulation set-up of the spherical water phantom in an air-filled detection
sphere. Right: The angle θ is formed from the longitudinal beam direction (z-axis) with the line
connecting the centre of the coordinate system and the point 𝑃. 𝑃 is the PG detection position on the
detection sphere traversed by the photons, and φ is the azimuthal angle. For the case of the cylindrical
phantom, it replaces the spherical phantom in the simulation set-up, with the main axis along the direction
of the incident beam.

A modularised Geant4 Physics List was used which included both electromagnetic
(G4EmStandardPhysics_option3) and hadronic physics processes (QGSP_BIC_HP). The
G4RadioactiveDecayPhysics and G4HadronElasticPhysicsHP modules were active. The
QGSP_BIC_HP was chosen as it was found adequate for proton and carbon therapy studies in
Ref. [190,199,221]. Total cross sections are described by the Glauber-Gribov theory [222] and
the final state of inelastic scattering is generated by the Binary Cascade model [223]. The High
Precision (HP) Neutron Data Libraries [224] were used to more accurately model the neutron
interactions from thermal energies up to 20 MeV.
The simulation output consisted of the yield of photons and neutrons generated within
the phantom, and those that reach the detection spherical surface. The yield was normalised to
the number of incident particles on the phantom. The PG emission time was calculated as the
time interval between the origin of the primary particle in the simulation (particle incident on
the surface of the phantom) and the time of origin of the PG ray in the phantom. The PG
detection time, defined as TOF, was calculated as the time interval between the origin of the
primary particle in the simulation and the time when the PG ray reaches the detection sphere.
The gamma TOF distribution mean and integral were retrieved from the simulation.
The primary PG rays are referred to those produced from the primary particle
interactions, and the secondary PG rays are referred to those produced from the interactions of
the secondary radiation field. The primary and secondary PG rays were differentiated to more
closely study their correlation to the particle beam range.
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In the post-simulation data analysis, several parameters of PG emission and detection
were investigated: 𝑅, the particle beam range defined as the position of 80% BP distal fall-off
along the beam path in the phantom; 𝑅 , the PG range defined as the position of 80% PG
emission yield fall-off in the phantom; ∆fall-off, the difference 𝑅 − 𝑅

used to quantify the

longitudinal correlation between the PG emission fall-off and the beam range; ∆FWHM, the
difference between the lateral PG emission distribution FWHM and lateral dose distribution
FWHM for a 10 mm longitudinal thickness at the BP position; 𝑇 , the 80% fall-off of the PG
emission time distribution; and 𝑇 , the time difference between 80% rise and fall-off of the
TOF spectra peak.
The energy spectrum of all photons generated in the water phantom, via any physical
interaction process, allowed the observation of the prominent PG emission lines and the
selection of two energy regions of interest: an energy threshold of ≥1 MeV, which eliminates
the low-energy background photon counts [225] (e.g. positron annihilation photons at 0.511
MeV), and a 3.0-7.0 MeV energy window, which includes the prominent PG emission lines and
has been employed in previous studies [176,226]. The energy threshold and window were used
to analyse the PG emission yield, the spatial correlation between PG rays and the BP position,
and the temporal and detection properties. In addition, in Section 3.4, when calculating the PG
emission yield to deposited energy ratio for the different ion species, the energy deposited and
scored at the BP maximum was taken.

3.1.2 Realistic DICOM-formulated Head Phantom
The high resolution voxelised head phantom utilised in this work was created from the
CT scan of the ATOM® Model 715 HN, CIRS Inc., Norfolk, VA, paediatric head phantom. In
this study, Geant4 (version 10.04.p02) was used to simulate a mono-energetic 100 MeV proton
beam irradiating the realistic head phantom. At this energy, the proton CSDA range is 7.7 cm in
water and 8.1 cm in adipose tissue (ICRP) according to NIST [218]. The proton beam energy
was chosen so that the position of the BP corresponds to the centre of the phantom. The beam
had a radius of 2.5 mm and a sigma_r (traverse standard deviation of beam position profile) of
11 mm. The protons are incident on the left-side of the head phantom, with an air gap between
the initialisation of the beam to the phantom surface of approximately 30 cm, which is a
common distance in particle therapy. Figure 15 shows an image of the realistic head phantom as
implemented in the Geant4 simulation. 109 incident protons were simulated to obtain a
statistical uncertainty of 3% in the yield of PG rays. Depth dose curves were obtained by
calculating the energy deposited in the phantom along the direction of incidence of the beam (xaxis). The bin size of the depth dose profile was 1 mm. This study also included the idealised
detecting spherical surface as used in the previous section; in this case the centre of the
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detection sphere corresponds to the centre of the phantom. This was done so to have the centre
of the detection sphere and phantom correspond also to the position of the BP; as mentioned, the
proton beam energy of 100 MeV was chosen to have the beam range at the centre of the
phantom. The Geant4 physics, scoring/simulation output, and post-simulation data analysis are
as described in the previous section. Additionally, the realistic heterogeneous head phantom as
readily available in Geant4 was modified to obtain a water-based head phantom. That is, air
pockets in the phantom remained unmodified while all other voxels were changed to water
(density of 1 g/cm3) such that only two materials, air and water, made up the head phantom.

Figure 15: Geant4 visualisation of a slice of the realistic head phantom, as implemented in the Geant4
extended example DICOM [216]. The proton beam is not to scale.

3.2 Energy Spectra of Prompt Gamma Emission
In this section, the results for the PG emission spectra of proton, 4He and

12

C ions

irradiating water, PMMA and adipose tissue phantoms are presented. PG rays have a broad
energy spectrum with strong interference background from secondary neutrons and stray
gamma rays, which makes their detection a challenge. And so, an optimal energy threshold or
window to be applied potentially in practice for improving the PG signal-to-noise ratio was
investigated. Additionally, the PG spectrum is characteristic to the elemental composition of the
target material, and so this aspect was also investigated for both homogeneous and
heterogeneous (a realistic paediatric head) phantoms.

3.2.1 Homogeneous Phantoms
In this study, the energy spectra of photons generated within the spherical water
phantom was first examined. Figure 16 shows the spectra resulting from any physical
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interaction (including gamma photons induced by neutrons) for the three beam particle types. A
consistent shape over a wide energy range is seen in the spectra for each particle type, with
several characteristic emission lines produced by inelastic particle-nuclei interactions with
major constituent elements of the phantom material.
Positron annihilation from the decay of

15

O and

11

C nuclei, among other isotopes,

contributes to the 0.511 MeV peak. Secondary thermal neutron capture by hydrogen nuclei
results in the 2.22 MeV peak. A 2.31 MeV peak arises from 14N* by proton and alpha spallation
reactions with

16

O [227], which may be difficult for a detector to resolve from the 2.22 MeV

emission line. The prominent PG emission lines are observed with energy 4.44, 5.21 and 6.13
MeV, which are the most proposed for beam range verification. The 4.44 MeV PG emission
line originates from the de-excitation of

12

C* nuclei, derived from nuclear interactions of

particles with oxygen nuclei. The 5.21 and 6.13 MeV PG emission lines arise from
16

15

O* and

O* de-excitations, respectively. The distinctive 6.92 and 7.12 MeV lines are higher nuclear

level emissions from 16O*. The intensity of 4.44, 5.21 and 6.13 MeV lines are comparable to the
2.31 MeV line, but the 2.31 MeV line could be challenging to detect since it could be merged
with the neutron capture line and detection will depend on the energy resolution of the detector.
The 0.718 MeV PG line can also potentially be used for beam range verification but it may too
be challenging to resolve in some detectors, such as LYSO detectors where detector intrinsic
radioactivity may interfere with the PG signal.
The energy spectra of gamma ray emission within PMMA and adipose tissue phantoms
also show a spectrum characteristic to the elemental composition of the materials. Figure 17
shows the spectra from homogeneous cylindrical water, PMMA and tissue phantoms for the
three beam particle species with a range of ~16 cm in the materials. A higher concentration of
carbon or oxygen in the target material is representative in the corresponding gamma emission
spectra. The gamma energy spectra from PMMA and tissue show a larger intensity of the 4.44
MeV line due to the higher concentration of carbon in the materials. On the other hand, the
water phantom gives a larger intensity peak at the 5.21 and 6.13 MeV lines due to its larger
concentration of oxygen when compared to the other materials under study. In addition, two
peaks are seen to arise in the spectra from PMMA and tissue targets, at 3.21 and 4.94 MeV,
from

12

C and

13

C respectively, which are not present in the spectra obtained with the water

phantom. The characteristic gamma emission spectra, which are dependent on the elemental
composition of the irradiated target can thus be exploited for identifying the target material, as
studied in Ref. [26,28,140].
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Figure 16: Energy spectra of photons generated in the homogeneous spherical water phantom deriving
from pencil beams of protons, 4He and 12C ions. The emission lines are characteristic to the major
constituent elements of the phantom material. The distinctive PG emission lines of energy 4.44, 5.21 and
6.13 MeV result from 12C, 15O and 16O nuclear de-excitations, respectively.
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Figure 17: Energy spectra of photons generated in the homogeneous cylindrical water, PMMA and
adipose tissue phantoms deriving from pencil beams of protons, 4He and 12C ions with a range of ~16 cm
in the materials. The emission lines are characteristic to the major constituent elements of the phantom
material. The distinctive PG emission lines of energy 4.44, 5.21 and 6.13 MeV result from 12C, 15O and
16
O nuclear de-excitations, respectively.
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3.2.2 Realistic Head Phantom
Figure 18 shows the energy spectra of photons originating within the water-based and
realistic heterogeneous head phantoms, which show PG emission peaks characteristic to the
elemental compositions of the phantom. The 2.31 MeV peak from 14N is clearly evident in the
spectra arising primarily from the air pockets in the phantom: the material of air in the model
comprises 70% nitrogen. However, as mentioned in the previous section, this peak may be
difficult for a detector to resolve from the 2.22 MeV peak. The prominent PG emission lines of
4.44, 5.21 and 6.13 MeV from

12

C,

15

O and

16

O nuclei, respectively, remain dominant in the

spectrum. In the water-based head phantom the intensity of emission peaks from oxygen (e.g.
5.21 and 6.13 MeV) appear larger, while in the realistic phantom those from carbon (e.g. 3.21
and 4.44 MeV) are larger, as expected, since for example materials such as adipose tissue
comprise 60% carbon and trabecular bone comprise 40% carbon.

Figure 18: Energy spectra of photons generated in the water-based and realistic head phantoms irradiated
with a 100 MeV proton beam. The emission lines are characteristic to the major constituent elements of
the phantom material. The distinctive PG emission lines of energy 4.44, 5.21 and 6.13 MeV result from
12
C, 15O and 16O nuclear de-excitations, respectively.

The relative intensity of emission lines for the prominent PG energies 4.44, 5.21 and
6.13 MeV from 12C, 15O and 16O, respectively, show a dependency on the material composition
of the target. In water, the 6.13 MeV emission line from 16O is largest, followed by the 4.44 and
5.21 MeV lines. In PMMA and adipose tissue, as with the realistic head phantom, the 4.44 MeV
emission line is seen to increase, due to the greater concentration of carbon in the materials. In
considering evaluated nuclear cross section libraries ENDF/B-VIII.0 [228] and TENDL-2017
[229], for which the IAEA website [230] was referred to, the simulation is seen to reproduce
these prominent PG emission lines relatively reasonably. For example, cross section data from
ENDF/B-VIII.0 show for 16O(p,)16O a maximum of ~0.40 barns at an incident proton energy
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of ~10 MeV, while for 12C(p,)12C a maximum of ~0.25 barns at ~8 MeV, and for 16O(p,)15O a
maximum of ~0.1 barns at ~30 MeV. However, for incident helium ions cross section data from
TENDL-2017 suggest that the emission yield for
16

12

C(4He,)12C reactions is greater than

16

O(4He,)16O, followed by

O(4He,)15O, with a maximum cross section of ~0.3 barns for

12

C(4He,)12C and ~0.14 barns for 16O(4He,)16O for an incident ion energy of ~35 MeV, and a

maximum cross section of ~0.1 barns for

16

O(4He,)15O at ~40 MeV. The simulated gamma

energy spectra from PMMA and tissue phantoms seem to agree with the cross section data
available in the literature [230], although the greater concentration of carbon in the materials is
also an influencing factor. Yet in the water phantom the 4.44 MeV emission line from 4He
irradiation appears to be underestimated.

3.3 Spatial Correlation between Prompt Gamma Emission and Particle
Beam Range
In this section, the results of the PG emission spatial correlation with the particle beam
range are presented. The spatial correlation between PG production and dose deposition is not
one-to-one, since the two result from different physical processes. Here, the correlation was
studied quantitatively in homogeneous and heterogeneous phantoms to observe the correlation
resulting in the different types of targets. PG rays were also differentiated into primary and
secondary to more closely study their respective correlation to the beam range.

3.3.1 Homogeneous Phantoms
Figure 19 shows the longitudinal and lateral distribution of gamma rays with an applied
1 MeV threshold originating in the phantom. The Bragg curve (depicted for a range of ~16 cm)
is plotted with the total, primary and secondary gamma ray longitudinal emission distribution to
show their correlation with the dose deposition. The primary PG profile is seen to exhibit the
closest correlating relationship to the beam range regarding the sharpness and fall-off in the BP
region, which can offer reliable BP monitoring in particle therapy. The secondary PG profile,
which is more dominant in the heaver ions compared to protons, shows a broader distribution
with a long tail beyond the BP downstream, which could cause significant interference for BP
monitoring. A discontinuity can be seen in the PG emission of 4He and 12C beams, which may
be due to the transition to the precompound model at low energy nuclear reactions. The
transition between high- and low-energy nuclear reaction models occurs at around 140 mm for
4

He and at around 160 mm for 12C. The lateral profiles of PG emissions are consistent with the

lateral dose spreads; the PG emissions are broader with increasing beam energy, and the carbon
ion beam shows narrower lateral spread than the proton beam, as expected.
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Figure 19: Left: Longitudinal yield distribution of total, primary and secondary gamma rays ≥1 MeV
originating in the water phantom for protons (150 MeV), 4He (150 MeV/u) and 12C (285 MeV/u) ions.
The percent depth dose is normalised to the dose maximum at the Bragg peak. Right: Lateral yield
distribution of total gamma rays ≥1 MeV for a longitudinal width of 10 mm at the BP positions for each
of the beam energies.

Table 2 presents data for the particle beam range and corresponding PG range for the
applied energy threshold and window, for each incident particle type and energy studied. The
quantified longitudinal difference, ∆fall-off, shows that the PG rays within 3.0-7.0 MeV offer
better correlation to the particle range, particularly in the case of incident protons. For a ~16 cm
beam range, the ∆fall-off values are (-5.1 ± 0.5) mm, (+0.2 ± 0.5) mm and (+0.3 ± 0.5) mm,
for proton, 4He and 12C ions, respectively. Negative ∆fall-off values indicate that the PG range is
upstream of the particle range, while positive values indicate downstream of the particle range.
It was found that the selected energy window offers a lower gamma statistical yield (see Table
5), whereas the energy threshold which still incorporates the prominent PG rays while
eliminating low-energy background counts offers the benefit of a higher yield with good
particle-PG range correlation, i.e. ∆fall-off values of within ~1.2 mm for 4He and

12

C ions.

Helium and carbon ions are seen to offer an improved accuracy (∆fall-off) in estimating the
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beam range compared to protons. The quantified lateral difference, ∆FWHM, shows millimetre
conformity of the PG production with the dose deposition laterally.
Table 2: Particle beam range and corresponding PG range for the applied energy threshold and window
studied, for each particle beam type and energy. The ∆fall-off and ∆FWHM, defined in Section 3.1.1, are
reported for quantitative evaluation.

Particle
type

Beam
energy
(MeV/u)

Gamma
energy
selection
(MeV)

𝑹
(±0.5
mm)

𝑹𝐏𝐆
(±0.1
mm)

∆fall-off *
(±0.5
mm)

Lateral dose
FWHM
(±0.2 mm)

Lateral PG
FWHM
(±0.2 mm)

∆FWHM
(±0.3
mm)

Proton

62

≥1

31.9

27.0

-4.9

1.2

1.0

0.2

27.2

-4.7

1.0

0.2

150.2

-5.3

6.7

0.4

150.4

-5.1

6.7

0.4

250.8

-5.5

11.8

0.1

251.4

-4.9

11.4

0.5

368.2

-6.2

16.4

1.1

369.6

-5.1

16.6

0.9

31.8

-0.4

0.6

0.1

32.0

-0.2

0.6

0.1

156.6

0.

3.6

0.1

156.8

+0.2

3.5

0.

258.3

+0.1

6.3

0.4

258.4

+0.2

6.1

0.2

377.4

0.

9.0

0.5

377.4

0.

9.4

0.9

35.5

+0.3

0.4

0.1

35.4

+0.2

0.4

0.1

157.8

+0.5

2.0

0.1

157.6

+0.3

1.8

0.1

258.7

+1.2

3.4

0.3

258.3

+0.8

3.3

0.2

378.7

+1.0

5.2

0.7

378.6

+0.9

4.8

0.3

3.0-7.0
150

≥1

155.5

3.0-7.0
200

≥1

256.3

3.0-7.0
250

≥1

374.7

3.0-7.0
4

He

62

≥1

32.2

3.0-7.0
150

≥1

156.6

3.0-7.0
200

≥1

258.2

3.0-7.0
250

≥1

377.4

3.0-7.0
12

C

120

≥1

35.2

3.0-7.0
285

≥1

157.3

3.0-7.0
385

≥1

257.5

3.0-7.0
490

≥1
3.0-7.0

377.7

7.1

11.9

17.5

0.7

3.5

5.9

8.5

0.3

1.9

3.1

4.5

* Negative values indicate that the PG range is upstream of the particle range, while positive values
indicate downstream of the particle range.

Table 3 presents the data for the particle beam range and corresponding PG range for
each incident particle type with a range of ~16 cm in water, PMMA and adipose tissue. The
quantified longitudinal difference, ∆fall-off, is found to not vary largely between the three
homogeneous phantoms, i.e. within ~1.4 mm for protons and within only ~0.3 mm for 4He/12C
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ions. Rather, a more considerable difference is observed between the ion species, with ∆fall-off
values of around 5-6 mm for protons and around 0-1 mm for 4He/12C ions. This suggests that for
the case of homogeneous targets, regardless of composition, there is a somewhat consistent PGBP fall-off correlation for a particular beam type.
Table 3: Particle beam range and corresponding PG range in water, PMMA and adipose tissue for the
applied energy threshold and window studied, for each particle beam type with ~16 cm range. The ∆falloff, defined in Section 3.1.1, is reported for quantitative evaluation.
Particle type

Phantom
material

Gamma energy
selection (MeV)

𝑹 (±0.5 mm)

𝑹𝐏𝐆 (±0.1 mm)

∆fall-off * (±0.5 mm)

Proton

Water

≥1

156.2

150.9

-5.3

151.0

-5.2

151.3

-5.5

152.2

-4.6

149.6

-6.4

150.0

-6.0

155.2

-0.2

155.2

-0.2

156.6

+0.2

156.6

+0.2

155.4

+0.1

155.6

+0.3

155.7

+0.4

155.6

+0.3

156.7

+0.4

156.4

+0.1

155.9

+0.6

155.3

0.

3.0-7.0
PMMA

≥1

156.8

3.0-7.0
Tissue

≥1

156.0

3.0-7.0
4

He

Water

≥1

155.4

3.0-7.0
PMMA

≥1

156.4

3.0-7.0
Tissue

≥1

155.3

3.0-7.0
12

C

Water

≥1

155.3

3.0-7.0
PMMA

≥1

156.3

3.0-7.0
Tissue

≥1
3.0-7.0

155.3

* Negative values indicate that the PG range is upstream of the particle range, while positive values
indicate downstream of the particle range.

3.3.2 Realistic Head Phantom
The longitudinal emission distribution of gamma rays within the head phantoms rises
and falls in relation to the beam entering the various materials of the phantom, such that the
emission is sensitive to the elemental composition and the medium density. In higher density
materials (e.g. bone) the gamma emission increases and in lower density materials (e.g. air) the
gamma emission decreases. The published work, Zarifi et al. (2017) [231] (see Appendix 1),
shows effects of target inhomogeneity, whereby the PG emission from a proton beam irradiating
a multi-layered phantom was investigated.

3 Characterisation of Prompt Gamma Rays for Beam Range Verification

81

Figure 20 shows the longitudinal distribution of total, primary and secondary gamma
rays with a threshold of 1 MeV originating in the water-based and realistic head phantoms. The
Bragg curve is also plotted to show the correlation of the gamma emission with the dose
deposition. A (3.6 ± 0.7) mm shift in the proton beam range is seen between the water-based
and realistic head phantoms, whereby the PG emission closely correlates to this shift. That is,
for both phantoms the PG-BP fall-off difference remains at around 2-3 mm (see Table 4). This
suggests that the PG emission fall-off closely correlates to the BP fall-off for heterogeneous
targets as well as homogeneous ones.

Figure 20: Longitudinal yield distribution of total, primary and secondary gamma rays ≥ 1 MeV
originating in the water-based and realistic head phantom for 100 MeV protons. The percent depth dose is
normalised to the dose maximum at the Bragg peak. A (3.6 ± 0.7) mm shift in the proton beam range is
seen between the two phantoms, and the PG emission closely correlates (~2 mm) to this shift.
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Table 4: Particle beam range and corresponding PG range in the water-based and realistic head phantom
for the applied energy threshold and window studied, for a proton beam of 100 MeV. The ∆fall-off,
defined in Section 3.1.1, is reported for quantitative evaluation.
Head phantom

Gamma energy
selection (MeV)

𝑹 (±0.5 mm)

𝑹𝐏𝐆 (±0.1 mm)

∆fall-off * (±0.5 mm)

Water-based

≥1

76.1

73.7

-2.4

73.5

-2.6

70.2

-2.3

70.3

-2.2

3.0-7.0
Realistic

≥1
3.0-7.0

72.5

* Negative values indicate that the PG range is upstream of the particle range.

It is therefore seen from these results that the primary PG emissions from the beam’s
nuclear interactions offer the closest correlation to the deposited dose with sharp fall-off in the
region of the BP, which is most suitable for BP monitoring in particle therapy. The PG-BP
correlations are better for the heavier ions (millimetre accuracy) than for proton beams (within
~7 mm). In studying the quantified longitudinal difference between three different
homogeneous target materials, a larger difference is observed between the ion species rather
than the ∆fall-off values for a particular material. This suggests that for homogeneous targets the
PG emission fall-off consistently correlates to the BP fall-off for a particular beam type. The PG
emission fall-off was also seen to closely correlate (within ~3 mm) to the BP fall-off for
heterogeneous targets (water-based and realistic head phantoms) as well as the homogeneous
ones. In the lateral spread, the PG emission and dose deposition were also observed to be
correlated with millimetre accuracy. These properties indicate that the PG signal is a reliable
means for in vivo beam range verification and dose monitoring in particle therapy. However, the
primary and secondary PG rays are not quite differentiable in experimental measurements, such
that the measurable PG signal is largely masked by the concurrent emission of secondary PG
rays which arise from the nuclear reactions of secondary particles/fragments created along the
primary ion path. This becomes a greater challenge for heavy ions whereby the secondary PG
emissions (broad distribution and tail beyond the BP region) are more prominent.

3.4 Prompt Gamma Emission and Detectable Yield
In this section, the results on the emission yield of PG rays orginiating within the
phantom and the detectable yield of those reaching the idealised detection sphere are presented.
The possible available statistics, which may be one challenge for range verification in particle
therapy due to the specific beam delivery structure and intensity constraints, were investigated.
The PG emission yield and corresponding dose deposition was also investigated to determine a
possible correlation which may be valuable to in vivo dosimetry.
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3.4.1 Homogeneous Phantoms
Table 5 presents the yield values of gamma photons originating in the spherical water
phantom and those reaching the detection sphere, and with applied energy threshold/window,
normalised to the number of incident particles on the phantom. For each beam type, the PG
emission yield increases with particle depth, as expected. The

12

C beam produces the highest

yield of gamma emission, with a relatively larger yield of low-energy photon counts. For
example, comparing the beam types with the same range of ~16 cm, the total gamma yield per
incident particle is 0.87 for 150 MeV protons, 2.60 for 150 MeV/u 4He ions and 17.35 for 285
MeV/u

12

C ions, while the yield for PG rays within 3.0-7.0 MeV is 0.07, 0.22 and 0.62,

respectively. This gives a ratio of total gamma to PG of 12.4, 11.8 and 28.0 for proton, 4He and
12

C, respectively. In other words, for 150 MeV protons the energy deposited at the BP

maximum is ~3 MeV/ion, with a PG yield of ~7×10-4 /ion, which corresponds to ~2×10-4 PG
rays emitted per MeV deposited energy at the BP. For 150 MeV/u 4He ions the energy deposited
at the BP maximum is ~13 MeV/ion, with a PG yield of ~1×10-3 /ion, and ~8×10-5 PG/MeV at
the BP. For 285 MeV/u 12C ions the energy deposited at the BP maximum is ~69 MeV/ion, with
a PG yield of ~4×10-3 /ion, and ~6×10-5 PG/MeV at the BP.
The detectable yield is less than the emission yield as expected, since the gamma rays
interact within the water phantom and can eventually be absorbed. The detectable PG yield
within 3.0-7.0 MeV on the detection sphere is found to be around 65%. The results again show
that the 12C beam produces a larger yield of detectable PG rays per incident ion compared to the
proton and 4He beams. The PG yield within 3.0-7.0 MeV per incident particle for the beams
with ~16 cm range is 0.05 for protons (150 MeV), 0.14 for 4He (150 MeV/u) ions and 0.40 for
12

C (285 MeV/u) ions.
Table 6 presents the yield values of gamma photons originating in the cylindrical water,

PMMA and adipose tissue phantoms and those reaching the detection sphere, normalised to the
number of incident particles on the phantom, for a beam range of ~16 cm. For each particle type,
the gamma yield is greatest in the PMMA target and least in the tissue target. For example, for
water, PMMA and tissue phantoms the total gamma yield per incident particle is 0.90, 0.92 and
0.74, respectively for protons, 2.70, 2.87 and 2.27, respectively for 4He ions, and 17.73, 17.94
and 14.39, respectively for

12

C ions. In other words, for protons in water, ~1×10-4 PG rays

within 3.0-7.0 MeV are emitted per MeV deposited at the BP maximum, i.e. ~3 MeV/ion with
PG yield of ~3×10-4 /ion. Table 7 presents this quantitiative data for each particle type and
target material. The detectable PG yield within 3.0-7.0 MeV on the detection sphere is found to
be around 60% for a beam range of ~16 cm within the cylindrical phantoms.
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Table 5: Yield of gamma photons originating within the spherical water phantom and those reaching the
detection sphere once emitted from the phantom. The simulation statistical uncertainty is within 5%.
Particle
type

Particle beam energy
(MeV/u)

Gamma energy
selection (MeV)

Proton

62

150

200

250

4

He

62

150

200

250

12

C

120

285

385

490

Gamma yield per incident particle
In phantom

Detection sphere

No window

0.19

0.06

≥1

0.03

0.02

3.0-7.0

0.02

0.01

No window

0.87

0.25

≥1

0.13

0.09

3.0-7.0

0.07

0.05

No window

1.40

0.39

≥1

0.20

0.14

3.0-7.0

0.10

0.07

No window

1.95

0.53

≥1

0.27

0.19

3.0-7.0

0.13

0.09

No window

0.41

0.17

≥1

0.10

0.08

3.0-7.0

0.05

0.04

No window

2.60

0.86

≥1

0.54

0.36

3.0-7.0

0.22

0.14

No window

4.00

1.25

≥1

0.77

0.51

3.0-7.0

0.32

0.20

No window

5.20

1.55

≥1

0.90

0.61

3.0-7.0

0.38

0.25

No window

3.91

0.73

≥1

0.32

0.23

3.0-7.0

0.15

0.10

No window

17.35

2.94

≥1

1.42

0.95

3.0-7.0

0.62

0.40

No window

25.02

4.25

≥1

2.00

1.35

3.0-7.0

0.86

0.56

No window

30.40

5.42

≥1

2.44

1.66

3.0-7.0

1.01

0.67
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Table 6: Yield values of gamma photons originating within the cylindrical water, PMMA and adipose
tissue phantoms for the beam energy corresponding to a range of ~16 cm, and the gamma yield reaching
the detection sphere once emitted from the phantom. The simulation statistical uncertainty is within 1%.
Particle
type

Phantom material

Proton

Water

PMMA

Tissue

4

He

Water

PMMA

Tissue

12

C

Water

PMMA

Tissue

Gamma energy
selection (MeV)

Gamma yield per incident particle
In phantom

Detection sphere

No window

0.90

0.25

≥1

0.14

0.09

3.0-7.0

0.07

0.04

No window

0.92

0.28

≥1

0.15

0.09

3.0-7.0

0.07

0.04

No window

0.74

0.23

≥1

0.12

0.08

3.0-7.0

0.05

0.03

No window

2.70

0.89

≥1

0.59

0.37

3.0-7.0

0.23

0.14

No window

2.87

1.03

≥1

0.69

0.41

3.0-7.0

0.25

0.14

No window

2.27

0.84

≥1

0.53

0.34

3.0-7.0

0.18

0.11

No window

17.73

2.91

≥1

1.56

0.98

3.0-7.0

0.65

0.40

No window

17.94

3.45

≥1

1.93

1.12

3.0-7.0

0.74

0.42

No window

14.39

2.78

≥1

1.41

0.90

3.0-7.0

0.51

0.32
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Table 7: Yield values of PG rays within 3.0-7.0 MeV emitted per MeV deposited at the BP maximum
within the cylindrical water, PMMA and adipose tissue phantoms for the beam energy corresponding to a
range of ~16 cm. The simulation statistical uncertainty is within 1%.
Particle type

Phantom material

PG/ion

MeV/ion

PG/MeV

Proton

Water

~3×10-4

~3

~1×10-4

PMMA

~4×10-4

~3

~1×10-4

Tissue

~3×10-4

~3

~1×10-4

Water

~1×10-3

~13

~8×10-5

PMMA

~2×10-3

~12

~2×10-4

Tissue

~1×10-3

~12

~8×10-5

Water

~3×10-3

~70

~4×10-5

PMMA

~4×10-3

~65

~6×10-5

Tissue

~3×10-3

~71

~4×10-5

4

He

12

C

3.4.2 Realistic Head Phantom
Table 8 presents the yield values of gamma photons originating in the head phantoms
and those reaching the detection sphere, normalised to the number of incident particles on the
phantom. The gamma emission yields are found to be considerably different for the two targets;
a factor of around 2-3 higher for the realistic head phantom than the water-based head phantom.
The realistic to water-based head phantom ratio of total, ≥1 MeV and 3.0-7.0 MeV gamma
yield is 2.2, 3.3 and 2.5, respectively. This is a result of the higher density materials within the
realistic head phantom, in particular the bone structures. In other words, for 100 MeV protons in
the water-based head phantom the energy deposited at the BP maximum is ~4.1 MeV/ion, with
a PG yield within 3.0-7.0 MeV of ~6×10-4 /ion, which corresponds to ~1×10-4 PG rays emitted
per MeV deposited energy at the BP. In the realistic head phantom the energy deposited at the
BP maximum is ~4.3 MeV/ion, with a PG yield of ~5×10-4 /ion, and ~5×10-5 PG/MeV at the
BP. In terms of dose at the BP position (1 mm thickness), ~6×105 PG rays emitted in the waterbased head phantom and ~5×105 PG rays emitted in the realistic head phantom correspond to
approximately 0.02 Gy and 0.03 Gy delivered, respectively.
The detectable PG yield within 3.0-7.0 MeV on the detection sphere is found to be 50%
for the water-based head phantom and 80% for the realistic head phantom. Again, the higher
yield of PG rays for the realistic head phantom compared to the water-based phantom may be
due to factors such as elemental composition and material density. A higher concentration of
elements such as carbon and oxygen increase the PG emission intensity at, for example, 4.44
and 6.13 MeV, respectively. At higher density media (compared to water), the PG production
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yield also increases, and in lower density media, the gamma ray attenuation is less, resulting in
an increased detectable yield.
Table 8: Yield values of gamma photons originating within the water-based and realistic head phantoms
for 100 MeV proton beams, as well as the gamma yield reaching the detection sphere once emitted from
the phantom. The simulation statistical uncertainty is within 3%.
Gamma yield per incident particle
Head phantom

Water-based

Realistic

Gamma energy selection (MeV)
In phantom

Detection sphere

No window

0.19

0.06

≥1

0.03

0.02

3.0-7.0

0.02

0.01

No window

0.41

0.17

≥1

0.10

0.08

3.0-7.0

0.05

0.04

An important concept in particle therapy is whether there are enough PG statistics for
spot tracking in PBS. Considering a typical PBS proton beam with a rate of 108 protons per
second and a spot duration of about 20 ms, each spot will have 2×106 incident protons. Taking
the case of the realistic head phantom and if the simulated beam incidence is considered as a
single spot, for 2×106 incident protons at 100 MeV, the total detectable PG yield at energy ≥1
MeV on the idealised detecting sphere would be ~1.6×105 with a production yield of ~2.0×105
within the phantom. Considering a 5 × 5 cm2 detector size on the simulated sphere, the
detectable PG counts are ~3×102, yielding a statistical error of about 6%. This implies that spotby-spot monitoring using PG rays for this particular beam energy/geometry/detector size is a
challenge in terms of obtaining sufficient statistics for clinical practice. However, improving the
statistics can be achieved by accumulating data from several beam spots when they correspond
to the same expected range, but this is at the expense of spatial resolution [57].

3.5 Angular Distribution for Detectable Prompt Gamma Rays
In this section, the results on the angular distribution of PG rays reaching the idealised
detection sphere are presented. This would allow identifying eventual preferential PG emission
propagation, and in turn, identifying preferential positions for the PG detector/s to maximise the
detected PG yield and minimise the neutron yield. Moreover, two different shaped phantoms,
spherical and cylindrical, were studied to investigate the phantom geometric effects on PG
detection.
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3.5.1 Homogeneous Phantoms
Figure 21 shows the angular distributions of total gamma rays reaching the idealised
detection sphere once emitted from the spherical water phantom, normalised per incident ion per
steradian, for each beam ion species and energy studied. At the low energies of 62 MeV/u
(proton and 4He beams) and 120 MeV/u (12C beam), the detectable gamma rays are slightly
preferred backward in θ = 100-180o (angle θ is defined in Section 3.1.1, see Figure 14). Yet at
higher beam energies the detectable gamma rays become more forward in θ = 20-40o. Hence,
with increasing depth of the BP position, the favourable PG detection is likely to be increasingly
forward, and such forwardness appears to increase for the heavier ion species. The published
work, Zarifi et al. (2017) [231] (see Appendix 1), shows further analysis from proton beam
irradiations with respect to the BP position.

Figure 21: Angular distribution of total gamma rays reaching the idealised detecting sphere once emitted
from the spherical water phantom normalised per incident ion per steradian for the lower two beam
energies (left) and the higher two beam energies (right) for protons, 4He and 12C ions.

Figure 22 shows the angular distributions of total gamma rays reaching the idealised
detection sphere once emitted from cylindrical phantoms for each beam ion species and the
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lowest/highest energy, normalised per incident ion per steradian. At the lowest energy (a beam
range of ~3 cm) the detectable gamma rays from the different phantom materials are slightly
preferred in θ = 100-180o, whereas at the highest beam energy (a beam range of ~38 cm) the
detectable gamma rays become more forward in θ = 20-40o. Hence, the angular detection
distribution properties for the cylindrical phantoms (see Figure 22) are similar to those for the
spherical phantoms (see Figure 21), such that with increasing depth of the BP position within
the phantom the favourable PG detection is likely to be increasingly forward. However, the
geometric effects of the phantom on the angular distribution are evident on the idealised
detection sphere. The noticeable troughs in the plots are indicative of the greater path length the
gamma

rays

travel

within

the

phantom,

and

hence

increased

probability

of

attenuation/absorption and therefore reduced gamma yield.

Figure 22: Angular distribution of total gamma rays reaching the idealised detecting sphere once emitted
from the cylindrical water, PMMA and adipose tissue phantoms normalised per incident ion per steradian
for the lowest beam energy (beam range of ~3 cm) (left) and the highest beam energies (beam range of
~38 cm) (right) for protons, 4He and 12C ions.
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By using an idealised detecting sphere, the angular distribution of detectable PG rays
was investigated as a global context, for each particle type and energy under study. The
observed non-isotropic longitudinal distribution of the detectable gamma rays is likely due to
the kinematics of the nuclear reactions. The default cascade model of Geant4 physics was
employed in this simulation study, which does not take into account angular momentum
coupling of the gamma quanta emitted in a cascade. Understanding the influence of activating
angular

momentum

coupling

on

the

angular

distribution

requires

further

study.

Attenuation/absorption of gamma rays within the phantom was considered, and so the geometric
effect (e.g. phantom shape and size) also play a role in the angular variances seen on the
idealised detecting sphere. In replacing the sphere phantom with a cylinder phantom, it was seen
(Figures 21 and 22) that the shape of the phantom does have a considerable effect on the angular
distribution due to attenuation/absorption. Additionally, since the target is not in the centre of
the detection sphere, this introduces a dependency from the origin of the PG rays with 1/𝑟 .
These factors may explain why the results of angular distribution in this study, which show a
non-isotropic trend, are different to the experimental data in Ref. [94], for which no angular
dependence was observed in the prompt photon yield at 90o and 60o measured with a LYSO
detector (for deposited energy >2 MeV). Therefore, further investigation is necessary for the
factors influencing the angular distribution of the detectable PG rays.

3.6 Temporal Properties of Prompt Gamma Emission and Detection:
Relationship with Particle Beam Range
In this section, results on the timing properties of PG rays emitted within the phantom
and those reaching the idealised detection sphere are presented. The relationship between the
emission time and TOF distributions with the particle beam range were investigated, which may
provide valuable information for in vivo range and dose monitoring using the temporal feature
of PG rays, such as in the PGT [171] and PGPI [173] methods.

3.6.1 Homogeneous Phantoms
Figure 23 shows the emission time distribution of total gamma rays and those ≥1 MeV
for each particle type and energy. The emission time profiles vary with particle energy, as
expected, since the beam range/transit time also increases and so gamma rays are produced at
greater depths in the phantom and hence at later time. The profiles with the applied threshold
show a clear fall-off which is correlated to the dose profile fall-off. The PG emission time 𝑇
for gamma rays ≥1 MeV is (2.5 ± 0.1) ns, (2.7 ± 0.1) ns and (1.9 ± 0.1) ns for protons, 4He
and 12C ions with a range of ~38 cm. The gamma ray emission time from carbon ions is seen to
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be quicker than that of proton and helium ions; possibly due to the carbon ions moving at
greater speed as they traverse the phantom. Similar time emission properties are seen for
PMMA and adipose tissue, in Figures 24 and 25, respectively.

Figure 23: Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right)
originating in the spherical water phantom for protons, 4He and 12C ions. The bin width is 0.01 ns.
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Figure 24: Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right)
originating in the cylindrical PMMA phantom for protons, 4He and 12C ions. The bin width is 0.01 ns.
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Figure 25: Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right)
originating in the cylindrical adipose tissue phantom for protons, 4He and 12C ions. The bin width is 0.01
ns.
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The TOF profiles of total gamma rays, neutrons and gamma rays ≥1 MeV reaching the
idealised detecting sphere after emitted from the phantom are shown in Figure 26. As the
incident particle energy increases their penetration depth (and travel time) becomes larger,
hence the PG TOF peak mean exhibits a shift to longer TOF values while the peak
width/integral increases. For proton beams, neutrons are not predominantly detected until
around 3 ns, which may suggest another means of discriminating PG rays from the (neutroninduced) background and therefore improve the signal-to-background ratio of PG detection. In
the case of heavier ions, this may be more difficult particularly at high beam energies for which
there is a greater presence of neutron production and temporal overlap between PG and neutrons.
Similar TOF properties are seen for PMMA and adipose tissue, in Figures 27 and 28,
respectively.

Figure 26: TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the
detection sphere once emitted from the spherical water phantom for protons, 4He and 12C ions. The bin
width is 0.1 ns.
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Figure 27: TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the
detection sphere once emitted from the cylindrical PMMA phantom for protons, 4He and 12C ions. The
bin width is 0.1 ns.
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Figure 28: TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the
detection sphere once emitted from the cylindrical adipose tissue phantom for protons, 4He and 12C ions.
The bin width is 0.1 ns.
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Figures 29 and 30 show 2D representations of the TOF spectra of primary gamma rays
and those ≥1 MeV along the polar angle θ for each beam type and energy, respectively. Both
the angular and TOF distributions of PG rays reaching the detection sphere are seen to change
with increasing particle energy. With respect to the phantom surface, PG detection is seen to be
increasingly forward-peaked with higher beam energy (as also seen in Figure 21). In addition,
the TOF width increases and its maximum shifts to longer time values, particularly for proton
and 4He ions, whereas 12C ion irradiations show less widening/shift in the TOF distribution with
greater local increase in PG yield. Applying an energy threshold of 1 MeV to the primary
gamma rays reaching the detecting sphere is seen to almost entirely eliminate the TOF tail, such
that only the highly localised TOF peak remains.

Figure 29: TOF spectra along the polar angle θ of primary gamma rays reaching the detection sphere
once emitted from the phantom for protons, 4He and 12C ions.
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Figure 30: TOF spectra along the polar angle θ of primary gamma rays ≥1 MeV reaching the detection
sphere once emitted from the phantom for protons, 4He and 12C ions.

Figure 31 shows the particle range plotted with the PG range and emission time, as well
as PG TOF data (peak mean, width and integral), for each particle type and energy under study,
irradiating a homogeneous spherical-shaped water phantom. The PG data are for those with 1
MeV energy threshold. The PG range offers good correlation with the particle range, as seen in
Section 3.3. 𝑇

values show a linear increase with particle energy, since the PG emission time

is correlated to the beam transit time and hence the beam range. For a global idealised detection
set-up, the PG TOF peak mean and width are found to only slightly increase with particle
energy, with a minor drop in the case of 12C ions at higher energies. Conversely, the PG TOF
peak integral values exhibit a greater linear increase with particle beam energy. This may
suggest that a correlation between the PG range and corresponding emission yield with the
beam’s range and corresponding energy deposition could potentially serve as a means for in
vivo dosimetry. In the case of the homogeneous PMMA and adipose tissue cylindrical-shaped
phantoms, the quantitative correlation of PG emission with the beam range and PG detection
properties are found to be consistent to those for the spherical water phantom, seen in Figures
32 and 33, respectively. This suggests that the quantitative PG emission and TOF detection data
are a suitable means for range or dose monitoring for homogeneous phantoms of varying
material and shape.

3 Characterisation of Prompt Gamma Rays for Beam Range Verification

99

Figure 31: Quantitative comparison of the particle beam range with PG emission and detection data in
the spherical water phantom for protons, 4He and 12C ions. Left: Particle beam range and corresponding
PG range, with PG emission time. The dotted line joining the particle range values serves to guide the eye.
Right: PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1 MeV. The uncertainty
in the beam range is 0.5 mm, PG range is 0.1 mm, emission time/TOF mean is 0.1 ns, and TOF width is
0.2 ns.
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Figure 32: Quantitative comparison of the particle beam range with PG emission and detection data in
the cylindrical PMMA phantom for protons, 4He and 12C ions. Left: Particle beam range and
corresponding PG range, with PG emission time. The dotted line joining the particle range values serves
to guide the eye. Right: PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1
MeV. The uncertainty in the beam range is 0.5 mm, PG range is 0.1 mm, emission time/TOF mean is 0.1
ns, and TOF width is 0.2 ns.
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Figure 33: Quantitative comparison of the particle beam range with PG emission and detection data in
the cylindrical adipose tissue phantom for protons, 4He and 12C ions. Left: Particle beam range and
corresponding PG range, with PG emission time. The dotted line joining the particle range values serves
to guide the eye. Right: PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1
MeV. The uncertainty in the beam range is 0.5 mm, PG range is 0.1 mm, emission time/TOF mean is 0.1
ns, and TOF width is 0.2 ns.

3.6.2 Realistic Head Phantom
The PG production distribution was seen in Figure 20 to closely correlate to the shift in
the proton beam range between the water-based and realistic head phantoms. Figure 34 shows
the emission time distribution of total gamma rays and those ≥1 MeV within the phantoms.
Although minor, the distributions show a profile fall-off difference between the two phantoms
as a result of the beam range shift. The rise in the emission time profile at approximately 2.4 ns
is due to the time taken for the protons to arrive at the phantom upon initialisation within the
simulation. Figure 34 also shows the TOF spectra of total gamma rays and those ≥1 MeV, as
well as neutrons, for the two head phantoms. The difference in proton beam range between the
two phantoms is also shown in the TOF distribution of detected gamma rays, for which the
integral and fall-off are different for the two cases. The TOF distribution of gamma rays emitted
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from the water-based head phantom shows a fall-off in the profile at a slightly longer time than
the gamma rays from the realistic phantom due to the greater depth of the proton beam range.
The integral of the TOF spectrum of gamma rays from the realistic head phantom is slightly
larger than that from the water-based phantom, which may be correlated to the higher energy
gamma rays emitted from the realistic head phantom (see Figure 18) that are not attenuated
within the phantom.

Figure 34: Top: Emission time distribution of total gamma rays and gamma rays ≥1 MeV originating in
the water-based and realistic head phantoms. The bin width is 0.01 ns. Bottom: TOF spectra of total
gamma, gamma rays ≥1 MeV and neutrons reaching the detection sphere once emitted from the head
phantoms. The bin width is 0.1 ns. The proton beams irradiating the phantoms are of 100 MeV.

The temporal properties of emitted and detected PG rays were studied with the beam
incidence marking the start time. As the PG emission time is associated with the beam transit
time, the particle range can therefore be extracted from the measured PG TOF spectrum as well.
The PGT [171] method retrieves the beam range by means of the TOF peak’s mean and width
while the PGPI [173] method makes use of the TOF spectrum count integral; the integral being
a potential means for in vivo dosimetry. The PG TOF spectrum on the idealised detection sphere
is most likely to reflect the intrinsic characteristics of the PG TOF spectroscopy from the
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phantom. In practice, the realistic spectrum could be much more complicated and it largely
depends on the nature of the delivered beam time structure as well as the detector’s time
resolution [232]. The very narrow time range of PG TOF (a few nanoseconds) implies that
ultra-high time resolution of the detector (<1 ns) is needed in order to accurately extract the
range/dose information from the measured PG TOF spectroscopy. Furthermore, the temporal
separation between PG rays and neutrons can be exploited to discriminate the PG signal from
the neutrons and neutron-induced backgrounds. This has been proposed by Testa et al. (2008)
[146] for 12C ions at low energies where the RF signal of the accelerator at the GANIL facility
could be used as the start time reference. However, this technique is not suitable for synchrotron
facilities, where instead a trigger signal from a fast transmission detector may be used. The TOF
neutron rejection technique for protons was investigated using Monte Carlo simulations [145].
Hueso-González et al. (2018) [59] performed experimental measurements of the technique for
protons accelerated by cyclotrons. However, the application of TOF for proton, 4He and 12C ions
in synchrotron facilities at clinical energies and intensities has not yet been demonstrated
experimentally. TOF may be inefficient for PG detection in proton therapy due to long bunch
times from synchrotrons, while for carbon therapy the detection of individual ion impacts may
be possible at mean intensities of 107-108 ions/second by means of fast beam hodoscopes [57].
Combining the angular preference and TOF of PG measurements may further improve the PG
signal-to-background ratio.

3.7 Discussion
In this study, the emission energy, position and time of PG rays in homogeneous water,
PMMA and adipose tissue phantoms irradiated with three different particle types (proton, 4He
and

12

C ions) of varying energy were investigated using Geant4 simulations. Heterogeneous

DICOM-formulated head phantoms (realistic and water-based) were also studied to explore the
heterogeneity effects on PG range monitoring. The PG production and detectable yields, energy
spectral, spatial and temporal correlation characteristics with the depth dose profile were
quantified. A relatively low gamma ray energy threshold of 1 MeV was used to ensure higher
statistics, while a PG energy window of 3.0-7.0 MeV (adopted in other studies [176,226]) was
also included for comparison. This thesis study shows that the energy spectra of emitted gamma
rays are characteristic to the elemental composition of the phantom materials. Higher
concentrations of oxygen in the target result in greater intensity of the 5.21 and 6.13 MeV
emission lines of the spectra, while higher concentrations of carbon result in greater intensity of
the 4.44 MeV line. Hence, the characteristic gamma emission spectra from irradiated phantoms
can be exploited to identify the target material.
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The PG signal is seen to be a reliable means for in vivo range verification in particle
therapy. The primary PG rays exhibit the closest correlation to the particle range but it is
masked by the concurrent secondary PG rays; which may impose a greater challenge for BP
tracking in heavy ion therapy (e.g. carbon ions) where secondary PG rays are dominant. The
effects of target inhomogeneities are seen on the PG production distribution in relation to the
beam crossing the various materials of the phantom, but the quantitative data shows that the PGBP fall-off correlation is consistent for heterogeneous targets as well as homogeneous ones.
The angular distribution of detected PG rays was studied from spherical and cylindrical
phantoms, which saw that geometric effects of the phantom play a role in the angular variances
seen on the idealised detecting sphere due to attenuation/absorption of the gamma rays. The
angular distribution was also seen to change with beam energy, which may suggest that a
movable PG detector coordinated with respect to the beam range could serve to optimise the PG
detection efficiency. The emission and detection (TOF) properties of PG rays showed a
correlation with the particle beam range that is consistent between the homogeneous target
geometries and materials under investigation in this study. The PG TOF peak integral showed a
linear correlation to the increasing beam range for each of the particle species; this suggests that
associating the PG range and corresponding emission yield with the beam’s range and
corresponding energy deposition may be a technique toward in vivo dosimetry. Combining an
energy threshold/window to the PG TOF distribution, in addition to locating the PG detector/s at
optimal angular positions, could serve to improve the PG signal-to-noise ratio, as seen in the 2D
representations in Figure 30. The PG TOF spectroscopy encodes essential information on the
particle range, and potentially dose, but the technique requires fast detection (excellent time
resolution). Hybrid PG detection systems to exploit the energy, spatial and timing information is
desirable for real-time range verification and dosimetry in particle therapy.
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4
Scintillation Detector Characterisation for
Prompt Gamma Measurement
Experimental work was performed at ANSTO to investigate a suitable scintillation
detector for fast and efficient PG ray timing measurements. As described in the previous
chapters, real-time range verification utilising the temporal information of the PG rays requires
fast gamma ray detectors, data acquisition and analysis. This is also crucial for neutron rejection
techniques and improving the PG signal-to-noise ratio. The detector’s speed of response to a
gamma ray detection event should complement its efficiency and energy resolution, such that
the detector can handle the relatively high gamma yield and adequately resolve the PG emission
energies. This is particularly important for gamma energy selections/windowing or spectroscopy
techniques used for range/dose monitoring. Hybrid PG detection systems utilising more than
one feature of PG rays have the potential to overcome the challenges of PG measurements and
offer a simple technique for in vivo dosimetry. In this study, several scintillation detectors were
characterised in terms of timing – signal rise and decay times – and spectroscopy – energy
resolution and efficiency – to determine the most suitable choice for hybrid PG measurements.

4.1 Experimental Set-up of Scintillation Detector Characterisation
Table 9 lists the four radioactive sources used in this work, their predominant energies
emitted and intensity of emission 𝐼 . The photopeak energies utilised for spectroscopic studies
were 59.5 keV (241Am), 356.0 keV (133Ba), 661.7 keV (137Cs), 1173.2 keV and 1332.5 keV
(60Co). The energies were selected to be easily resolvable by the detector material of interest
whilst covering a wide energy range.
Table 10 lists the instruments used in the measurements and a short statement on their
purpose. Figure 35 depicts the electronic circuit diagrams of the two experimental set-ups: the
top set-up is best suited for timing measurements, while the bottom set-up is best suited for
spectroscopy. Figure 35 (top) shows that when the charge sensitive preamplifier is used there is
also a capacitor coupling from the detector, and an oscilloscope to display the output pulses. In
this case, to record the rise and decay times the direct output of the detector, or the preamplifier
pulses, were used. The preamplifier adds an additional rise time dependent on the amplifier used
and the input capacitance. In this study, the Amptek A250 charge sensitive preamplifier was
used, which has a rise time of 2.5 ns at 0 pF [233]. The capacitance added at the preamplifier
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input, i.e. detector capacitance, slows the rise time at a rate of 0.17 ns/pF, while the output rise
time is also limited by the speed of the detector [234]. The built-in charge sensitive preamplifier
preserves the basic information carried by the magnitude of the charge 𝑄, such that the circuit
uses feedback to mostly eliminate the output amplitude dependence on the capacitance and
restores proportionality to 𝑄 [66].
Table 9: Radiation sources used for detector characterisation measurements. The emission energies and
intensity of emission were taken from Ref. [235].
Photopeak energy (keV)

Intensity of emission, 𝑰𝜸 (%)

26.3

2.40

59.5

35.40

81.0

34.06

276.4

7.16

302.9

18.33

356.0

62.05

383.9

8.94

Cs

661.7

85.10

Co

1173.2

99.97

1332.5

99.99

Source
241

Am

133

Ba

137

60

Table 10: Instruments used for detector characterisation measurements. The amplifier and power supply
were mounted on a Nuclear Instrument Module (NIM).
Instrument

Purpose

Power supply

High voltage (HV) power supply (560 V)

Amptek A250 Preamplifier

Drive the input signal to the shaping amplifier (2.5 ns rise time)

Canberra 2025 Shaping
Amplifier

Produce a gain in the signal amplitude and shapes the signal pulse
into a Gaussian shaped pulse (1 μs shaping time)

LeCroy Oscilloscope
Wavesurfer 44Xs

Display and analyse electronic signals (400 MHz bandwidth, 875 ps
rise time)

Amptek Multichannel
Analyzer (MCA) 8000A

Digitise the input signal from the shaping amplifier to obtain a pulse
height spectrum

Personal computer (PC)

Access the ADMCA software for data analysis
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Figure 35 (bottom) shows an RC feedback preamplifier preceding a shaping amplifier,
followed by an MCA and PC. Part of the purpose of the preamplifier here is to stretch the signal
fall into a quasi-square wave for integration by the shaping amplifier. For spectroscopy, a
shaping amplifier is used to amplify and shape the pulse into a Gaussian for better signal-tonoise. The signal is then digitised with an MCA to obtain a pulse height spectrum which is
displayed on a PC for further spectroscopic data analysis. That is, the use of a preamplifier with
PMTs is better suited for spectroscopy applications where the preamplifier can be used to drive
the input to the shaping amplifier, whereas for timing studies no shaping amplifier is necessary.

Figure 35: Top: Circuit diagram of experimental set-up for timing measurements, showing a capacitor
coupling from the detector and a charge sensitive preamplifier. Bottom: Circuit diagram of set-up for
spectroscopy, showing a preamplifier, shaping amplifier, MCA and PC. The oscilloscope is connected for
display and analysis of signal pulses. The PMT or SiPM (not explicitly shown) is coupled to the detector.

Table 11 lists the scintillation detectors studied in this work as well as the crystal size
and supplier. In the table, it is indicated whether the detector was coupled to either a PMT
(gaseous-state) or SiPM (solid-state/semiconductor). LaBr3(Ce) and LaCl3(Ce) were studied
with and without a built-in charge sensitive preamplifier. PMTs and SiPMs have similar
response times, with time characteristics of a few nanoseconds rise times and ~10 ns decay
times. For example, the Saint-Gobain detectors coupled PMTs or SiPMs have positive charge
sensitive tail pulses with a ~50 μsec decay [236], and with for example a Photonis XP2060 PMT
(coupled to a ∅1” × 1” LaBr3(Ce) detector) having a rise time of 3 ns [237,238].
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Table 11: Scintillation detectors characterised in terms of timing and spectroscopy. * indicates the
detectors connected to a PMT and ** indicates the detectors connected to a SiPM. LaBr3(Ce) and
LaCl3(Ce) were studied with and without a built-in preamplifier.
Scintillation detector material

Scintillator crystal size

Supplier

LaBr3(Ce) *

∅1” × 1”

Saint Gobain

LaCl3(Ce) *

∅1” × 1”

Saint Gobain

NaI(Tl) **

∅2” × 2”

Saint Gobain

CeBr3 **

∅1.5” × 1.5”

Scionix Holland

SrI2(Eu) **

1 cm3

Radiation Monitoring Devices
(RMD)

CLYC **

1 cm3

Radiation Monitoring Devices
(RMD)

CLLBC376 **

∅1.5” × 1.5”

Radiation Monitoring Devices
(RMD)

CLLBC398 **

∅1” × 1”

Radiation Monitoring Devices
(RMD)

CLLBC406 **

∅1.5” × 1.5”

Radiation Monitoring Devices
(RMD)

CLLBC416 **

∅1” × 1”

Radiation Monitoring Devices
(RMD)

4.2 Response Time of the Scintillation Detectors
The timing properties of each scintillation detector was characterised in terms of the
signal rise and decay time. The data were recorded using the oscilloscope by measuring the time
at 10-90% (rise time) and 90-10% (decay time) of the signal amplitude. Figure 36 shows the
signal waveforms of the various detectors under study, each normalised in the time axis to the
20 mV signal amplitude. The CLLBC376 and CLLBC398 waveforms displayed in the figure
were averaged over four and five signal pulses, respectively, to remove pickup noise. Table 12
lists the rise and decay times of the detector signal waveform, as well as the corresponding
amplitude for the recorded measurement. The data demonstrates that the LaBr 3(Ce) and
LaCl3(Ce) scintillation detectors connected to a PMT, with bypassing the built-in preamplifier,
have the fastest timing properties among the detectors studied with sufficient current to still
drive the shaping amplifier. These detectors show rise times of around 34 ns. As mentioned,
part of the purpose of the RC feedback preamplifier is to stretch the signal fall into a quasisquare wave for integration by the shaping amplifier; this justifies the long signal tail (almost
100 μs decay time) for LaBr3(Ce) and LaCl3(Ce) with preamplifier. Thus, although the

4 Scintillation Detector Characterisation for Prompt Gamma Measurement

109

preamplifier is best suited for spectroscopy applications and to improve the system energy
resolution, its inclusion worsens the timing properties. Yet it is important that for hybrid PG
detection systems, both energy and timing capabilities should be optimised, and improving one
aspect should not come at the sacrifice of another. Comparing the scintillators coupled to SiPMs,
those from the elpasolite crystal group were found to have relatively better timing properties;
CLLBC398 and CLLBC416 were found to have ~200 ns rise times and ~2.5 μs decay times.
Since the measured rise times are much longer than the sampling rate of the
oscilloscope, the main contribution to uncertainty is noise. That is, the oscilloscope used in this
study had a rise time of 875 ps (which can be determined from the equation 𝑡 = 0.35/𝐵, where
𝐵 is the bandwidth [239]) which is smaller than the measured rise times and so they are not
bandwidth limited. Also, according to the Nyquist-Shannon sampling theorem [240-243], a
sufficient sample rate 𝑓 is achieved when 𝑓 > 2𝐵, where 𝐵 is the bandwidth. The oscilloscope
sample rate was 2.5 GS/s with a bandwidth of 400 MHz, so the theorem also holds. For the
worst case scenario, there would be ~82 samples over the measured rise times of 34 ns, so the
sampling rate is sufficient to reconstruct the high frequency components of the waveforms. For
the vertical resolution, it was estimated that the SNR ≈ 12 in the spectrum for the worst case
scenario, CLLBC398, and so the noise is not significant. In Table 12, the uncertainties are given
as the standard deviation of three repeated measurements.
Comparing the CLLBC scintillation detectors, the influence of crystal size is also seen:
CLLBC376 and CLLBC406 have size ∅1.5” × 1.5”, whereas CLLBC398 and CLLBC 416 have
size ∅1” × 1”. The size of the scintillation crystal influences the light collection efficiency and
uniformity of the scintillator. The largest possible fraction of light emitted isotropically should
ideally be collected, but fluctuations occur due to the scintillation efficiency and non-perfect
reflection conditions at the crystal surface. The non-uniform light collection can therefore
introduce statistical broadening of the signal, particularly in large size crystals [66]. As seen in
Figure 36, the CLLBC detectors of larger scintillation crystal size produce a broader signal
waveform compared to those with smaller crystals.
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Figure 36: Signal waveforms for each scintillation detector studied. The waveforms in the bottom row
figures are normalised in the time axis to the 20 mV signal amplitude for better visual comparison. The
CLLBC376 and CLLBC398 waveforms were averaged across four and five signal pulses, respectively, to
remove pickup noise. The bin size along the time axis in all figures is 0.4 ns.
Table 12:: Timing properties of each scintillation detector, measured at 10-90%
90% (rise time) and 90-10%
90
(decay time) the signal amplitude. The uncertainty is given by the standard deviation of three repeated
measurements.
Scintillation detector

Rise time (ns)

Decay time (μs)

Amplitude (mV)

LaBr3(Ce) (preamp)

56.12 ± 1.53

96.33 ± 0.66

106.2 ± 8.7

(no preamp)

33.88 ± 0.12

0.79 ± 0.01

538.0 ± 10.2

LaCl3(Ce) (preamp)

292.33 ± 2.90

95.18 ± 0.40

84.5 ± 12.7

(no preamp)

34.29 ± 5.66

0.89 ± 0.03

493.2 ± 22.4

CeBr3

843.52 ± 24.27

6.25 ± 0.50

120.9 ± 4.6

SrI2(Eu)

258.06 ± 0.85

5.85 ± 0.80

121.0 ± 17.2

NaI(Tl)

335.16 ± 22.38

78.83 ± 0.88

471.9 ± 3.5

CLYC

231.51 ± 20.69

5.80 ± 0.11

70.0 ± 1.5

CLLBC376

305.21 ± 7.33

6.11 ± 0.15

120.6 ± 2.8

CLLBC398

197.33 ± 6.24

2.55 ± 0.30

127.0 ± 9.7

CLLBC406

292.97 ± 7.83

5.78 ± 0.17

118.9 ± 5.1

CLLBC416

178.64 ± 10.51

2.45 ± 0.29

117.5 ± 13.5
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Several studies have utilised LaBr3(Ce) for PG range verification measurements due to
its fast timing and superior detection capabilities [59,170,173,232]. Yet CeBr 3 has been
determined as the best choice for PG timing range monitoring [60,123]. However, in this thesis
study, CeBr3 was found to be the slowest by over an order of magnitude with a rise time of
around 840 ns. Overall, the recorded timing values are larger than values in the literature
[66,244,245]. These discrepancies may be due to the PMT itself, which may present limitations
on the signal response, but are representative of the standard matched scintillator and PMT
detectors available commercially, compared to a specific high speed PMT with lower
amplification. The LaBr3(Ce) and LaCl3(Ce) scintillation detectors were optically coupled to a
PMT while the other detectors, including the CeBr3, were coupled to a matched SiPM by the
manufacturer. The response times of PMTs and SiPMs are comparable, with time characteristics
of a few nanoseconds rise times and ~10 ns decay times. PMTs are generally stable and low
noise, but bulky, affected by magnetic fields, and for a gain of 106 require a high bias voltage of
1-2 kV [114]. SiPMs maintain similar gains and speed to PMTs but have several advantages,
such as requiring 20-30 times less power than PMTs (achieves high gain with a very low bias
voltage of ~30 V), compact size, magnetic insensitivity, and higher photon detection efficiency
of 50-60% compared to 35% for PMTs [114,246]. Shorter recovery times of SiPMs can be
achieved with smaller microcells (lower fill factor), resulting in higher dynamic range and lower
capacitances, but is a compromise to lower photon detection efficiency and gain [114].

4.3 Spectroscopy: Energy Resolution and Detection Efficiency
Spectroscopic data analysis was performed using the ADMCA software on a PC, where
the MCA spectrum x-axis channels were calibrated to energy in units of keV. The energy
resolution of each detector was calculated as a percentage using equation 10 (Chapter 2).
As mentioned in Chapter 2 of this thesis, there are two common types of detector
efficiency: absolute detection efficiency and intrinsic detection efficiency. Counting efficiencies
can also be categorised by the nature of events recorded, namely peak detection efficiency and
total detection efficiency, the former being more commonly used. The peak detection efficiency
is given by the number of events under the full energy peak in a differential pulse height
spectrum divided by the number of radiation quanta emitted by the source. Total detection
efficiency is given by the total number of events under the entire differential pulse height
spectrum divided by the number of radiation quanta emitted by the source. In this study, the
intrinsic peak detection efficiency was calculated with:
𝜀

=

𝑁4𝜋
𝑆Ω

(13)
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where 𝑁 is the number of events in the full energy peak, 𝑆 is the number of radiation quanta
emitted by the source, and Ω ≅ 𝐴/𝑑 = 𝜋𝑎 /𝑑 (for d >> a) where 𝐴 is the detector area, 𝑎 is
the detector radius and 𝑑 is source-detector distance [66]. That is, 𝑁 is determined by the
number of events in the full energy peak taken from the differential pulse height spectrum
considering the photopeak intensity 𝐼𝜸 of which the number of events is true. The intensity
values used in the calculations for each source are presented in Table 9. 𝑆 is determined by the
activity of the source considering the duration of the measurement. The activity of the source at
the time of measurement can be determined with 𝐴(𝑡) = 𝐴(0)𝑒

/

where 𝐴(0) is the initial

activity, 𝑡 is the time since initial activity and 𝜏 is a decay constant whereby 𝜏 = 𝑇 / /𝑙𝑛2
where 𝑇 / is the radiation source half-life.
The detector thickness also governs the detection efficiency, since it relates to the
gamma ray attenuation within the detectors. Depending on the crystal thickness, gamma rays
can be partially or fully absorbed; a thicker crystal increases the probability of gamma ray
attenuation and full absorption which therefore increases the detection efficiency. For example,
for LaBr3(Ce) at 1 inch thickness, around 60% of 662 keV gamma rays are absorbed [247]. For
gamma rays of 4 MeV, the crystal thickness required to fully absorb the gamma ray would need
to be >30 cm, with only around 40% being absorbed for a thickness of 1 inch. The impact of
scintillator thickness should therefore be considered when comparing results in such
characterisation studies, particularly for detector efficiency.
For the energy resolution measurements, the radiation sources were positioned close to
the detectors (a few centimetres) while ensuring the dead time was still negligible, and the
spectra acquired for 5 minutes to obtain sufficient statistics. For the efficiency measurements,
the source-detector distance was 2 m; the distance between source and detector is an important
parameter in the calculations, such that the further the source the more accurate the calculation.
Table 13 presents the energy resolution and efficiency of each detector at the photopeak
energy of 662 keV. The energy resolution values recorded in this study agree within a factor of
two with those given in the literature [66,244,245]. In this thesis study, CLYC and LaBr 3(Ce)
were found to have the better energy resolution with values of 3.4% and 3.5%, respectively.
However, between the two, LaBr3(Ce) was seen to have the better efficiency; this could simply
be due to its thicker crystal of 1 inch, compared to the 1 cm thickness of CLYC. Yet the CLLBC
detectors of the same size as the LaBr3(Ce) have comparable energy resolutions but poorer
detection efficiency. Elpasolite detectors, such as CLYC and CLLBC, have the added advantage
of gamma-neutron discrimination capabilities, whereby differences in the scintillation decay
response/pulse shapes can be used to distinguish the two types of radiation [127,129,131].
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Decay times, rather than rise times, are conventionally used for pulse shape discrimination as it
is easier to measure.
Table 13: Energy resolution and detection efficiency at 662 keV, for each scintillator studied.
Uncertainties were calculated with reference to error propagation (see for example, Knoll (2000) [66]).
Scintillation detector

Energy resolution (%)

Detection efficiency

LaBr3(Ce)

3.5 ± 0.7

0.33 ± 0.02

LaCl3(Ce)

4.4 ± 0.8

0.15 ± 0.01

CeBr3

4.9 ± 0.9

0.30 ± 0.01

SrI2(Eu)

3.6 ± 0.7

0.04 ± 0.01

NaI(Tl)

6.3 ± 1.0

0.24 ± 0.01

CLYC

3.4 ± 0.7

0.06 ± 0.01

CLLBC376

3.8 ± 0.8

0.17 ± 0.01

CLLBC398

4.1 ± 0.8

0.21 ± 0.01

CLLBC406

3.7 ± 0.8

0.21 ± 0.01

CLLBC416

4.1 ± 0.8

0.19 ± 0.01

Figure 37: Intrinsic peak detection efficiency curves for each scintillator studied.

Figure 37 shows the intrinsic peak detection efficiency curves as a function of gamma
ray energy for each detector studied. As expected, an exponential trend is seen across the energy
range, such that at lower energies photoelectric absorption in the scintillator is dominant, where
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the full energy of the photons are absorbed, while at higher energies Compton scattering and
pair production are more probable. Although the CeBr3 detector has a larger crystal, the
detection efficiency is comparable (but slightly worse) than that of the LaBr 3(Ce) detector; yet
both are superior in detection efficiency relative to the other scintillators studied.

4.4 Discussion
In this work, the energy- and time-resolved capabilities of several scintillation detectors
were investigated to determine the most suitable for potential hybrid PG detection systems.
Hybrid PG detection systems utilising more than one characteristic of PG rays have the
potential to overcome present challenges and offer a simple technique for in vivo dosimetry. Yet
achieving simultaneous resolved detection and data acquisition is challenging.
The results in this study showed that the LaBr3(Ce) detector, without a built-in
preamplifier and coupled to a PMT, offered the fastest timing capabilites, having shorter signal
rise and decay times compared to the other detectors studied. Results also showed that LaBr 3(Ce)
and CLYC offered better energy resolution, with LaBr3(Ce) being the more efficient. Elpasolite
crystals, such as CLYC and CLLBC, have the added ability of gamma-neutron discrimination
via pulse shape differences between the two radiation types [127,129,131]. These scintillators
therefore have the potential for hybrid systems utilising PG energy and time information in
addition to simultaneous neutron discrimination. To the authors’ knowledge, these elpasolite
crystals have not yet been studied for the purpose of PG range monitoring in particle therapy.
In terms of efficiency, LaBr3(Ce) and CeBr3 were seen to be comparable but relatively
superior than the other scintillation detectors across the energy range. Although CeBr 3 has been
determined to be the best choice for PG timing measurements due to its fast response and
superior energy resolution [60,123], LaBr3(Ce) has been shown to be an adequate alternative,
with the best compromise between timing and energy resolution, and utilised in several PG
range verification studies [173,232], including the PGS measurements performed at MGH
[59,170].
In practice, the choice of detector should ideally exhibit excellent energy and timing
resolutions simultaneously, with superior efficiency for the high-energy PG rays. The data
acquisition system accompanying the detector should also be fast enough to allow timing
measurements that provide valuable data and real-time feedback. In addition, the overall
detection system should have the capability to cope with the beam time structure and accurately
synchronise with the accelerator RF; the bunch time spread is a key factor influencing the
resolution of PG timing measurements. A proton bunch monitor that measures the bunch time
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structure and potential phase drifts could be used to overcome these limitations. Highthroughput and high-efficient PG detector systems are desired for simultaneous energy- and
time-resolved PG measurements.
Future work investigating the scintillator performance for high-energy PG rays, through
measurements and in clinical conditions, as well as possible hybrid detector systems, will be
important as a means toward in vivo dosimetry for particle therapy QA.
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5 Simulating Prompt Gamma Rays for Clinical
Range Verification
Simulation tools are not only widely employed for the fundamental research concerning
PG ray physics and detection concepts, but they are also used clinically, and a PG method may
require comparing the obtained measurements with expected outcomes to determine deviations
from the prescribed treatment plan. Thus, it is important that the physics models and data in the
simulation are accurate and reliable for use in particle therapy beam range monitoring. In this
study, simulations were performed to determine the performance of physics models available in
Geant4/TOPAS for use in PG simulations. The simulation data were compared to measurements
performed in the pencil beam scanning treatment gantry at the Francis H. Burr Proton Therapy
Center, MGH, Boston USA. Preliminary measurements at MGH with the full-scale range
verification prototype using PGS was published in Hueso-González et al. (2018) [59]; this paper
should be referred to for details about the PGS detection system, measurements and data
analysis. This chapter provides an overview of relevant information from Ref. [59] (Sections
5.1-5.2) followed by my research work (Sections 5.3-5.4).
TOPAS was used to model the MGH PGS detection system, incident proton beam and
phantom. Simulation results were quantitatively compared with respect to the corresponding
experimental data obtained for a pencil beam spot. Two Geant4 physics lists (which are also
available in TOPAS), QGSP_BIC_HP and QGSP_BIC_AllHP, were investigated with Geant4
version 10.06.p01. Two phantom materials were explored, water and high-density polyethylene
(HDPE), to determine the simulation reproducibility for oxygen and carbon, respectively. The
same simulation was performed with Geant4 version 10.05.p01 for regression testing purposes.
Hence, this study is performed to offer recommendations to the scientific community for
simulating PG rays, which is a significant aspect in the current status of PG research, and
potentially in practice, for in vivo range/dose monitoring.

5.1 Experimental Set-up of the Prompt Gamma Detection System
The MGH proton therapy treatment facility housed an IBA C230 cyclotron (Ion Beam
Applications SA, Louvain-la-Neuve, Belgium) that accelerates protons to 230 MeV, which are
then degraded by an energy selection system and transported to the treatment room through a
~35 metre beam line. The RF of the cyclotron is 106.3 MHz. The beam current for
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all pencil beam layers is 2 nA incident on the phantom, which corresponds to approximately
100 protons per bunch every 9.4 ns. The reproducibility of the beam range in water is better
than 0.5 mm [59].
The PGS detection system consisted of eight LaBr3(Ce) scintillation crystals (50.8 mm
diameter, 76.2 mm length) coupled to a PMT and resting on a custom-built base. There were
two rows of four detectors, each focusing on a different position along the beam direction,
allowing for a larger field-of-view (FOV). The system was comprised of a tungsten collimator
configuration: five tungsten slabs (each 25.4 × 203.2 × 127.0 mm3 ± 0.5 mm) with a (12.7 ±
0.2) mm slit opening after the first and fourth slab (along the beam direction), and (6.4 ± 0.2)
mm slit opening after the second slab (see Figure 38), as well as an acrylic front plate and
aluminium aperture. The collimator spacing after the fourth slab was a trade-off between spatial
resolution and detector efficiency, while the spacing after the first and second slab allow for a
larger area of blocking background gamma rays (e.g. from the nozzle and range shifter) without
additional tungsten slabs (i.e. increasing the weight of the detector body). The system
(scintillators and electronics) can sustain high overall event rates of up to 107 events per second
[59].
Figure 38 shows the experimental set-up configuration used for cross section
optimisation measurements conducted by the MGH group. The PGS system remained in a fixed
position perpendicular to the beam incidence during treatment delivery. The distance from
isocentre (located centrally in the target volume) to the front face of the phantom (beam
incidence) was (124.0 ± 0.5) mm. The measurements were performed with a single high-dose
spot of 3×1010 protons delivered consecutively to 19 energy layers along the central beam axis.
That is, no merging of lateral spots was performed; this therefore allows a better comparison
with simulation results. Proton beam irradiation of water and HDPE phantoms were performed.
The proton beam ranged between (100 ± 1) mm and (150 ± 1) mm water equivalent depth. The
distance between isocentre and the collimator front plane was (150.0 ± 0.5) mm, including an
air gap of (100.0 ± 0.5) mm (between collimator and phantom) which is clinically realistic. The
reader is encouraged to see Ref. [59] for further details regarding the experimental set-up. For
the purpose of this thesis study, to compare simulation and measurement, a single pencil beam
spot in the most distal energy layer is used. Further details of the simulation modelling are given
in Section 5.3.
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Figure 38: Schematic diagrams showing the experimental set-up configuration for the water phantom
(left) and HDPE phantom (right). All units are in mm. The eight (two rows of four detectors) LaBr3(Ce)
detectors are 50.8 mm in diameter and 76.2 mm in length. The collimator consists of five tungsten slabs
(each 25.4 × 203.2 × 127.0 mm3 ± 0.5 mm) with a (12.7 ± 0.2) mm slit opening after the first and fourth
slab (along the beam direction), and (6.4 ± 0.2) mm slit opening after the second slab. For simplicity and
clarity, the front plate and aluminium aperture (between collimator and phantom) are omitted. The red
line indicates the proton pencil beam incidence on the phantom, and the centre of the target volume (red
dotted-square) represents the position of isocentre in the treatment room. The distance from isocentre to
the front face of the phantom was (124.0 ± 0.5) mm. The distance between isocentre and the collimator
front plane was (150.0 ± 0.5) mm, with an air gap of (100.0 ± 0.5) mm. Figures adapted from Ref. [59]
with permission.

5.2 Data Acquisition and Processing
The custom data acquisition system for the PGS detection system was synchronised
with the beam delivery system and the cyclotron. The signals from the detector modules were
independently read out with a 14-bit analog-to-digital converter that was phase-locked to the
accelerator at a frequency twice that of the cyclotron RF for a sampling rate of ~2.13×108
samples per second. The data streams were processed in real-time by field-programmable gate
arrays (FPGAs). An event was triggered when the digitised signal magnitude exceeded a
predefined threshold. Integrating the area under the pulse signal over a time window of 200 ns
was used to calculate the gamma ray energy. The gamma ray arrival time was determined by
subtracting a delayed copy of the digital signal from the original and finding the zero crossing
time of the resulting signal. The analysis of the arrival time was initially performed with a time
resolution equal to the sample rate, followed by a polynomial interpolation to achieve subnanosecond resolution [59].
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The acquired data were stored in a memory buffer that was continuously read out by the
control software (custom C++ application) which performed several corrections to normalise the
measurements to absolute units. Corrections included energy and time calibration, as well as
pile-up and coincidence rejection. The corrected data were then combined in energy vs time
histograms; two histograms were created for each proton pencil beam, i.e. one for each row of
four detectors. The measured 2D histograms were split into three components iteratively [59]:


proton-induced continuum, PG rays that undergo incoherent scattering in the detector or
have scattered prior to reaching the detector;



neutron-induced continuum, gamma rays that scatter before or inside the detector or
from unresolved cascades; and



resolved lines, whereby the continuum components (background) are subtracted from
the measured to give the neutron-induced and proton-induced spectrum.
See Ref. [59] for an example of such 2D histograms. The proton-induced continuum is

unresolved in energy but well-resolved in time, while the neutron-induced continuum is
unresolved in both dimensions, and the resolved lines spectrum is resolved in both energy and
time dimensions. The count rate in each detector was on the order of 106 events per second,
such that an energy resolution of 1.3% FWHM at 6.1 MeV was achieved. Due to several
sources of scatter such as the treatment head, phantom, couch, room walls and floor, half of the
detected gamma rays make up the background. A small fraction of neutron-induced gamma rays
are also produced in the collimator, but the majority of these will be re-absorbed internally [59].
In the PGS technique, the proton range for each pencil beam is determined by
comparing the intensity of measured PG emission lines in the gamma ray energy spectrum to
expected values obtained from a model. The model simulates the fundamental physical
processes (including nuclear interactions, attenuation and detector system response) and predicts
the PG emissions and detections. The PGS detection system geometry, CT to material
conversion, proton stopping, PG emission, gamma ray attenuation and detection made up the
model. Further details can be found in Ref. [59]. The reliability of such models/simulations is
therefore important. Hence, for the purpose of this thesis study, the performance of Monte Carlo
simulations was investigated, in particular, by comparing the intensity of simulated PG emission
lines with measured data.

5.3 Modelling of the Prompt Gamma Detection System
TOPAS version 3.3.p1_expanded was used with Geant4 version 10.06.p01 to model the
MGH PGS detection system, and proton beam irradiations of water and HDPE phantoms, as
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performed in the experimental measurements. The TOPAS version used at MGH had been
adapted to include the ParticleHP model (discussed later in this section).
Figure 39 shows an image of the simulation set-up with the water phantom. The same
set-up applies to the HDPE phantom (see Figure 38). The simulation application includes the
acrylic front plate and aluminium aperture of the collimator configuration. The water phantom
(“G4_WATER”, density of 1.0 g/cm3) was 406 × 200 × 200 mm3, including the acrylic
(C5O2H8, density of 1.19 g/cm3) tank walls and base. The HDPE phantom (C2H4, density of
0.955 g/cm3) was a 305 × 152 × 102 mm3 solid block. The proton pencil beam in the simulation
(and experiment) was incident on the phantom along the +x direction. In the simulation, the
source of particles is located on the beam axis 20 cm upstream from the phantom front surface.

Figure 39: TOPAS model of the MGH PGS detection system with the water phantom, based on the
experimental set-up. The proton beam is not to scale.

For the quantitative comparison between simulation and measurement, a single proton
pencil beam spot was considered; the spot in the simulation was the equivalent as in the
experiment in terms of beam parameters, incidental longitudinal and lateral position, as well as
beam range (80% distal dose fall-off). The proton beam was incident along the central axis of
the phantom in both model and experiment. The experimental proton beam range was (150 ± 1)
mm in the water phantom and (149 ± 1) mm in the HDPE phantom. The simulation proton
beam energies were tuned to obtain a simulated beam range within 1 mm agreement with the
experiments; beam energy of 149.0 MeV for the water phantom and 147.5 MeV for the HDPE
phantom. The number of simulated protons for the beam spot was 108 to obtain a 1% statistical
uncertainty in the simulation results. The physical quantity, subject of comparison between
simulation and experiment, was the absolute gamma ray counts per giga-protons (GP) (more
details are given in the next section).
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A TOPAS extension, written in C++, was included in the simulation framework to score
the gamma rays interacting in each of the detectors. Total gamma rays, proton-induced and
neutron-induced gamma rays were scored. The gamma ray energy deposition in the detector and
TOF were recorded. The TOF was calculated as the interval of time between the generation of
the proton beam to the gamma ray energy deposition in the detector. Optical photons, which
arise from scintillation, although measured in the experiment, were not modelled in the
simulation, and so the hypothesis is that all the optical photons were counted (reach the PMT
window). Experimentally, not all gamma rays were counted due to, for example, selecting
gamma rays between 1.4 and 7.2 MeV; this energy range of interest was thus also adopted to the
simulation analysis. Within this energy range, corrections were applied for dead time, energy
and time calibrations, pile-up and coincidence rejection, as discussed in Ref. [59]. A beam time
spread (𝜎) of 0.38 ns [248] was also incorporated into the simulation to more accurately mimic
the beam time structure of the proton therapy (accelerator) beam, such that the scoring of the
gamma rays resembled a 9.4 ns proton bunch time. That is, the IBA 230 cyclotron at the MGH
proton therapy centre has a RF of 106.3 MHz, and all pencil beam layers were delivered with
the standard clinical system at the full beam current of 2 nA incident on the phantom,
corresponding to a bunch of approximately 100 protons every 9.4 ns.
Simulation

results

using

the

Geant4

physics

lists

QGSP_BIC_HP

and

QGSP_BIC_AllHP were compared to investigate which physics approach was more accurate in
reproducing the PGS output (i.e. gamma ray energy spectra). In particular, the two physics lists
have the following features:


QGSP_BIC_HP is used for hadrons up to 200 MeV with the high precision neutron
(NeutronHP) data libraries used to model the neutron elastic and inelastic scattering, capture
and fission, below 20 MeV [249,250]. Hadronic inelastic scattering of primary protons and
neutrons on nucleons of the target nuclei is described by the Binary Intranuclear Cascade
(BIC) model below ~10 GeV [197]. Following the BIC, the Precompound model describes
the de-excitation of the remnant nucleus, followed by the Fermi breakup, neutron and light
ion evaporation and photon evaporation models [249]. The LightIonBinaryCascade
describes the intranuclear cascade of deuteron, triton, helium isotopes and heavier nuclei up
to 6 GeV/n [221,249].



QGSP_BIC_AllHP is identical to QGSP_BIC_HP but uses ParticleHP data libraries for
protons, deuterons, tritons, helium-3 and alpha particles below 200 MeV [249]. That is,
rather than using the Binary cascade model for these reactions, ParticleHP is used, which
uses only evaluated nuclear data, mostly derived from the TALYS-based Evaluated Nuclear
Data Library (TENDL) (i.e. TENDL-2014) with some isotopes from ENDF/B-VII.1 [251].
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Therefore, in comparing QGSP_BIC_HP and QGSP_BIC_AllHP, it is predominantly a
comparison between the Binary cascade and ParticleHP models.
The developers of Geant4 recommend the use of QGSP_BIC_HP for proton therapy
studies, and indicate that QGSP_BIC_AllHP is promising [221,249]. QGSP_BIC_HP was found
adequate for particle therapy studies in a recent benchmarking report by Arce et al. (2020) [221].
Hence, these physics lists were chosen to be studied in this work. While QGSP_BIC_HP has
been studied for many years for proton and carbon ion therapy [173,176,202,205,225,252],
QGSP_BIC_AllHP is a relatively new development and is worth to investigate its performance,
particularly for PG rays and particle therapy.
When using QGSP_BIC_HP, the modularised Geant4 physics modules included the
electromagnetic

physics

G4HadronElasticPhysicsHP

G4EmStandardPhysics_option4,
and

G4StoppingPhysics,

with

G4DecayPhysics,

G4IonBinaryCascadePhysics

modelling the final state of inelastic scattering. When using QGSP_BIC_AllHP, the modularised
modules G4EmStandardPhysics_option4, G4DecayPhysics, G4HadronElasticPhysicsPHP,
G4IonPhysicsPHP, G4IonElasticPhysics and G4StoppingPhysics were active in the physics list.

5.4 Comparison Study of Simulation and Experimental Results
The simulation data were quantitatively compared to measurements in terms of absolute
gamma ray counts per giga-protons (GP) for the two rows of detectors. The total gamma,
proton- and neutron-induced gamma ray counts were studied, as well as the 4.44 and 6.13 MeV
PG emission lines. The 2.22 MeV gamma ray line from neutron capture was also included to
study the neutron production in the simulation. The neutron-induced interference background
was also studied, in this case, by quantitatively comparing the simulated and measured count
per GP per MeV at 4.44 and 6.13 MeV.
In the measurement, the total count was taken as the total events recorded. The neutroninduced gamma count was taken as the background of the total count TOF histogram (counts vs
time), while the proton-induced gamma count was taken as the peak above this background
baseline. In other words, the neutron-induced counts do not include prompt neutron counts with
discrete energy lines. This results from the specific design of the Recursive Bisection Neutron
Subtraction (ReBiNS) algorithm applied to the experimental results; see Ref. [59] for details.
In the simulation, the total gamma count was taken as the total gamma rays recorded.
The total proton-induced count was retrieved from the TOF histogram of proton-induced
gamma rays with no background subtraction. The total neutron-induced count was taken as the

5 Simulating Prompt Gamma Rays for Clinical Range Verification

123

background count of the neutron-induced gamma energy spectrum, i.e. not including prompt
counts with discrete energy lines. The background from the simulations was retrieved using the
ROOT TSpectrum class reference [253]. For the aforementioned total counts, the integrals were
taken within the energy region 1.40-7.19 MeV, which is the same energy region of interest as in
the measurement.
For the PG emission lines, the proton-induced 4.44 and 6.13 MeV lines were retrieved
by subtracting the background of the proton-induced gamma energy spectrum and taking the
integral of a Gaussian fit of the respective peak. The neutron-induced 2.22 MeV count was
retrieved in the same manner.

5.4.1 Evaluating Geant4 Physics Lists: QGSP_BIC_HP and QGSP_BIC_AllHP
In this section, the simulation-measurement data comparison with the water phantom
using Geant4 version 10.06.p01 is presented. Figure 40 shows simulated energy spectra for total
gamma, proton- and neutron-induced gamma rays in detector row 1 obtained with the
QGSP_BIC_HP physics list. That is, as in Ref. [59], ‘detector row 0’ is labelled here as
detectors 0-3 and ‘detector row 1’ as detectors 4-7. The figure shows the proton- and neutroninduced components, which make up the total gamma spectrum. The prominent PG emission
lines at 2.31 MeV (14N*), 3.93 MeV (12C*), 4.44 MeV (12C*), 5.21 MeV (15O*), 5.62 MeV
(16O*) and 6.13 MeV (16O*) can be clearly seen. The 2.22 MeV line, arising from neutron
capture by hydrogen, is also present.

Figure 40: Simulated energy spectra of total gamma, proton- and neutron-induced gamma rays in
detector row 1 from the water phantom using Geant4 10.06.p01 and the QGSP_BIC_HP physics list.
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Figure 41 shows the energy spectra of proton-induced gamma rays in detector row 1
obtained from measurement and simulation using Geant4 physics lists QGSP_BIC_HP and
QGSP_BIC_AllHP. The measured spectrum clearly showed the gamma emission lines,
particularly the 3.93, 4.44, 5.21, 5.62 and 6.13 MeV lines. The relative intensities of measured
gamma emission lines seemed to agree with evaluated nuclear cross section data [230], such
that the intensity of lines from 16O are larger than those from 12C, followed by that from 15O. A
peak at 2.22 MeV from neutron capture remained present in the measured spectrum, since only
the neutron continuum was subtracted from the measured data, such that the neutron discrete
lines (energy resolved) were stored in the same histogram as the proton discrete lines. The use
of the PG ray timing information was utilised in the PGS technique to reduce the interference of
neutron-induced gamma rays, as discussed in Sections 5.2 and 5.4. Due to the dominating 2.22
MeV peak, the 2.31 MeV PG peak was barely visible in the measured spectrum, but could be
seen in the simulated (using QGSP_BIC_HP) spectrum.
The simulated spectrum obtained with QGSP_BIC_HP (Binary cascade) showed good
agreement with the 3.93 and 4.44 MeV peaks, but significant underestimation of the higher
energy PG emission lines, and slight overestimation of the lower energy region in the spectrum.
The QGSP_BIC_AllHP (ParticleHP) physics list showed an overall better base shape agreement
with the measured spectrum across the energy range, but does not reproduce the PG emission
lines. Further developments are still being made for ParticleHP, with some reactions not fully
described due to limited evaluated data or incomplete implementation of the model [250], and
QGSP_BIC_AllHP still needs extensive validation.

Figure 41: Energy spectra of proton-induced gamma rays in detector row 1 from the water phantom. The
measured spectrum is shown with the simulated spectra using Geant4 (10.06.p01) physics lists
QGSP_BIC_HP and QGSP_BIC_AllHP.
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Figure 42 shows the measured and simulated neutron-induced gamma ray background
curves from the water phantom for detector row 1, which indicate the contribution of neutron
interference to the PG signal. The simulated background was seen to be significantly lower than
the measured background. The simulated Count/GP/MeV around 4.44 MeV (1 MeV window)
was a factor of ~5 lower than the measured count with QGSP_BIC_HP and factor of ~7 with
QGSP_BIC_AllHP, while around 6.13 MeV (1 MeV window) the simulated count was a factor
of ~5 and ~6 lower than the measured with QGSP_BIC_HP and QGSP_BIC_AllHP,
respectively. The insert in the figure shows the measured data at 20%, to identify a possible
correlation in the trend with the simulated plots; the largest differences were seen below ~3
MeV. These discrepancies should be further investigated, but may be due to sources of neutrons
and neutron scatter that have not been taken into account in the simulation, as well as biases in
the subtraction algorithms applied to the data (the measured data were obtained with an
empirical background subtraction algorithm, such that changing the parameters may result in
variations of the data).

Figure 42: Measured and simulated neutron-induced gamma ray background curves for detector row 1
from the water phantom. The simulated plots were obtained using Geant4 (10.06.p01) physics lists
QGSP_BIC_HP and QGSP_BIC_AllHP. The insert shows the measured plot at 20%, to identify a
possible correlation in the trend with the simulated plots.

Table 14 presents the quantitative data of the total gamma, proton- and neutron-induced
gamma counts, comparing simulated with measured values. The total proton-induced gamma
count obtained from the simulation showed good agreement with the measured value; within a
factor of two different. Since rounding of the yields were done only taking into account
statistical errors, and there are additional systematic errors on the measurements (due to bias in
the background subtraction algorithm, etc) and in the simulation (uncertainties in the yields,
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differences among the physics lists, etc), the factor of two different is considered a reasonable
result. In contrast to the total proton-induced count, the total neutron-induced gamma count
exhibits a greater discrepancy between simulated and measured results, underestimating the
measured value within a factor of 10 different. The total gamma count was reproduced by the
simulation within a factor of four, with the divergence perhaps due to the discrepancy in the
neutron-induced count. Moreover, summing the proton- and neutron-induced gamma counts in
Table 14 (also Tables 16 and 18) do not exactly add up to the total gamma counts since, as
mentioned, the total neutron-induced gamma ray count does not include prompt neutron counts
with discrete energy lines.
Comparing the two Geant4 physics lists quantitatively, QGSP_BIC_HP was seen to
deliver a better outcome. This may be due to QGSP_BIC_HP producing the gamma ray
emission lines, whereas QGSP_BIC_AllHP does not, as seen in Figure 41. For example, for
detector row 1, the simulated total proton-induced count is a factor of ~1.1 different to the
measured count, while for QGSP_BIC_AllHP is a factor of ~1.4 different.
Table 14: Total gamma, proton- and neutron-induced gamma counts in the energy range of 1.40-7.19
MeV per giga-proton (GP) in the detector rows, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the water phantom. The total neutroninduced count was taken as the background (it does not include prompt counts with discrete energy lines).
Rounding of the counts was done only taking into account statistical errors.

Data

Detector row

Total gamma
count per GP

Proton-induced
gamma count per
GP

Neutron-induced
gamma count per
GP

QGSP_BIC_HP

0

41000

26100

10500

QGSP_BIC_AllHP

0

35300

21900

9700

Measured

0

113600

32000

81500

QGSP_BIC_HP

1

92100

63600

18000

QGSP_BIC_AllHP

1

78400

52200

15300

Measured

1

162300

70600

91700

Table 15 presents the quantitative data of the gamma ray energy spectra peak intensities,
comparing simulated with measured values. Binary cascade reproduced the proton-induced 4.44
MeV PG emission line quite well (within a factor of ~1.5 for detector row 0, and ~1.1 for row 1),
while significantly underestimating the 6.13 MeV PG peak (factor of ~15 for detector row 0,
and ~4 for row 1). The proton-induced counts for QGSP_BIC_AllHP are omitted in Table 15,
since this physics list does not reproduce the PG emission lines.
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Both physics lists reproduce the neutron-induced 2.22 MeV line within a factor of two
different to the measured data; NeutronHP data libraries are included in the modules to
accurately model neutron interactions from thermal energies up to 20 MeV. As mentioned,
experimentally, the measured data were obtained with an empirical background subtraction
algorithm, such that changing the background subtraction parameters may result in slight
variations in the measured data, and therefore may slightly bias the comparison.
Table 15: Absolute counts per giga-proton (GP) for the proton-induced 4.44 and 6.13 MeV PG peaks,
and the neutron-induced 2.22 MeV peak, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the water phantom. The proton-induced
counts from QGSP_BIC_AllHP are omitted since this physics list does not reproduce those PG emission
lines. Rounding of the counts was done only taking into account statistical errors.

Data

Detector row

Proton-induced gamma
count per GP

Neutron-induced gamma
count per GP

4.44

6.13

2.22

QGSP_BIC_HP

0

200

30

1690

QGSP_BIC_AllHP

0

-

-

1650

Measured

0

300

460

1380

QGSP_BIC_HP

1

990

320

4340

QGSP_BIC_AllHP

1

-

-

4170

Measured

1

1100

1160

3120

5.4.2 Evaluating the Reproducibility of Oxygen and Carbon: Water and HDPE
Here, the simulation-measurement data comparison for the HDPE phantom using
Geant4 version 10.06.p01 is presented. Water is comprised of hydrogen and oxygen, while
HDPE contains hydrogen and carbon, and so the ability for Monte Carlo to reproduce PG
emission from oxygen and carbon elements can be investigated.
Figure 43 shows the energy spectra of proton-induced gamma rays in detector row 1
obtained from measurement and simulation. The measured spectra showed the gamma emission
lines, particularly the 3.42, 3.93 and 4.44 MeV lines from 12C*. The 5.21, 5.62 and 6.13 MeV
peaks that arise from oxygen, and were evident in the energy spectrum from the water phantom
(Figure 41), do not appear in this spectrum since HDPE is not comprised of oxygen. The
simulated spectra obtained with both physics lists showed relatively good agreement to the
measured spectrum outside the region of the PG peaks (i.e. ~3-5 MeV), while QGSP_BIC_HP
significantly underestimates the PG emission lines. In contrast, the 3.42, 3.93 and 4.44 MeV
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peaks were reproduced quite well in the water phantom, from which the carbon nuclei were
produced from proton reactions with oxygen. This may suggest that simulated gamma emissions
from oxygen are more reliable than those from carbon, but for energies below ~5 MeV, since
those above ~5 MeV were also underestimated for the case of the water phantom.

Figure 43: Energy spectra of proton-induced gamma rays in detector row 1 from the HDPE phantom. The
measured spectrum is shown with the simulated spectra using Geant4 (10.06.p01) physics lists
QGSP_BIC_HP and QGSP_BIC_AllHP.

Figure 44 shows the measured and simulated neutron-induced gamma ray background
curves from the HDPE phantom for detector row 1. The insert in the figure shows the measured
data at 20%. Both magnitude and trend of the simulated plots differ significantly to the
measured. The simulated Count/GP/MeV around 4.44 MeV (1 MeV window) was a factor of ~8
lower than the measured count with both physics lists, while around 6.13 MeV (1 MeV window)
the simulated count was a factor of ~9 and ~13 lower than the measured with QGSP_BIC_HP
and QGSP_BIC_AllHP, respectively. The largest differences in the trend of the curves were
seen below ~3 MeV and around 5 MeV.
Tables 16 and 17 present the quantitative data of the total counts, and the gamma ray
energy spectra peak intensities, comparing simulated with measured values. Similar to the data
from the water phantom, the simulated total gamma count was seen to be within a factor of four
different to the measured count, the total proton-induced count was within a factor of two
different, and the total neutron-induced count within a factor of 10 different. The protoninduced 4.44 MeV PG line obtained with QGSP_BIC_HP was within a factor of ~4.5 different
to the measured count, which is a larger discrepancy than that for the water phantom (factor of
~1.5 different). As for the water phantom, the 2.22 MeV neutron-induced counts were seen to
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be within a factor of two different. Again, the proton-induced counts for QGSP_BIC_AllHP are
omitted in Table 17.

Figure 44: Measured and simulated neutron-induced gamma ray background curves for detector row 1
from the HDPE phantom. The simulated plots were obtained using Geant4 (10.06.p01) physics lists
QGSP_BIC_HP and QGSP_BIC_AllHP. The insert shows the measured plot at 20%, to identify a
possible correlation in the trend with the simulated plots.

Table 16: Total gamma, proton- and neutron-induced gamma counts in the energy range of 1.40-7.19
MeV per giga-proton (GP) in the detector rows, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the HDPE phantom. The total neutroninduced count was taken as the background (it does not include prompt counts with discrete energy lines).
Rounding of the counts was done only taking into account statistical errors.

Data

Detector row

Total gamma
count per GP

Proton-induced
gamma count per
GP

Neutron-induced
gamma count per
GP

QGSP_BIC_HP

0

24800

15100

6800

QGSP_BIC_AllHP

0

21500

12900

6600

Measured

0

74700

13500

61200

QGSP_BIC_HP

1

43600

28200

10100

QGSP_BIC_AllHP

1

41300

27500

9000

Measured

1

97800

33200

64700
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Table 17: Absolute counts per giga-proton (GP) for the proton-induced 4.44 and 6.13 MeV PG peaks,
and the neutron-induced 2.22 MeV peak, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the HDPE phantom. The proton-induced
counts from QGSP_BIC_AllHP are omitted since this physics list does not reproduce those PG emission
lines. Rounding of the counts was done only taking into account statistical errors.

Data

Detector row

Proton-induced gamma
count per GP

Neutron-induced gamma
count per GP

4.44

2.22

QGSP_BIC_HP

0

140

820

QGSP_BIC_AllHP

0

-

590

Measured

0

610

880

QGSP_BIC_HP

1

670

1950

QGSP_BIC_AllHP

1

-

1650

Measured

1

2130

2270

5.4.3 Comparison of Geant4 Versions: 10.05.p01 and 10.06.p01
In a study to determine the variation of outcomes from two different versions of Geant4,
simulations were performed with the QGSP_BIC_HP physics list and with the water phantom.
Figure 45 shows the proton-induced gamma ray energy spectra from Geant4 10.05.p01 and
10.06.p01 with QGSP_BIC_HP physics list, along with the measured spectrum for comparison.
In the lower energy region of the spectrum (below ~3.3 MeV), version 10.05.p01 was seen to
better reproduce the measured data, where 10.06.p01 slightly overestimates. Both Geant4
versions reproduced the 3.93 and 4.44 MeV emission lines well, but significantly underestimate
the higher energy PG lines (above ~4.5 MeV).
Tables 18 and 19 present the quantitative data of the total counts, and the gamma ray
energy spectra peak intensities, comparing simulated with measured values. The Geant4 version
10.05.p01 reproduced the measured total gamma count within a factor of ~3.3, whereas
10.06.p01 reproduced the count within a factor of ~2.8. The total proton-induced count was
reproduced better with 10.06.p01 than 10.05.p01, such that differences to the measured count
were within a factor of ~1.2 and ~1.6, respectively. Both versions of Geant4 resulted in
significant, within a factor of 10, underestimation of the total neutron-induced count. The
proton-induced 4.44 MeV PG line was reproduced quite well by both versions, within a factor
of ~1.3 with 10.05.p01 and ~1.5 with 10.06.p01, while the 6.13 MeV PG line was significantly
underestimated. Again, the neutron-induced 2.22 MeV gamma line was within a factor of two
different to the measured count.
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Figure 45: Energy spectra of proton-induced gamma rays in detector row 1 from the water phantom,
using Geant4 versions 10.06.p01 and 10.05.p01 with the QGSP_BIC_HP physics list. The measured
spectrum is also included for comparison.

Table 18: Total gamma, proton- and neutron-induced gamma counts in the energy range of 1.40-7.19
MeV per giga-proton (GP) in the detector rows, obtained with Geant4 (10.05.p01) QGSP_BIC_HP
physics list, from proton beam irradiation of the water phantom. The total neutron-induced count was
taken as the background (it does not include prompt counts with discrete energy lines). Rounding of the
counts was done only taking into account statistical errors. Data from version 10.06.p01 (Table 14) are
also added for comparison.

Data

Detector row

Total gamma
count per GP

Proton-induced
gamma count per
GP

Neutron-induced
gamma count per
GP

10.05.p01

0

34000

20600

9500

10.06.p01

0

41000

26100

10500

Measured

0

113600

32000

81500

10.05.p01

1

73100

47200

16000

10.06.p01

1

92100

63600

18000

Measured

1

162300

70600

91700
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Table 19: Absolute counts per giga-proton (GP) for the proton-induced 4.44 and 6.13 MeV PG peaks,
and the neutron-induced 2.22 MeV peak, obtained with Geant4 (10.05.p01) QGSP_BIC_HP physics list,
from proton beam irradiation of the water phantom. Rounding of the counts was done only taking into
account statistical errors. Data from version 10.06.p01 (Table 15) are also added for comparison.

Data

Detector row

Proton-induced gamma
count per GP

Neutron-induced gamma
count per GP

4.44

6.13

2.22

10.05.p01

0

270

10

1560

10.06.p01

0

200

30

1690

Measured

0

300

460

1380

10.05.p01

1

1390

120

4090

10.06.p01

1

990

320

4340

Measured

1

1100

1160

3120

5.5 Discussion
In this study, TOPAS was used to model the MGH PGS detection system, proton beam
and phantom. Simulated and measured data were quantitatively compared in terms of the
intensity of selected gamma emission peaks to determine the performance of Monte Carlo codes
for PG ray simulations. ParticleHP showed an overall better base shape agreement with the
measured proton-induced gamma ray spectrum across the energy range of interest (1-7 MeV),
but it does not reproduce the PG emission lines. Binary cascade, although underestimated the
PG emission lines above ~5 MeV, reproduced the 4.44 MeV PG line within a factor of ~1.1 (for
detector row 1, from the water phantom). QGSP_BIC_AllHP is an experimental physics list
which requires further work and validations, unlike QGSP_BIC_HP which has been developed
and validated extensively. Some reactions are not fully described in ParticleHP due to limited
evaluated data and implementation of the model is incomplete [250]. With further developments
and improvements, ParticleHP could potentially be a suitable choice for simulating PG rays and
associated detection systems. In the meantime, Binary cascade is a suitable choice, as it
reproduces the gamma emission intensities around 4 MeV well, but for higher energy emissions
the models need further improvement.
The simulated gamma ray energy spectra also showed characteristic differences
between the water and HDPE phantoms. Data from the water phantom showed a better
quantitative correlation, particularly in terms of the proton-induced PG emission line intensities.
For example, the 4.44 MeV PG line obtained with QGSP_BIC_HP was within a factor of ~1.5
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different to the measured count for the water phantom, and factor of ~4.5 different for the
HDPE phantom. The 3.42, 3.93 and 4.44 MeV gamma ray peaks from 12C* were present in the
spectra from both phantoms and reproduced better for the water phantom (see Figure 41) than
the HDPE phantom (see Figure 43). This may suggest that gamma emissions from oxygen are
more reliably reproduced than those from carbon. With further improvements to the models to
achieve superior reproducibility of simulated to measured data, the composition of irradiated
tissue could be predicted prior to measurement by means of PG spectroscopy.
Additionally, Geant4 versions 10.05.p01 and 10.06.p01 were compared for the case of
the water phantom to observe the differences between various versions of the Monte Carlo
toolkit. The main variation between the two versions was seen at energies below ~3.3 MeV and
above ~4.5 MeV, while the simulated intensities of PG rays around 4 MeV were in good
agreement with the measurement. That is, the 4.44 MeV PG line agreed with the measured data
within a factor of ~1.3 with version 10.05.p01 and ~1.5 with 10.06.p01. These variations may
be due to differences in the nuclear reaction data of the particular version, such that the
parameters of models used to calculate the nuclear cross sections are generally tuned for
different releases of Geant4.
High precision (HP) physics modules accurately model neutron interactions from
thermal energies up to around 20 MeV. In this study, the simulation was seen to overestimate
the 2.22 MeV neutron capture gamma ray peak from proton irradiation of the water phantom,
within a factor of two different to the measured value, but significantly underestimate (within a
factor of 10) the total neutron-induced gamma count. Generally, the number of neutrons
captured in the target will be dependent on the energy distribution of created neutrons produced
by the model, as well as the angular distribution and scattering accuracy of the models. The
neutron-induced gamma count then depends on the accuracy of the PG distributions when the
nucleus de-excites. Another factor to consider in modelling PG detection systems is the
contribution of neutrons in an unwanted background gamma signal. In particle therapy, there are
several sources of neutron production and scatter: components of the gantry, collimator,
phantom, patient table, floor and walls, etc.
A simulation was performed testing the theory that the absence of the treatment room
walls may play a role in the discrepancies seen for neutron-induced counts between simulated
and measured data. The MGH treatment room walls [254] were modelled as concrete, taken as
the NIST composition, density of 2.3 g/cm3, as also used in Ref. [255]. The simulation retrieved
the neutron-induced counts from the water phantom, with Geant4 version 10.06.p01 and
QGSP_BIC_HP physics list. The data were compared to the case in which the treatment room
walls were not modelled (Tables 14-15), and it was found that the data differed within 3% only.
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This suggests that perhaps the treatment room walls have a minor impact on the background
signal arising from neutrons, whereas a greater impact may be present from other sources of
neutrons/scatter that are in closer proximity to the detection system, particularly the beam
delivery nozzle, collimator and phantom. Hence, future PG simulations may benefit from taking
into account these close-distance sources of neutrons and neutron scatter, to more accurately
determine the influence on the PG signal.
It should also be noted that the results shown in this study only apply to the TOPAS and
Geant4 versions studied. That is, depending on which version of Geant4 is used, the results can
vary significantly, particularly for nuclear reaction data, as this is a domain of on-going
improvement in Geant4. As well, rounding of the yields was done only taking into account
statistical errors. Yet there are additional systematic errors on the experimental measurements
(due to bias in the background subtraction algorithm, etc) and in the simulations (uncertainties
in the yields, differences among the physics lists, etc).
The MGH PGS prototype detection system has demonstrated that hybrid PG detection
from simultaneous energy- and time-resolved spectral measurements can provide superior beam
range verification in realistic clinical conditions [59]. The remaining challenges are to explore
clinical integration with treatment systems and practices.
In practice, Monte Carlo simulations could be used to generate PG distributions for real
patient data obtained from CT scans of the patient, such that the PG data would be integrated
into the TPS. The detection system would also be modelled, including the geometry and
composition of the scintillators, collimators (if employed), etc, to predict the PG ray detection.
Deviations from the prescribed treatment plan could then be determined by comparing the
measured PG data with pre-calculated ones. Yet, this implies that the Monte Carlo codes
providing the reference are indeed accurate. Although the PG energy lines are modelled well,
the yields require further improvements. As seen in this study, simulated PG emission peak
intensities as well as the background neutron contributions varied significantly from the
measured data. Hence, the nuclear models and cross section data need improvement, with
experimental data and extensive validations. Modelling the full treatment room could offer a
better indication of the background contributions, but this may lead to long compute times.
Accelerated Monte Carlo simulations are beneficial for the high patient throughput and realtime monitoring. Overcoming these limitations could see Monte Carlo codes advancing PG ray
beam monitoring in clinical applications, by having a solid reference for comparing the
measured data, and fast data analysis for real-time treatment delivery verification.
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Conclusion
The research effort of this thesis was focused on PG detection methodology and
technology from in vivo range verification towards non-invasive in vivo dosimetry for highprecision charged particle therapy. The ultimate goal is to pave an effective pathway in the
development of clinically applicable and reliable PG detectors and procedures, which can
further improve cancer treatment precision and release the full clinical efficacy of particle
therapy. Three major aspects were investigated in this work: (i) systematic simulation studies of
PG emission and detection characteristics in energy, space and time dimensions (Chapter 3).
This has led to a proposal for hybrid PG detection to utilise multi-features of PG characteristics
for enhanced beam range extraction. (ii) Characterisation of commercially available advanced
scintillation crystals to explore suitable high-performance detectors for energy- and timeresolved PG ray measurements towards potential hybrid PG detection systems (Chapter 4). (iii)
Evaluation of the performance of Geant4-based Monte Carlo simulation predictions with the
experimental data from MGH’s PGS system (Chapter 5). This was the first comprehensive
evaluation study regarding the PG signal along with interference backgrounds in a realistic
clinical condition. This work provides valuable information on Geant4 physics capability to
investigate PG detection systems and predict outcomes for comparison to measured data to
determine deviations from the prescribed treatment plan.
The PG emission characteristics from water, PMMA and adipose tissue targets, in either
sphere or cylinder phantoms irradiated with three different particle types (proton, 4He and 12C)
of varying beam energies, have been investigated using Geant4 simulations and presented in
Chapter 3 of this thesis. The PG production yield, energy spectral characteristics and spatial
correlation with the BP have been quantified [217,231]. The results of this work showed that the
PG signal is a reliable means for in vivo BP tracking in particle therapy, particularly the primary
PG rays generated from the incident particles. In this case, the closest correlation between the
PG emission yield and particle beam range was found. The characteristic energy and spatial PG
emission results for proton and carbon ion beams agreed with prior published results
[57,140,150]. However, the concurrent secondary PG rays may impose a greater challenge for
BP tracking in heavy-ion therapy, such as carbon ions, where secondary PG rays become
dominant. The effects of target inhomogeneities were seen on the PG production distribution in
relation to the beam crossing the various materials of the phantom, but the quantitative data
shows that the PG-BP fall-off correlation is consistent for heterogeneous targets as well as
homogeneous ones.

Conclusion

136

The detectable PG characteristics have been investigated by virtue of an air-filled
idealised detecting sphere encompassing the phantoms. The spatial and temporal properties
regarding PG propagation to the detecting sphere have been characterised with changing beam
ranges. Several important points were found in this study:
(i)

Energy- and time-resolved PG detections would be essential for high-precision BP
tracking. The PG time properties can be utilised not only for interference
background rejection but also for beam range extraction. The PG TOF encodes the
essential information of the beam range but needs high time resolution
measurements to retrieve it.

(ii) A non-isotropic longitudinal distribution of the detected PG rays was observed and
showed a changing angular propagation distribution with beam energy. This may
suggest that a movable PG detector coordinated with respect to the beam range
could serve to optimise the detection efficiency of PG rays.
(iii) The geometric size and shape of phantoms also exhibit a considerable effect on the
angular distribution. This indicates that the attenuation, absorption and scatter of
PG rays inside the phantom are factors which should be taken into account in the
development of quantitative in vivo range and dosimetry verifications.
(iv) Hybrid PG detection systems, to utilise the energy, timing and spatial
characteristics of PG rays, is highly desirable for BP tracking in real-time.
This work has provided a solid basis for further PG system design.
The energy- and time-resolved spectroscopy capabilities of several scintillation
detectors were also characterised in this work to determine a suitable choice for high-throughput
and highly efficient hybrid PG ray systems. Presented in Chapter 4 of this thesis, LaBr 3(Ce),
LaCl3(Ce), NaI(Tl), CeBr3, SrI2(Eu), CLYC and CLLBC scintillators were studied in terms of
rise/decay times, energy resolution and intrinsic peak detection efficiency. LaBr3(Ce) and
LaCl3(Ce) scintillators were coupled to a PMT, whereas the others were coupled to a SiPM,
while LaBr3(Ce) and LaCl3(Ce) were also studied with and without a built-in charge sensitive
preamplifier. Comparable traits were seen when using a PMT or SiPM, and the inclusion or
absence of a preamplifier. Although the preamplifier is generally best suited for spectroscopy
applications and to improve the system energy resolution, this study showed that its inclusion
worsens the timing properties. Yet it is crucial that, for hybrid PG detection systems, both
energy and timing capabilities are optimised without a trade-off between the two features. The
results in this work could therefore offer beneficial information for the development of hybrid
PG detection systems.
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The results showed that LaBr3(Ce), without a built-in charge sensitive preamplifier, is
an excellent choice for PG measurements due to its superior timing (34 ns rise time and 790 ns
decay time) and energy resolution (3.5% at 662 keV). Other studies have also shown the
potential of LaBr3(Ce), which has been utilised in several PG beam range verification studies
[173,232], including the PGS measurements performed at MGH [59,170]. Furthermore,
elpasolite crystals such as CLYC and CLLBC have not yet been studied for the purpose of
range monitoring in particle therapy using PG rays. They have the added ability of gammaneutron discrimination, and therefore have the potential for hybrid systems utilising PG energy
and time information in addition to simultaneous neutron discrimination. CLLBC detectors of
various sizes were also studied, and it was seen that those of smaller crystal size produced a
faster signal compared to those with larger crystal. Among those studied, CLYC was also seen
to offer a good energy resolution of 3.4% at 662 keV.
A comparison study between simulated and measured gamma emission peak intensities
was carried out to determine the performance of Monte Carlo codes for PG ray simulations in
research and clinical applications. This study is presented in Chapter 5 of this thesis. TOPAS
was used to model the MGH PGS detection system, proton beam and phantom. Two Geant4
physics lists, QGSP_BIC_HP and QGSP_BIC_AllHP, were investigated with Geant4 version
10.06.p01. Two phantom materials, water and HDPE, were also explored to determine the
simulation reproducibility for oxygen and carbon elements, respectively. The simulations were
repeated for Geant4 version 10.05.p01 for regression testing purposes. The total gamma, protonand neutron-induced counts, as well as PG emission lines 4.44 and 6.13 MeV, were analysed
and quantitatively compared for a specific proton pencil beam spot.
Several important points are highlighted from this study:
(i)

The QGSP_BIC_HP physics list underestimates the higher energy (above ~5
MeV) PG emission lines, whereas QGSP_BIC_AllHP showed an overall better
base shape agreement across the energy spectrum but does not reproduce the
PG emission peaks. Therefore, this work showed that QGSP_BIC_HP is
currently more suitable, as it reproduces the gamma emission intensities around
4 MeV quite well, e.g. the 4.44 MeV PG line agreed with the measured count
within a factor of two for the case of the water phantom, but for higher energy
emissions the models need further improvement.

(ii)

Data from the water phantom showed a better quantitative correlation,
particularly in terms of the proton-induced PG emission line intensities. This
may suggest that simulated gamma emissions from oxygen are more reliably
reproduced than those from carbon. Also, simulated gamma ray energy spectra
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showed characteristic differences between water and HDPE; with further
improvements to the models, the composition of irradiated tissue could be
predicted and determined by means of PG spectroscopy.
(iii)

The simulation overestimated the 2.22 MeV neutron capture peak in the gamma
energy spectra from the water phantom within a factor of two compared with
the measured data, but significantly underestimated (within a factor of 10) the
total neutron-induced gamma count. This may be due to various factors,
including sources of neutrons and unwanted background signal. Yet a
difference of only 3% in the neutron-induced counts was seen when comparing
simulated data with and without modelling the MGH treatment room walls.
This suggests that future PG ray simulations may benefit from taking into
account potential neutron sources in closer proximity to the measuring device,
to more accurately predict the PG signal.

(iv)

The comparison of the simulation results obtained with Geant4 versions
10.05.p01 and 10.06.p01 showed differences at energies below ~3.3 MeV and
above ~4.5 MeV, while the simulated intensities of PG rays around 4 MeV
were in good agreement with the measurement. That is, the 4.44 MeV PG line
agreed with the measured data within a factor of ~1.3 with version 10.05.p01
and ~1.5 with 10.06.p01. Thus, simulation results can greatly depend on the
Geant4 version utilised and it is therefore recommended to perform regression
testing on some physical observables among different versions of Geant4,
including the latest one.

The novelty of this project is such that it combines several areas of research to improve
the PG detection methodology, detector technology and simulation resources for non-invasive
real-time beam range monitoring in particle therapy. The characteristic properties of PG
emission and detection have been investigated for not only proton and carbon beam irradiation,
but also helium ions for which the PG distributions have not yet been widely studied. The
results showed that there is the opportunity to optimise the strategy for PG detection and
improve image formation with optimal energy, angular and TOF windows. Hence, combining
space, energy and time methods could be utilised to improve the PG signal for range/dose
monitoring. As well, several scintillators were characterised in terms of energy and timing
properties for potential hybrid PG systems. To the authors’ knowledge, elpasolite scintillation
crystals have not yet been studied for the purpose of PG range monitoring in particle therapy,
and therefore the results obtained here could also be beneficial to other groups. Moreover, a
quantitative comparison study of Monte Carlo simulation data with experimental measurements
conducted in a particle therapy facility was performed. Binary cascade was seen to reproduce
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the measured data well, but the models need further improvement, particularly if PG
spectroscopy is to be utilised for determining target material compositions, and in turn,
exploited for in vivo dosimetry.
The PGS prototype detection system developed at MGH demonstrates the possibility of
hybrid PG detection from simultaneous energy- and time-resolved spectral measurements with
clinical proton beams, but challenges remain for its integration with clinical treatment systems
and practices. As well, utilising both energy and time characteristics for the purpose of range
verification, in addition to neutron background rejection, is worth further exploration. Superior
detectors and data acquisition offering excellent energy and time resolutions simultaneously are
desired, as well as the ability to cope with the beam time structure and accurately synchronise
with the accelerator RF. Reliable Monte Carlo codes are also important, as they would provide
the reference for which the measured data would be compared. The PG data and detection
system would be incorporated into the TPS to obtain the predicted outcomes, with accelerated
simulations beneficial for the high patient throughput and real-time monitoring. Yet the nuclear
models and cross section data require further improvement, with experimental data and
extensive validations.
Hence, this thesis work will aid in developing optimal PG detection strategies and
support the implementation of clinically feasible PG systems for improving cancer treatment
QA. Further studies investigating the scintillator performance for high-energy PG rays through
measurements, and in clinical conditions, will be valuable for the development of highresolution and high-performance novel detector systems with fast electronics and highthroughput processing. Future work will focus on the acquisition system and implementation of
a hybrid PG detection system that utilises the energy- and time-resolved information, which is
desirable and has strong potential for in vivo dosimetry during particle therapy.
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Appendix 1 – Previous Publication
In Chapter 3, I referred to my previous publication, Zarifi et al. (2017) [231], which I
include here for reference.
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